0001493152-18-005063.txt : 20180412 0001493152-18-005063.hdr.sgml : 20180412 20180412080125 ACCESSION NUMBER: 0001493152-18-005063 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 58 CONFORMED PERIOD OF REPORT: 20180228 FILED AS OF DATE: 20180412 DATE AS OF CHANGE: 20180412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novo Integrated Sciences, Inc. CENTRAL INDEX KEY: 0001138978 STANDARD INDUSTRIAL CLASSIFICATION: ENGINES & TURBINES [3510] IRS NUMBER: 593691650 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-109118 FILM NUMBER: 18751182 BUSINESS ADDRESS: STREET 1: 11120 NE 2ND STREET STREET 2: SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: (206) 617-9797 MAIL ADDRESS: STREET 1: 11120 NE 2ND STREET STREET 2: SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 FORMER COMPANY: FORMER CONFORMED NAME: TURBINE TRUCK ENGINES INC DATE OF NAME CHANGE: 20010420 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2018

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______, 20___, to _____, 20___.

Commission File Number 333-109118

Novo Integrated Sciences, Inc.

(Exact Name of Registrant as Specified in its Charter)

Nevada		59-3691650
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification Number)

11120 NE 2nd Street, Suite 200 Bellevue, Washington		98004
(Address of Principal Executive Offices)		(Zip Code)

(206) 617-9797

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former name or former address, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “accelerated filer,” “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	[ ]	Accelerated filer	[ ]
Non-accelerated filer	[ ]	Smaller reporting company	[X]
(Do not check if a smaller reporting company)
Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes [ ] No [X]

There were 214,673,720 shares of the Registrant’s $0.001 par value common stock outstanding as of April 9, 2018.

Novo Integrated Sciences, Inc.

Contents

PART I – FINANCIAL INFORMATION		3

Item 1.	Financial Statements	3

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operation	17

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	25

Item 4.	Controls and Procedures	25

PART II – OTHER INFORMATION		26

Item 1.	Legal Proceedings	26

Item 1A.	Risk Factors	26

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26

Item 3.	Defaults Upon Senior Securities	26

Item 4.	Mine Safety Disclosures	26

Item 5.	Other Information	26

Item 6.	Exhibits	27

Signatures		28

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONDENSED CONSOLIDATED BALANCE SHEETS

As of February 28, 2018 (unaudited) and August 31, 2017

	February 28, 2018			August 31, 2017
	(unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	1,036,602		$	1,896,572
Accounts receivable, net		1,348,847			1,128,898
Other receivables		402,112			372,024
Prepaid expenses and other current assets		217,286			252,536
Total current assets		3,004,847			3,650,030

Property and equipment, net		314,442			302,951
Acquisition deposits		1,135,824			1,162,009
Goodwill		616,832			399,400
TOTAL ASSETS	$	5,071,945		$	5,514,390

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

Current Liabilities:
Accounts payable	$	1,743,738		$	1,703,342
Accrued expenses		291,098			341,657
Accrued interest (principally to related parties)		142,207			403,119
Due to related parties		880,915			1,812,613
Notes payable, current portion		6,205			13,171
Total current liabilities		3,064,163			4,273,902

Debentures, related parties		1,249,770			5,114,327
Notes payable, net of current portion		404,710			414,351
TOTAL LIABILITIES		4,718,643			9,802,580

Commitments and contingencies		-			-

STOCKHOLDERS’ EQUITY (DEFICIT)
Novo Integrated Sciences, Inc.
Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at February 28, 2018 and August 31, 2017
Common stock; $0.001par value; 499,000,000 shares authorized; 214,673,720 and 201,837,254 shares issued and outstanding at February 28, 2018 and August 31, 2017		214,674			201,837
Additional paid-in capital		9,834,276			3,381,643
Other comprehensive income		1,153,503			1,240,844
Accumulated deficit		(10,823,822	)		(9,091,977	)
Total Novo Integrated Sciences, Inc. stockholders’ equity (deficit)		378,631			(4,267,653	)
Noncontrolling interest		(25,329	)		(20,537	)
Total stockholders’ equity (deficit)		353,302			(4,288,190	)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$	5,071,945		$	5,514,390

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

For the Three and Six Months Ended February 28, 2018 and 2017 (unaudited)

	Three Months Ended						Six Months Ended
	February 28, 2018			February 28, 2017			February 28, 2018			February 28, 2017
	(unaudited)			(unaudited)			(unaudited)			(unaudited)

Revenues	$	2,145,919		$	1,834,620		$	4,399,656		$	3,652,759

Cost of revenues		1,307,596			1,189,908			2,715,289			2,354,021

Gross profit		838,323			644,712			1,684,367			1,298,738

Operating expenses:
Selling expenses		30,601			8,259			68,740			18,560
General and administrative expenses		1,934,479			589,378			2,914,754			1,170,242
Total operating expenses		1,965,080			597,637			2,983,494			1,188,802

Income (loss) from operations		(1,126,757	)		47,075			(1,299,127	)		109,936

Non operating income (expense)
Interest income		160			11,010			211			21,988
Interest expense		(304,132	)		(114,617	)		(438,285	)		(231,705	)
Total other income (expense)		(303,972	)		(103,607	)		(438,074	)		(209,717	)

Loss before income taxes		(1,430,729	)		(56,532	)		(1,737,201	)		(99,781	)

Income tax expense (benefit)		(54,216	)		-			-			-

Net loss	$	(1,376,513	)	$	(56,532	)	$	(1,737,201	)	$	(99,781	)

Net loss attributed to noncontrolling interest		(1,956	)		(2,764	)		(5,356	)		(4,491	)

Net loss attributed to Novo Integrated Sciences, Inc.	$	(1,374,557	)	$	(53,768	)	$	(1,731,845	)	$	(95,290	)

Comprehensive loss:
Net loss		(1,376,513	)		(56,532	)		(1,737,201	)		(99,781	)
Foreign currency translation gain (loss)		(211,528	)		(94,248	)		(87,341	)		66,895
Comprehensive loss:	$	(1,588,041	)	$	(150,780	)	$	(1,824,542	)	$	(32,886	)

Weighted average common shares outstanding - basic and diluted		206,091,162			167,797,406			203,953,457			167,797,406

Net loss per common share - basic and diluted	$	(0.01	)	$	(0.00	)	$	(0.01	)	$	(0.00	)

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

NOVO INTEGRATED SCIENCES, INC. (formerly Turbine Truck Engines, Inc.)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Six Months Ended February 28, 2018 and 2017 (unaudited)

	Six Months Ended
	February 28, 2018			February 28, 2017
	(unaudited)			(unaudited)

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(1,737,201	)	$	(99,781	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		32,719			30,540
Fair value of vested stock options		1,109,416			-
Changes in operating assets and liabilities:
Accounts receivable		(250,133	)		(318,228	)
Prepaid expenses and other current assets		30,326			31,770
Accounts payable		80,084			89,904
Accrued expenses		(43,843	)		1,615
Accrued interest		303,699			158,039
Net cash used in operating activities		(474,933	)		(106,141	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of furniture and equipment		(43,431	)		(17,320	)
Amounts loaned for other receivables		(39,215	)		-
Repayments of other receivables		-			377,550
Net cash provided by (used in) investing activities		(82,646	)		360,230

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments to related parties		(263,403	)		(202,314	)
Payments on notes payable		(7,108	)		(57,986	)
Net cash used in financing activities		(270,511	)		(260,300	)

Effect of exchange rate changes on cash and equivalents		(31,880	)		(1,040	)

NET DECREASE IN CASH AND CASH EQUIVALENTS		(859,970	)		(7,251	)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		1,896,572			110,315

CASH AND CASH EQUIVALENTS, END OF PERIOD	$	1,036,602		$	103,064

CASH PAID FOR:
Interest	$	128,098		$	81,598
Income taxes	$	-		$	-

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

NOVO INTEGRATED SCIENCES, INC.

(formerly Turbine Truck Engines, Inc.)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Six Months Ended February 28, 2018 and 2017 (unaudited)

Note 1 - Organization and Basis of Presentation

Organization and Line of Business

Novo Integrated Sciences, Inc. was incorporated in Delaware on November 27, 2000, under the name Turbine Truck Engines, Inc. On February 20, 2008, the Company was re-domiciled to the State of Nevada. Effective July 12, 2017, the Company’s name was changed to Novo Integrated Sciences, Inc. When used herein, the terms the “Company,” “we,” “us” and “our” refer to Novo Integrated Sciences, Inc. and its consolidated subsidiaries.

We provide specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, private personal training and dental services to our clients. Our multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through our 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations throughout Canada. Directly and indirectly through our contractual relationships, we provide our specialized services to over 300,000 patients annually. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company’s services do not require a medical or nursing license.

On April 25, 2017 (the “Effective Date”), the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) by and between (i) the Company; (ii) NHL, (iii) ALMC-ASAP Holdings Inc. (“ALMC”); (iv) Michael Gaynor Family Trust (the “MGFT”); (v) 1218814 Ontario Inc. (“1218814”) and (vi) Michael Gaynor Physiotherapy Professional Corp. (“MGPP,” and together with ALMC, MGFT and 1218814, the “NHL Shareholders”). Pursuant to the terms of the Share Exchange Agreement, the Company agreed to acquire from the NHL Shareholders all of the shares of both common and preferred stock of NHL, held by the NHL Shareholders, in exchange for the issuance by the Company to the NHL Shareholders of shares of the Company’s common stock, such that following the closing of the Share Exchange Agreement, the NHL Shareholders would own 167,797,406 restricted shares of Company common stock, representing 85% of the issued and outstanding Company common stock, calculated including all granted and issued options or warrants to acquire the Company common stock as of the Effective Date, but to exclude shares of Company common stock that are subject to a then-current Regulation S offering that was undertaking by the Company (the “Exchange”).

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

The Exchange was accounted for as a reverse acquisition under the purchase method of accounting since NHL obtained control of Novo Integrated Sciences, Inc. Accordingly, the Exchange was recorded as a recapitalization of NHL, with NHL being treated as the continuing entity. The historical financial statements presented are the financial statements of NHL. The Share Exchange Agreement was treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the closing date of the Exchange, the net assets of the legal acquirer, Novo Integrated Sciences, Inc., were $6,904.

On May 9, 2017, our Board of Directors determined, in connection with the closing of the Exchange, to change our fiscal year end from December 31 to August 31 but did not memorialize such determination in writing. On July 17, 2017, the Board ratified and memorialized in writing its May 9, 2017 determination regarding the change in fiscal year end.

The unaudited consolidated financial statements are prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company’s financial position, the results of its operations, and cash flows for the periods presented. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) were omitted pursuant to such rules and regulations. The results of operations for the three and six months ended February 28, 2018 are not necessarily indicative of the results for the year ending August 31, 2018.

Basis of Presentation

The accompanying consolidated financial statements were prepared in conformity with U.S. GAAP. The Company’s Canadian subsidiaries’ functional currency is the Canadian Dollar (“CAD”); however, the accompanying consolidated financial statements were translated and presented in United States Dollars (“$” or “USD”).

Foreign Currency Translation

The accounts of the Company’s Canadian subsidiaries are maintained in CAD. The accounts of these subsidiaries are translated into USD in accordance with ASC Topic 830 Foreign Currency Transaction, with the CAD as the functional currency. According to Topic 830, all assets and liabilities are translated at the exchange rate on the balance sheet date, stockholders’ equity is translated at historical rates and statement of operations items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statement of operations and comprehensive income. The following table details the exchange rates used for the respective periods:

	February 28, 2018		February 28, 2017		August 31, 2017

Period end: CAD to USD exchange rate	$	0.7808	$	0.7548	$	0.7988
Average period: CAD to USD exchange rate	$	0.7959	$	0.7551

Note 2 – Summary of Significant Accounting Policies

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.

Noncontrolling Interest

The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents

For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.

Accounts Receivable

Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of February 28, 2018 and August 31, 2017, the allowance for uncollectible accounts receivable was $484,145 and $507,636, respectively.

Property and Equipment

Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:

	Leasehold improvements	5 years
	Clinical equipment	5 years
	Computer equipment	3 years
	Office equipment	5 years
	Furniture and fixtures	5 years

Long-Lived Assets

The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at February 28, 2018 and August 31, 2017, the Company believes there was no impairment of its long-lived assets.

Goodwill

Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. At February 28, 2018, the Company recorded goodwill of $390,400 and $226,432, respectively, related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017 and Executive Fitness Leaders during the fiscal year ended August 31, 2018.

Acquisition Deposits

The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,135,824 and $1,162,009 at February 28, 2018 and August 31, 2017, respectfully.

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

	●	Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

	●	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

	●	Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement.

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

As of February 28, 2018 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition

Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

Income Taxes

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.

Stock-Based Compensation

The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.

Basic and Diluted Earnings Per Share

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 10,030,000 options/warrants outstanding as of February 28, 2018. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.

Foreign Currency Transactions and Comprehensive Income

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains of $1,153,503 and $1,240,844 at February 28, 2018 and August 31, 2017, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

Statement of Cash Flows

Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

Recent Accounting Pronouncements

In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Note 3 – Related Party Transactions

Due to related parties

Amounts loaned to the Company by stockholders and officers of the Company that are payable upon demand.

On January 31, 2018, a related party converted $813,125 of outstanding amounts loaned to the Company into 1,976,483 shares of the Company’s common stock. The per share price used for the conversion of this loan was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price. At February 28, 2018, the amount due to related parties was $880,915.

Note 4 – Other Receivables

Other receivables at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018		August 31, 2017
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.	$	-	$	39,940
Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 8% per annum; secured by certain assets; due May 23, 2018.		292,800		299,550
Advance to corporation; non-interest bearing; unsecured; payable upon demand		31,232		32,534
Advance to corporation; non-interest bearing; unsecured; payable upon demand		78,080		-
Total other receivables	$	402,112	$	372,024

Note 5 – Property and Equipment

Property and equipment at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018			August 31, 2017
Leasehold Improvements	$	331,696		$	329,985
Clinical equipment		204,013			177,514
Computer equipment		23,113			21,020
Office equipment		23,771			24,319
Furniture and fixtures		26,010			18,218
		608,603			571,056
Accumulated depreciation		(294,161	)		(268,105	)
Total	$	314,442		$	302,951

Depreciation expense for the six months ended February 28, 2018 and 2016 was $32,719 and $30,540, respectively.

Note 6 – Notes Payable

Notes payable at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018			August 31, 2017
Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.		-			7,134
Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 27, 2019.		390,400			399,400
Notes payable to financial institution assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $623; unsecured; due April 8, 2019.		20,515			20,988
		410,915			427,522
Current portion		(6,205	)		(13,171	)
Long-term portion	$	404,710		$	414,351

Aggregate future maturities of notes payable as of February 28 are as follows:

Twelve months ending February 28,
2019	$	6,205
2020		404,710
	$	410,915

Note 7 – Debentures, related parties

On September 30, 2013, the Company issued five debentures totaling CAD$6,402,512 ($4,968,900 at November 30, 2017) in connection with the acquisition of certain business assets. The holders of the debentures are current stockholders, officers and/or affiliates of the Company. The debentures are secured by all the assets of the Company, accrue interest at 8% per annum and were originally due on September 30, 2016. On December 2, 2017, the debenture holders agreed to extend the due date to September 30, 2019.

On January 31, 2018, the debenture holders converted seventy-five percent (75%) of the debenture value of $3,894,809 plus accrued interest of $414,965 into 10,475,872 shares of the Company’s common stock. The per share price used for the conversion of each debenture was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price. At February 28, 2018, the amount of debentures outstanding was $1,249,770.

Note 8 – Stockholders’ Deficit

Convertible preferred stock

The Company has authorized 1,000,000 shares of $0.001 par value convertible preferred stock. At February 28, 2018 and August 31, 2017 there were 0 and 0 convertible preferred shares issued and outstanding, respectively.

Common stock

The Company has authorized 499,000,000 shares of $0.001 par value common stock. At February 28, 2018 and August 31, 2017 there were 214,673,720 and 201,837,254 common shares issued and outstanding, respectively.

During the six months ended February 28, 2018, the Company issued 384,110 shares of common stock for the acquisition of Executive Fitness Leaders valued at $233,155. The value was based on the closing price of the Company’s common stock on the acquisition date. In addition, during the same period, the Company issued 12,452,356 shares of common stock for the conversion of debt totaling $5,122,899. The per share price used for the conversion was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

Stock options/warrants

On September 8, 2015, the Company adopted the 2015 Incentive Compensation Plan (the “2015 Plan”), which authorizes the issuance of up to 5,000,000 shares of common stock to employees, officers, directors or independent consultants of the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. During 2017 and 2016, the Company did not grant any awards under the 2015 Plan. As of August 31, 2017, 4,987,500 shares were available under the 2015 Plan for future grants, awards, options or share issuances. However, because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the Plan are no longer registered under the Securities Exchange Act of 1934, as amended, the Company does not intend to issue any additional grants under the 2015 Plan.

On January 16, 2018, the Company adopted the Novo Integrated Sciences, Inc. 2018 Incentive Plan (the “2018 Plan”). Under the 2018 Plan, 10,000,000 shares of common stock are authorized for issuance to employees, non-employees, directors and key consultants to the Company or its subsidiaries. The 2018 Plan authorizes equity-based and cash-based incentives for participants. There were 9,950,000 shares available for award at February 28, 2018 under the 2018 Plan.

The following is a summary of stock option/warrant activity:

					Weighted
			Weighted		Average
	Options/		Average		Remaining		Aggregate
	Warrants		Exercise		Contractual		Intrinsic
	Outstanding		Price		Life		Value
Outstanding, August 31, 2017		7,860,000	$	0.27		3.53	$	660,000
Granted		2,170,000		0.42
Forfeited		-
Exercised		-
Outstanding, February 28, 2018		10,030,000		0.30		3.44		781,000
Exercisable, February 28, 2018		8,970,000	$	0.30		3.32	$	781,000

The exercise price for options/warrants outstanding at February 28, 2018:

Outstanding			Exercisable
Number of			Number of
Options/	Exercise		Options/		Exercise
Warrants	Price		Warrants		Price
5,500,000	$	0.16		5,500,000	$	0.16
1,000,000		0.32		-		0.32
50,000		0.33		50,000		0.33
120,000		0.40		60,000		0.40
2,000,000		0.42		2,000,000		0.42
100,000		0.50		100,000		0.50
1,000,000		0.62		1,000,000		0.62
250,000		0.80		250,000		0.80
10,000		2.00		10,000		2.00
10,030,000				8,970,000

For options granted during fiscal year 2017 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.58 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2017 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.

For options granted during fiscal year 2018 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.41 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2018 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.

The fair value of the stock options is being amortized to stock option expense over the vesting period. The Company recorded stock option expense of $1,109,416 during the six months ended February 28, 2018. At February 28, 2018, the unamortized stock option expense was $165,515.

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

Risk-free interest rate	1.83	%
Expected life of the options	2.5 to 3.5 years
Expected volatility	314	%
Expected dividend yield	0	%

Note 9 – Commitments and Contingencies

Litigation

The Company is party to certain legal proceedings from time to time incidental to the conduct of its business. These proceedings could result in fines, penalties, compensatory or treble damages or non-monetary relief. The nature of legal proceedings is such that the Company cannot assure the outcome of any particular matter, and an unfavorable ruling or development could have a materially adverse effect on our consolidated financial position, results of operations and cash flows in the period in which a ruling or settlement occurs. However, based on information available to the Company’s management to date, the Company’s management does not expect that the outcome of any matter pending against the Company is likely to have a materially adverse effect on the Company’s consolidated financial position as of February 28, 2018, results of operations, cash flows or liquidity of the Company.

Leases

The Company leases its office space and certain facilities under long-term operating leases expiring through fiscal year 2023. Rent expense under these leases was $409,350 and $387,110 for the six months ended February 28, 2018 and 2017, respectively.

Note 10 – Acquisition of Assets

On December 1, 2017, the Company and Executive Fitness Leaders, located in Ottawa Ontario Canada, entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance, by the Company, of 384,110 restricted shares of its common stock valued at $233,155. The purchase price was allocated to furniture and equipment of $7,772 and goodwill of $225,383. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

Note 11 – Subsequent Events

Michael Gaynor Resignation

Emily Mattacchione Appointment

Effective March 15, 2018, Emily Mattacchione was appointed as the Company’s Treasurer. ALMC-ASAP Holdings, Inc. (“ALMC-ASAP”) owns approximately 59.1% of the Company’s outstanding common stock. ALMC-ASAP’s shares are held by the Mattacchione Family Trust. Ms. Mattacchione and her spouse, Robert Mattacchione, are co-trustees of the Mattacchione Family Trust and share voting and depository power over the ALMC-ASAP shares.

At August 31, 2017 and February 28, 2018, the Company had a debenture totaling $2,396,400 and $585,600, respectively, due to ICC Healthnet Canada, Inc. Also, at August 31, 2017 and February 28, 2018, the Company had a debenture totaling $1,597,600 and $390,400 respectively, due to Healthnet Assessment Inc. Each of ICC Healthnet Canada, Inc. and Healthnet Assessment Inc. is owned by Mr. Mattacchione, Ms. Mattacchione’s spouse. The conversion rate used for the respective periods August 31, 2017 and February 28, 2018 is $0.7988 and $0.7808.

Amendment of Brands Letter of Intent

On December 26, 2017, the Company entered into a binding letter of intent (the “LOI”) with Brands International Corporation (“Brands”), pursuant to which the Company agreed to acquire 60% of the issued and outstanding shares of Brands in exchange for the arrangement of secured debt financing in the amount of CAD$2,350,000 (approximately $1,873,256 per the Bank of Canada posted exchange rate of 0.7977 on December 29, 2017) arranged or provided by the Company (the “Acquisition”). Upon completion of the Acquisition, the Company will own 60% of Brands’ issued and outstanding shares and Brands will be a majority-owned subsidiary of the Company. In connection with the Acquisition, the Company will enter into a shareholder agreement with Mark Rubinoff and a management agreement with Mark Rubinoff and DJ Rubinoff. In addition, pursuant to the terms of the LOI, the Company agreed to provide Mark Rubinoff with a buyout structure for the remaining 40% of Brands’ shares with a trigger date of 24 months from the closing of the Acquisition.

The parties to the LOI agreed to proceed reasonably and in good faith toward negotiation and execution of a definitive acquisition agreement, and to use their commercially reasonable best efforts to obtain necessary board, stockholder and regulatory approvals and third party consents.

The LOI provided for a termination date of January 30, 2018. On January 30, 2018, the Company and Brands executed a letter agreement (the “Letter Agreement”) that had the effect of amending the LOI to extend the termination date to March 20, 2018.

On March 16, 2018, the Company and Brands executed Amendment #2 to the LOI, as amended, that had the effect of amending the LOI to extend the termination date to April 20, 2018. The terms of the LOI, as amended, otherwise remain in full force and effect.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), provide a safe harbor for forward-looking statements made by or on behalf of the Company. The Company and its representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this report and other filings with the Securities and Exchange Commission (“SEC”) and in our reports and presentations to stockholders or potential stockholders. In some cases forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties can be found in the Part I, Item 1A, “Risk Factors” section of the Company’s Form 10-K for the fiscal year ended August 31, 2017.

Although we believe the expectations reflected in our forward-looking statements are based upon reasonable assumptions, it is not possible to foresee or identify all factors that could have a material effect on the future financial performance of the Company. The forward-looking statements in this report are made on the basis of management’s assumptions and analyses, as of the time the statements are made, in light of their experience and perception of historical conditions, expected future developments and other factors believed to be appropriate under the circumstances.

Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained in this Quarterly Report on Form 10-Q and the information incorporated by reference in this report to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based.

Overview of the Company

Our strict adherence to public regulatory standards, as well as self-imposed standards of excellence, have allowed us to navigate with ease through the industry’s licensing and regulatory framework. Compliant treatment, data and administrative protocols are managed through a team of highly-trained, certified healthcare and administrative professionals. Novo Healthnet Limited, our wholly owned subsidiary (“NHL”), and its direct and indirect subsidiaries are regulated under the Financial Services Commission of Ontario (“FSCO”). In 2013, NHL received its accreditation from the Commission on Accreditation of Rehabilitation Facilities (“CARF”). Currently, NHL is undergoing the CARF re-accreditation process.

Recent Developments

Share Exchange Agreement

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

Increase in Size of Board of Directors; Officer and Director Changes

In connection with the Exchange closing, our Board of Directors increased the size of the Board, such that the size of the Board is currently comprised of three members.

On May 9, 2017, in connection with the Exchange, (i) Enzo Cirillo resigned his positions as the Company’s Chairman of the Board, a member of the Board of Directors and Interim Chief Executive Officer, (ii) Christopher David resigned his position as the Company’s Secretary and Treasurer, and (iii) Judith Norstrud resigned her position as the Company’s Principal Financial Officer and Principal Accounting Officer. Mr. David retained his responsibilities as the Company’s President and as a member of the Company’s Board of Directors.

Also on May 9, 2017, the Board appointed Dr. Pierre Dalcourt, D.C. and Mr. Michael Gaynor as directors, and Ms. Klara Radulyne, CPA as the Company’s Principal Financial Officer, effective immediately. Mr. Gaynor is the trustee of MGFT. As a result of the Exchange, MGFT acquired 16,779,740 shares of the Company’s common stock, which represented approximately 8.5% of the Company’s outstanding common stock as of the date of the closing of the Exchange. As of the closing date of the Exchange, the value of MGFT’s stock ownership was $14,094,982, based on the closing price of the Company’s common stock of $0.84 on May 9, 2017. Dr. Dalcourt is the President and 50% owner of 1218814. Amanda Dalcourt, NHL’s Chief Executive Officer and Dr. Dalcourt’s spouse, also is a 50% owner of 1218814. As a result of the Exchange, 1218814 acquired 31,881,507 shares of the Company’s common stock, which represented approximately 16.2% of the Company’s outstanding common stock as of the date of the closing of the Exchange. As of the closing date of the Exchange, the value of 1218814’s stock ownership was $26,780,466, based on the closing price of the Company’s common stock of $0.84 on May 9, 2017. The value of each of Dr. Dalcourt’s and Ms. Dalcourt’s ownership interests in 1218814’s Company common stock as of May 9, 2017, based on the closing price of the Company’s common stock on May 9, 2017, was $13,390,233.

Acquisition of Executive Fitness Leaders

On December 1, 2017, the Company and Executive Fitness Leaders, located in Ottawa Ontario Canada, entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance of 384,110 restricted shares of its common stock valued at approximately $233,155. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

Extension of Due Date of Debentures

On December 2, 2017, the Company and certain related party debenture holders of five debentures totaling $5,114,327 (CAD$6,402,512) dated September 30, 2013 with an original due date of September 30, 2016 (see financial note 7 for further details) agreed to extend the due date of the debentures to September 30, 2019.

Agreement to Convert Debentures

On December 5, 2017, the related party debenture holders and the Company signed a binding Letter of Intent to convert no less than 75% of the debenture value, plus any interest or fees owed, to the Company’s common stock. The per share price to be used for the conversion of each debenture will be the average price of the five trading days immediately preceding the date of conversion with a 10% premium added to the calculated per share price.

Brands International Corporation Letter of Intent

On December 26, 2017, the Company entered into a binding letter of intent (the “LOI”) with Brands International Corporation (“Brands”), pursuant to which the Company agreed to acquire 60% of the issued and outstanding shares of Brands in exchange for the arrangement of secured debt financing in the amount of CAD$2,350,000 (approximately $1,873,256 per the Bank of Canada posted exchange rate of 0.7977 on December 29, 2017) arranged or provided by the Company (the “Acquisition”). Upon completion of the Acquisition, the Company will own 60% of Brands’ issued and outstanding shares and Brands will be a partially-owned subsidiary of the Company. In connection with the Acquisition, the Company will enter into a shareholder agreement with Mark Rubinoff and a management agreement with Mark Rubinoff and DJ Rubinoff. In addition, pursuant to the terms of the LOI, the Company agreed to provide Mark Rubinoff with a buyout structure for the remaining 40% of Brands’ shares with a trigger date of 24 months from the closing of the Acquisition.

The parties to the LOI agreed to proceed reasonably and in good faith toward negotiation and execution of a definitive acquisition agreement (a “Definitive Agreement”), and to use their commercially reasonable best efforts to obtain necessary board, stockholder and regulatory approvals and third party consents.

The parties to the LOI also agreed that from the date of the LOI until the earlier of January 30, 2018 (the “Termination Date”) and the date the parties enter into a Definitive Agreement, the parties and their respective directors, officers, agents and representatives will not:

	●	solicit, initiate or encourage the initiation of any expression of interest, inquiries or proposals regarding, constituting or that may reasonably be expected to lead to any merger, amalgamation, takeover bid, tender offer, arrangement, recapitalization, liquidations, dissolution, share exchange, sale of material assets involving the parties or a proposal or offer to do so (the “Acquisition Proposal”) (including without limitation, any grant of an option or other right to take any such action);

	●	participate in any discussions or negotiations regarding an Acquisition Proposal;

	●	accept or enter into, or propose publicly to accept or enter into, any agreement, letter of intent, memorandum of understanding or any arrangement in respect of an Acquisition Proposal; and

	●	otherwise cooperate in any way, assist or participate in, facilitate or encourage any effort or attempt by any person to do any of the foregoing.

In addition, Brands agreed not to solicit funds in any secured or unsecured debt form resulting in a change in the company’s financials unless the Company is made aware of such solicitation in writing.

If the Definitive Agreement is not negotiated and executed by both parties on or before the Termination Date, or such other date as agreed to by the parties in writing, the terms of the LOI will be of no further force or effect except for the confidentiality, costs and governing laws provisions, which sections will remain in effect for a period of one year following the date on which the LOI is terminated.

On January 30, 2018, the Company and Brands executed a letter agreement that had the effect of amending the LOI to extend the termination date to March 20, 2018. On March 16, 2018, the Company and Brands executed Amendment #2 to the LOI, as amended, that had the effect of amending the LOI to extend the termination date to April 20, 2018. The terms of the LOI, as amended, otherwise remain in full force and effect.

David Employment Agreement & Option Grant

On December 29, 2017, the Company entered into an employment agreement (the “Employment Agreement”) with Christopher David, the Company’s President and a member of the board of directors, effective January 1, 2018. The Employment Agreement terminates on July 30, 2018, subject to the termination provisions contained in the Employment Agreement.

Pursuant to the terms of the Employment Agreement, Mr. David agreed to serve as the Company’s President. In consideration thereof, the Company agreed to (i) pay Mr. David a monthly salary of $8,000, and (ii) grant Mr. David a 5-year option (the “Option”) to purchase 2,000,000 shares of the Company’s restricted common stock at an exercise price of $0.42 per share. The Option vested on December 29, 2017.

Pursuant to the terms of the Employment Agreement, the Company may terminate Mr. David at any time, with or without Cause (as defined below); provided, however, that if the Company terminates Mr. David without Cause:

(a) The Option shall be deemed fully vested effective as of December 29, 2017, and is not subject to revocation or return, and

(b) The Company will continue to owe Mr. David his monthly salary through July 30, 2018.

“Cause” means Mr. David must have (i) been willful, gross or persistent in his inattention to his duties or he committed acts which constitute willful or gross misconduct and, after written notice of the same, has been given the opportunity to cure the same within 30 days after such notice, and (ii) been found guilty of having committed a fraud against the Company.

On December 29, 2017, the Company granted the Option to Mr. David pursuant to that certain Option to Purchase Common Stock (the “Option Agreement”). The Option Agreement provides for the cashless exercise of all or a portion of the Option, or exercise through payment of the exercise price in cash.

2018 Incentive Plan

On January 16, 2018, the Company adopted the Novo Integrated Sciences, Inc. 2018 Incentive Plan (the “2018 Plan”). Under the 2018 Plan, 10,000,000 shares of common stock are authorized for issuance employees, non-employee directors and key consultants to the Company or its subsidiaries. The 2018 Plan authorizes equity-based and cash-based incentives for participants. There were 9,950,000 shares available for award at February 28, 2018 under the 2018 Plan.

Debt Conversion

On September 30, 2013, NHL issued five debentures totaling approximately $4,968,990 (CAD$6,402,512) at November 30, 2017 in connection with the acquisition of certain business assets. The holders of the debentures are current stockholders, officers and/or affiliates of the Company. The debentures are secured by all the assets of the Company, accrue interest at 8% per annum and were originally due on September 30, 2016. On December 2, 2017, the debenture holders agreed to extend the due date to September 30, 2019.

On December 5, 2017, the debenture holders, NHL and the Company signed a binding letter of intent to convert no less than 75% of the respective debenture value plus any interest or fees owed to the Company’s common stock and a per share price equal to the average price of the five trading days immediately preceding the date of conversion with a 10% premium added to the calculated per share price.

On January 31, 2018, each of the debenture holders entered into a debenture amendment with NHL and the Company pursuant to which (i) each debenture holder agreed to convert 75% of the amount owed, both principal and interest, under the respective debenture into shares of Company common stock in lieu of accepting a cash payment for 75% of the amount owed, both principal and interest, and (ii) NHL and the Company agreed to issue to each debenture holder shares of common stock at a Canadian-to-United States dollar exchange rate of 0.8111.

NHL and ALMC-ASAP Holdings Inc. (“ALMC”) are parties to that certain loan agreement dated as of January 19, 2016, as amended (the “Loan Agreement”), totaling approximately $875,988 (CAD$1,080,000). On January 31, 2018, ALMC, NHL and the Company entered into an amendment to the Loan Agreement pursuant to which (i) ALMC agreed to convert 75% of the amount owed, both principal and interest, under the Loan Agreement into shares of Company common stock in lieu of accepting a cash payment for 75% of the amount owed, both principal and interest, and (ii) NHL and the Company agreed that the Company would issue to ALMC shares of the Company’s common stock at a Canadian-to-United States dollar exchange rate of 0.8111.

As a result, on January 31, 2018, the Company issued an aggregate of 12,452,346 shares of common stock to the debenture holders and ALMC.

Officer Changes

On February 1, 2018, Amanda Dalcourt resigned her position as Chief Executive Officer of NHL. Effective February 1, 2018, Ms. Dalcourt will serve as Executive Vice-President of Novo Healthnet Limited’s Eldercare and Long-Term Care divisions and of Novo Peak Health. Also, effective February 1, 2018, Pierre Dalcourt, the Company’s Chairman of the Board, was appointed as Novo Healthnet’s President.

On March 15, 2018, Michael Gaynor resigned his position as the Company’s Treasurer. Mr. Gaynor will continue to act as the Company’s Secretary and as a member of the Company’s board of directors. Effective March 15, 2018, Emily Mattacchione was appointed as the Company’s Treasurer. ALMC-ASAP Holdings, Inc. (“ALMC-ASAP”) owns approximately 59.1% of the Company’s outstanding common stock. ALMC-ASAP’s shares are held by the Mattacchione Family Trust. Ms. Mattacchione and her husband, Robert Mattacchione, are co-trustees of the Mattacchione Family Trust and share voting and depository power over the ALMC-ASAP shares.

At August 31, 2017 and February 28, 2018, the Company had a debenture totaling $2,396,400 and $585,600, respectively, due to ICC Healthnet Canada, Inc. Also, at August 31, 2017 and February 28, 2018, the Company had a debenture totaling $1,597,600 and $390,400 respectively, due to Healthnet Assessment Inc. Each of ICC Healthnet Canada, Inc. and Healthnet Assessment Inc. is owned by Mr. Mattacchione, Ms. Mattacchione’s husband. The conversion rate used for the respective periods August 31, 2017 and February 28, 2018 is $0.7988 and $0.7808.

For the three months ended February 28, 2018 compared to the three months ended February 28, 2017

Revenues for the three months ended February 28, 2018 were $2,145,919, representing an increase of $311,299, or 17.0%, from $1,834,620 for the same period in 2017. The increase in revenue is principally due to the Company’s entry into new occupational therapy service contracts in January 2017 and the acquisitions of Apka Health, Inc. in April 2017 and Executive Fitness Leaders in December 2017.

Cost of revenues for the three months ended February 28, 2018 were $1,307,596, representing an increase of $117,688, or 9.9%, from $1,189,908 for the same period in 2017. The increase in cost of revenues is principally due to the increase in revenues. Cost of revenues as a percentage of revenue was 60.9% for the three months ended February 28, 2018 and 64.9% for same period in 2017. The decrease in cost of revenues as a percentage of revenue is principally due to slightly lower costs.

Operating costs for the three months ended February 28, 2018 were $1,965,080, representing an increase of $1,367,443, or 228.8%, from $597,637 for the same period in 2017. The increase in operating costs is attributed to stock-based compensation of $966,751 for the three months ended February 28, 2018 (there was no stock-based compensation for the same period in 2017), as well as an increase in both operating payroll expenses and professional fees.

Interest expense for the three months ended February 28, 2018 was $304,132, representing an increase of $189,515, or 165.3%, from $114,617 for the same period in 2017. The increase for the three months ended February 28, 2018 is due to interest on debt obligations.

Net loss for the three months ended February 28, 2018 was $1,376,513, representing an increase of $1,319,981, or 2,335%, from $56,532 for the same period in 2017. The increase in net loss is due to the reasons described above.

For the six months ended February 28, 2018 compared to the six months ended February 28, 2017

Revenues for the six months ended February 28, 2018 were $4,399,656, representing an increase of $746,897, or 20.4%, from $3,652,759 for the same period in 2017. The increase in revenue is principally due to the Company’s entry into new occupational therapy service contracts in January 2017 and the acquisitions of Apka Health, Inc. in April 2017 and Executive Fitness Leaders in December 2017.

Cost of revenues for the six months ended February 28, 2018 were $2,715,289, representing an increase of $361,268, or 15.3%, from $2,354,021 for the same period in 2017. The increase in cost of revenues is principally due to the increase in revenues. Cost of revenues as a percentage of revenue was 61.7% for the six months ended February 28, 2018 and 64.4% for same period in 2017. The decrease in cost of revenues as a percentage of revenue is principally due to slightly lower costs.

Operating costs for the six months ended February 28, 2018 were $2,983,494, representing an increase of $1,794,692, or 151.0%, from $1,188,802 for the same period in 2017. The increase in operating costs is attributed to stock-based compensation of $1,109,416 for the six months ended February 28, 2018 (there was no stock-based compensation for the same period in 2017), as well as an increase in both operating payroll expenses and professional fees.

Interest expense for the six months ended February 28, 2018 was $438,285, representing an increase of $206,580, or 89.2%, from $231,705 for the same period in 2017. The increase for the six months ended February 28, 2018 is due to interest on debt obligations and interest related to payroll withholdings originating in fiscal years 2014 and 2015.

Net loss for the six months ended February 28, 2018 was $1,737,201, representing an increase of $1,637,420, or 1,641%, from $99,781 for the same period in 2017. The increase in net loss is due to the reasons described above.

Liquidity and Capital Resources

As shown in the accompanying financial statements, for the six months ended February 28, 2018, the Company had a net loss of $1,737,201.

During the six months ended February 28, 2018, the Company used cash in operating activities of $474,933 compared to $106,141 for the same period in 2017. The principal reason for the increase is the additional net loss incurred during the six months ended February 28, 2018 as compared to the same period in 2017 and a larger increase in operating assets and liabilities during the six months ended February 28, 2018 compared to the same period in 2017.

During the six months ended February 28, 2018, the Company used cash in investing activities of $82,646 compared to cash provided by investing activities of $360,230 for the same period in 2017. The principal reason for the change is the repayment of other receivables during the six months ended February 28, 2017.

During the six months ended February 28, 2018, the Company used cash of $270,511 from financing activities compared to $260,300 for the same period in 2017. The principal reason for the decrease is due to repayments of amounts due to related parties.

On March 8, 2017, the Company sold 33,333 restricted shares of common stock to 2367416 Ontario, Inc. The shares were sold at a price of $0.45 per share, for an aggregate purchase price of $15,000. This sale of 33,333 restricted shares occurred prior to the share exchange as described above. The $15,000 was provided to fund the Company’s ongoing operational and product development expenses. At the time of the sale, Enzo Cirillo was the Company’s Interim CEO, Chairman of the Board and a greater than 10% shareholder of the Company’s common stock, as well as the principal partner of 2367416 Ontario, Inc. Effective May 9, 2017, Mr. Cirillo resigned as an officer and director of the Company. Additionally, with the closing of the Share Exchange Agreement between the Company and Novo Healthnet Limited, Mr. Cirillo is no longer a greater than 10% shareholder of the Company’s common stock.

On May 19, 2017, the Company sold 8,368,500 restricted shares of common stock to an aggregate of 23 accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $2,510,550. The $2,510,550 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

On June 20, 2017, the Company sold 2,140,839 restricted shares of common stock to an aggregate of 12 accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $642,250. The $642,250 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act. The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

On August 24, 2017, the Company sold 779,202 restricted shares of common stock to an aggregate of three accredited investors. The shares were sold at a price of $0.30 per share, for an aggregate purchase price of $233,760. The $233,760 was provided to fund the Company’s ongoing operational and product development expenses. The shares were issued in reliance upon the exemptions provided by Regulation S promulgated pursuant to the Securities Act. The issuances involved offers and sales of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

We believe that the following critical policies affect our more significant judgments and estimates used in preparation of our financial statements.

Use of Estimates

Noncontrolling Interest

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Revenue Recognition

Stock-Based Compensation

Basic and Diluted Earnings Per Share

Foreign Currency Transactions and Comprehensive Income

U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains (losses) are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

New Accounting Pronouncements

Recent accounting pronouncements issued by the FASB, the AICPA and the Securities and Exchange Commission did not or are not believed by management to have a material effect on the Company’s financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

The Company’s President and Principal Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of February 28, 2018. Based upon such evaluation, the Company’s President and Principal Financial Officer have concluded that, as of February 28, 2018, the Company’s disclosure controls and procedures were not effective. The Company’s disclosure controls and procedures were determined to be ineffective due to the lack of segregation of duties. Currently, management contracts with an outside certified public accountant to assist the Company with preparation of its filings required pursuant to the Exchange Act.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the fiscal quarter ended February 28, 2018 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Except as set forth herein, as of the date of this Quarterly Report on Form 10-Q, there are no material pending legal proceedings, other than ordinary routine litigation incidental to our business, to which we are a party or which our property is the subject. In addition, none of our officers, directors, affiliates or 5% stockholders (or any associates thereof) is a party adverse to us, or has a material interest adverse to us, in any material proceeding.

The Company is currently involved in litigation in Taiwan, wherein the Company engaged Formosan Brothers, a Taiwan-based law firm, to file a criminal complaint with the Taipei, Taiwan District Prosecutors Office (the “Prosecutor”) seeking criminal charges against the principal partners of ETS, Mr. Chen, Chong-Ping (“Alan Chen”) and Huang, Ren-Ju (“Mr. Huang”) for fraud in connection with their actions related to the Company’s business initiative to commercialize the HPBS technology in Asia.

On December 25, 2015, the Company received a written ruling from the Taiwan District Prosecutor’s Office that it had declined to prosecute Alan Chen and Mr. Huang for criminal fraud.

On January 4, 2016, the Company filed an appeal to the Taiwan High Prosecution Office. On February 1, 2016, the Company’s appeal was granted and the case was returned to the Taiwan District Court Prosecutor with instructions to conduct a new investigation of the facts and evidence. The Company intends to continue to pursue this matter until a final resolution is obtained.

On June 12, 2017, Mr. Chen was indicted and charged with criminal fraud and the Company was informed that Mr. Huang will not be indicted.

On the recommendation of both the Company’s Taiwan attorneys and the judge overseeing the criminal fraud case against Mr. Chen, the Company filed an ancillary civil action against Mr. Chen allowing the judge overseeing the criminal fraud case to initiate a mediation proceeding between the Company and Mr. Chen for a potential financial settlement. Mr. Chen did not appear for an August 1, 2017 mediation hearing but did appear for the subsequent criminal hearing. The defendant pleaded not guilty and the judge notified both parties the case will proceed to trial.

In late August 2017, the Company filed a Confiscation Application with the Taiwan Taipei District Court requesting the prosecutor’s office search for and confiscate any assets the prosecutor can locate in the name of Alan Chen as security for the compensation to the Company pending the criminal trial’s outcome. As of the date of this filing, the Company is awaiting the results of this Confiscation Application.

On November 23, 2017, Mr. Chen and the Company’s legal team appeared for a hearing to determine accepted facts and any additional evidence. The next court date is scheduled for April 26, 2018.

ITEM 1A. RISK FACTORS

Not required for smaller reporting companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On January 31, 2018, the Company issued an aggregate of 12,452,346 shares of common stock to certain related parties in connection with conversion by such related parties of outstanding debentures and/or loans.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

There have been no defaults in any material payments during the covered period.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

(a) None.

(b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.

ITEM 6. EXHIBITS

Exhibit Number		Description of Document

31.1		Rule 13a-14(a) Certification of Principal Executive Officer

31.2		Rule 13a-14(a) Certification of Principal Financial Officer

32.1		Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Principal Executive Officer and Principal Financial Officer

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase

101.DEF		XBRL Taxonomy Extension Definition Linkbase

101.LAB		XBRL Taxonomy Extension Labels Linkbase

101.PRE		XBRL Taxonomy Extension Presentation Linkbase

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereto duly authorized:

	NOVO INTEGRATED SCIENCES, INC.

Dated: April 12, 2018	By:	/s/ Klara Radulyne
		Klara Radulyne
		Principal Financial Officer

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

CERTIFICATIONS

I, Christopher David, certify that:

1.	I have reviewed this quarterly report on Form 10-Q for the quarter ended February 28, 2018 of Novo Integrated Sciences, Inc.; and

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; and

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

	d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 12, 2018	By:	/s/ Christopher David
		Christopher David
		President (principal executive officer)

EX-31.2 3 ex31-2.htm

EXHIBIT 31.2

CERTIFICATIONS

I, Klara Radulyne, certify that:

1.	I have reviewed this quarterly report on Form 10-Q for the quarter ended February 28, 2018 of Novo Integrated Sciences, Inc.; and

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; and

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

	d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 12, 2018	By:	/s/ Klara Radulyne
		Klara Radulyne
		Principal Financial Officer

EX-32.1 4 ex32-1.htm

EXHIBIT 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Novo Integrated Sciences, Inc. (the “Company”) on Form 10-Q for the quarter ended February 28, 2018 as filed with the Securities and Exchange Commission (the “Report”), I, Christopher David, President of the Company, and I, Klara Radulyne, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: April 12, 2018	/s/ Christopher David
	Christopher David, President (principal executive officer)

	/s/ Klara Radulyne
	Klara Radulyne, Principal Financial Officer (principal financial officer)

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

EX-101.INS 5 nvos-20180228.xml XBRL INSTANCE FILE 0001138978 2017-09-01 2018-02-28 0001138978 2018-04-09 0001138978 2017-08-31 0001138978 2018-02-28 0001138978 NVOS:TurbineTruckEnginesIncMember 2017-09-01 2018-02-28 0001138978 NVOS:TurbineTruckEnginesIncOneMember 2017-09-01 2018-02-28 0001138978 NVOS:ShareExchangeAgreementMember NVOS:NHLMember 2017-04-23 2017-04-25 0001138978 NVOS:PeriodEndMember NVOS:CADMember 2017-08-31 0001138978 NVOS:NovoHealthnetKemptvilleCentreIncMember 2018-02-28 0001138978 2016-09-01 2017-02-28 0001138978 us-gaap:LeaseholdImprovementsMember 2017-09-01 2018-02-28 0001138978 NVOS:ClinicalEquipmentMember 2017-09-01 2018-02-28 0001138978 us-gaap:ComputerEquipmentMember 2017-09-01 2018-02-28 0001138978 us-gaap:OfficeEquipmentMember 2017-09-01 2018-02-28 0001138978 us-gaap:FurnitureAndFixturesMember 2017-09-01 2018-02-28 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2017-08-31 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenAndMayTwentyThreeTwoThousandSeventeenMember 2017-08-31 0001138978 NVOS:AdvanceToCorporationOneMember 2017-08-31 0001138978 NVOS:AdvanceToCorporationTwoMember 2017-08-31 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2016-09-01 2017-08-31 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2017-09-01 2018-02-28 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenAndMayTwentyThreeTwoThousandSeventeenMember 2016-09-01 2017-08-31 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenAndMayTwentyThreeTwoThousandSeventeenMember 2017-09-01 2018-02-28 0001138978 us-gaap:LeaseholdImprovementsMember 2017-08-31 0001138978 NVOS:ClinicalEquipmentMember 2017-08-31 0001138978 us-gaap:ComputerEquipmentMember 2017-08-31 0001138978 us-gaap:OfficeEquipmentMember 2017-08-31 0001138978 us-gaap:FurnitureAndFixturesMember 2017-08-31 0001138978 us-gaap:LeaseholdImprovementsMember 2018-02-28 0001138978 NVOS:ClinicalEquipmentMember 2018-02-28 0001138978 us-gaap:ComputerEquipmentMember 2018-02-28 0001138978 us-gaap:OfficeEquipmentMember 2018-02-28 0001138978 us-gaap:FurnitureAndFixturesMember 2018-02-28 0001138978 NVOS:NotePayableOneMember 2017-08-31 0001138978 NVOS:NotePayableTwoMember 2017-08-31 0001138978 NVOS:NotePayableThreeMember 2017-08-31 0001138978 NVOS:NotePayableOneMember 2018-02-28 0001138978 NVOS:NotePayableTwoMember 2018-02-28 0001138978 NVOS:NotePayableThreeMember 2018-02-28 0001138978 NVOS:NotePayableOneMember 2016-09-01 2017-08-31 0001138978 NVOS:NotePayableTwoMember 2016-09-01 2017-08-31 0001138978 NVOS:NotePayableThreeMember 2016-09-01 2017-08-31 0001138978 NVOS:ExercisePriceRangeOneMember 2018-02-28 0001138978 NVOS:ExercisePriceRangeTwoMember 2018-02-28 0001138978 NVOS:ExercisePriceRangeThreeMember 2018-02-28 0001138978 NVOS:ExercisePriceRangeFourMember 2018-02-28 0001138978 NVOS:ExercisePriceRangeFiveMember 2018-02-28 0001138978 NVOS:NotePayableOneMember 2017-09-01 2018-02-28 0001138978 NVOS:NotePayableTwoMember 2017-09-01 2018-02-28 0001138978 NVOS:NotePayableThreeMember 2017-09-01 2018-02-28 0001138978 2017-02-28 0001138978 NVOS:FiveDebenturesMember 2013-09-30 0001138978 NVOS:FiveDebenturesMember NVOS:CADMember 2013-09-30 0001138978 NVOS:FiveDebenturesMember 2017-11-29 2017-12-02 0001138978 NVOS:TwoThousandAndFifteenIncentiveCompensationPlanMember us-gaap:MaximumMember 2015-09-07 2015-09-08 0001138978 NVOS:TwoThousandAndFifteenIncentiveCompensationPlanMember 2016-09-01 2017-08-31 0001138978 NVOS:ExercisePriceRangeSixMember 2018-02-28 0001138978 2016-08-31 0001138978 NVOS:PeriodEndMember NVOS:CADMember 2018-02-28 0001138978 NVOS:PeriodEndMember NVOS:CADMember 2017-02-28 0001138978 NVOS:AveragePeriodMember NVOS:CADMember 2018-02-28 0001138978 NVOS:AveragePeriodMember NVOS:CADMember 2017-02-28 0001138978 NVOS:NotesReceivableDatedNovemberFifteenTwoThousandAndFourteenMember 2018-02-28 0001138978 NVOS:NotesReceivableDatedAprilOneTwoThousandAndFifteenAndMayTwentyThreeTwoThousandSeventeenMember 2018-02-28 0001138978 NVOS:AdvanceToCorporationOneMember 2018-02-28 0001138978 NVOS:AdvanceToCorporationTwoMember 2018-02-28 0001138978 NVOS:TwoThousandEighteenMember 2017-09-01 2018-02-28 0001138978 NVOS:ExercisePriceRangeSevenMember 2018-02-28 0001138978 us-gaap:SubsequentEventMember NVOS:BrandsInternationalCorporationMember 2017-12-26 0001138978 us-gaap:SubsequentEventMember NVOS:BrandsInternationalCorporationMember NVOS:CADMember 2017-12-26 0001138978 us-gaap:SubsequentEventMember NVOS:BrandsInternationalCorporationMember 2017-12-25 2017-12-26 0001138978 us-gaap:SubsequentEventMember NVOS:ShareholderAgreementMember NVOS:MarkRubinoffMember 2017-12-25 2017-12-26 0001138978 2017-12-01 2018-02-28 0001138978 2016-12-01 2017-02-28 0001138978 NVOS:ApkaHealthIncMember 2018-02-28 0001138978 NVOS:ExecutiveFitnessLeadersMember 2018-02-28 0001138978 2018-01-29 2018-01-31 0001138978 2018-01-31 0001138978 NVOS:AssetPurchaseAgreementMember NVOS:ExecutiveFitnessLeadersMember 2017-11-29 2017-11-30 0001138978 NVOS:AssetPurchaseAgreementMember NVOS:ExecutiveFitnessLeadersMember 2017-11-30 0001138978 NVOS:FiveDebenturesMember 2013-09-29 2013-09-30 0001138978 NVOS:FiveDebenturesMember 2018-01-29 2018-01-31 0001138978 NVOS:FiveDebenturesMember 2018-01-31 0001138978 NVOS:ExecutiveFitnessLeadersMember 2017-09-01 2018-02-28 0001138978 NVOS:TwoThousandAndEighteenIncentivePlanMember 2018-01-15 2018-01-16 0001138978 2016-09-01 2017-08-31 0001138978 NVOS:ExercisePriceRangeEightMember 2018-02-28 0001138978 NVOS:ExercisePriceRangeNineMember 2018-02-28 0001138978 us-gaap:MinimumMember 2017-09-01 2018-02-28 0001138978 us-gaap:MaximumMember 2017-09-01 2018-02-28 0001138978 us-gaap:SubsequentEventMember NVOS:ALMCASAPHoldingsIncMember 2018-03-15 0001138978 us-gaap:SubsequentEventMember NVOS:ICCHealthnetCanadaIncMember 2017-08-31 0001138978 us-gaap:SubsequentEventMember NVOS:ICCHealthnetCanadaIncMember 2018-02-28 0001138978 us-gaap:SubsequentEventMember NVOS:HealthnetAssessmentIncMember 2017-08-31 0001138978 us-gaap:SubsequentEventMember NVOS:HealthnetAssessmentIncMember 2018-02-28 0001138978 us-gaap:SubsequentEventMember 2017-08-31 0001138978 us-gaap:SubsequentEventMember 2018-02-28 0001138978 us-gaap:SubsequentEventMember NVOS:BrandsInternationalCorporationMember 2018-03-14 2018-03-16 0001138978 NVOS:TwoThousandAndEighteenIncentivePlanMember 2017-12-01 2018-02-28 0001138978 us-gaap:SubsequentEventMember NVOS:LetterAgreementMember 2018-01-28 2018-01-30 0001138978 NVOS:FiveDebenturesMember 2017-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD Novo Integrated Sciences, Inc. 0001138978 10-Q 2018-02-28 false --08-31 Smaller Reporting Company Q2 214673720

1896572

1036602

103064

110315

1128898

1348847

372024

402112

39940

299550

32534

292800

31232

78080

252536

217286

302951

314442

5514390

5071945

1703342

1743738

341657

291098

403119

142207

414965

1812613

880915

13171

6205

414351

404710

9802580

4718643

201837

214674

3381643

9834276

1240844

1153503

-9091977

-10823822

5514390

5071945

4399656

3652759

2145919

1834620

2715289

2354021

1307596

1189908

1684367

1298738

838323

644712

68740

18560

30601

8259

2983494

1188802

1965080

597637

-1299127

109936

-1126757

47075

-438074

-209717

-303972

-103607

-1737201

-99781

-1430729

-56532

-54216

-5356

-4491

-1956

-2764

-1731845

-95290

-1374557

-53768

-1824542

-32886

-1588041

-150780

-0.01

-0.00

-0.01

-0.00

203953457

167797406

206091162

167797406

0.001

1000000

0.001

499000000

201837254

214673720

201837254

214673720

-1109416

32719

30540

80084

89904

-43843

1615

303699

158039

-474933

-106141

-82646

360230

-270511

-260300

-31880

-1040

-859970

-7251

250133

318228

-30326

-31770

43431

17320

39215

7108

57986

The following table details the exchange rates used for the respective periods:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%; line-height: 107%">Period end: CAD to USD exchange rate</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7808</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7548</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7988</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Average period: CAD to USD exchange rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.7959</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.7551</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table> Delaware State of Nevada 2000-11-27 2008-02-20

0.80

0.591

167797406

384110

0.7988

0.7808

0.7548

0.7959

0.7551

10030000

P5Y

P3Y

P5Y

0.08

2017-10-31

2019-03-27

2019-04-08

2017-10-31

2019-03-27

2019-04-08

2016-09-30

571056

608603

329985

177514

21020

24319

18218

331696

204013

23113

23771

26010

268105

294161

427522

410915

7134

399400

20988

390400

20515

6205

404710

410915

7860000

10030000

2170000

8970000

0.27

0.30

0.42

0.30

P3Y6M10D

660000

781000

10030000

5500000

1000000

50000

120000

2000000

100000

1000000

250000

10000

0.16

0.32

0.33

0.40

0.42

0.50

0.62

0.80

2.00

8970000

5500000

50000

60000

2000000

100000

1000000

250000

10000

0.16

0.32

0.33

0.40

0.42

0.50

0.62

0.80

2.00

0.0183

P2Y6M

P3Y6M

3.14

0.00

0.41

0.58

0.42

1109416

2023

409350

387110

0.85

6402512

1873256

2350000

3894809

2396400

585600

1597600

390400

4968900

-20537

-25329

-4288190

353302

-4267653

378631

2914754

1170242

1934479

589378

211

21988

160

11010

438285

231705

304132

114617

-1737201

-99781

-1376513

-56532

6904

233155

507636

484145

0.08

2016-11-15

2018-05-23

0.072

0.00

0.06

0.072

0.00

0.06

P3Y3M26D

2018

5114327

1249770

399400

616832

390400

226432

225383

128098

81598

The per share price used for the conversion was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

The per share price used for the conversion of this loan was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

The per share price used for the conversion of each debenture was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.

5000000

10000000

4987500

9950000

2019-09-30

1162009

1135824

377550

Note 1 - Organization and Basis of Presentation   Organization and Line of Business   Novo Integrated Sciences, Inc. was incorporated in Delaware on November 27, 2000, under the name Turbine Truck Engines, Inc. On February 20, 2008, the Company was re-domiciled to the State of Nevada. Effective July 12, 2017, the Company’s name was changed to Novo Integrated Sciences, Inc. When used herein, the terms the “Company,” “we,” “us” and “our” refer to Novo Integrated Sciences, Inc. and its consolidated subsidiaries.   We provide specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, private personal training and dental services to our clients. Our multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention through our 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations throughout Canada. Directly and indirectly through our contractual relationships, we provide our specialized services to over 300,000 patients annually. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company’s services do not require a medical or nursing license.   On April 25, 2017 (the “Effective Date”), the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) by and between (i) the Company; (ii) NHL, (iii) ALMC-ASAP Holdings Inc. (“ALMC”); (iv) Michael Gaynor Family Trust (the “MGFT”); (v) 1218814 Ontario Inc. (“1218814”) and (vi) Michael Gaynor Physiotherapy Professional Corp. (“MGPP,” and together with ALMC, MGFT and 1218814, the “NHL Shareholders”). Pursuant to the terms of the Share Exchange Agreement, the Company agreed to acquire from the NHL Shareholders all of the shares of both common and preferred stock of NHL, held by the NHL Shareholders, in exchange for the issuance by the Company to the NHL Shareholders of shares of the Company’s common stock, such that following the closing of the Share Exchange Agreement, the NHL Shareholders would own 167,797,406 restricted shares of Company common stock, representing 85% of the issued and outstanding Company common stock, calculated including all granted and issued options or warrants to acquire the Company common stock as of the Effective Date, but to exclude shares of Company common stock that are subject to a then-current Regulation S offering that was undertaking by the Company (the “Exchange”).   On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.   The Exchange was accounted for as a reverse acquisition under the purchase method of accounting since NHL obtained control of Novo Integrated Sciences, Inc. Accordingly, the Exchange was recorded as a recapitalization of NHL, with NHL being treated as the continuing entity. The historical financial statements presented are the financial statements of NHL. The Share Exchange Agreement was treated as a recapitalization and not as a business combination; therefore, no pro forma information is disclosed. At the closing date of the Exchange, the net assets of the legal acquirer, Novo Integrated Sciences, Inc., were $6,904.   On May 9, 2017, our Board of Directors determined, in connection with the closing of the Exchange, to change our fiscal year end from December 31 to August 31 but did not memorialize such determination in writing. On July 17, 2017, the Board ratified and memorialized in writing its May 9, 2017 determination regarding the change in fiscal year end.   The unaudited consolidated financial statements are prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company’s financial position, the results of its operations, and cash flows for the periods presented. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) were omitted pursuant to such rules and regulations. The results of operations for the three and six months ended February 28, 2018 are not necessarily indicative of the results for the year ending August 31, 2018.   Basis of Presentation   The accompanying consolidated financial statements were prepared in conformity with U.S. GAAP. The Company’s Canadian subsidiaries’ functional currency is the Canadian Dollar (“CAD”); however, the accompanying consolidated financial statements were translated and presented in United States Dollars (“$” or “USD”).   Foreign Currency Translation   The accounts of the Company’s Canadian subsidiaries are maintained in CAD. The accounts of these subsidiaries are translated into USD in accordance with ASC Topic 830 Foreign Currency Transaction, with the CAD as the functional currency. According to Topic 830, all assets and liabilities are translated at the exchange rate on the balance sheet date, stockholders’ equity is translated at historical rates and statement of operations items are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance with ASC Topic 220, Comprehensive Income. Gains and losses resulting from the translations of foreign currency transactions and balances are reflected in the statement of operations and comprehensive income. The following table details the exchange rates used for the respective periods:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 43%; line-height: 107%">Period end: CAD to USD exchange rate</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7808</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7548</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">0.7988</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Average period: CAD to USD exchange rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.7959</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">0.7551</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> </table>

Note 2 – Summary of Significant Accounting Policies   Use of Estimates   The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.   Principles of Consolidation   The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.   Noncontrolling Interest   The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.   The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).   Cash Equivalents   For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.   Accounts Receivable   Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of February 28, 2018 and August 31, 2017, the allowance for uncollectible accounts receivable was $484,145 and $507,636, respectively.   Property and Equipment   Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 8%; line-height: 107%"> </td> <td style="width: 57%; line-height: 107%">Leasehold improvements</td> <td style="width: 35%; line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%">3 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%">5 years</td></tr> </table>   Long-Lived Assets   The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at February 28, 2018 and August 31, 2017, the Company believes there was no impairment of its long-lived assets.   Goodwill   Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. At February 28, 2018, the Company recorded goodwill of $390,400 and $226,432, respectively, related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017 and Executive Fitness Leaders during the fiscal year ended August 31, 2018.   Acquisition Deposits   The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,135,824 and $1,162,009 at February 28, 2018 and August 31, 2017, respectfully.   Fair Value of Financial Instruments   For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.   FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px; line-height: 107%"> </td> <td style="width: 24px; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement. </td></tr> </table>   The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.   As of February 28, 2018 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.   Revenue Recognition   Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.   Income Taxes   The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.   Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.   Stock-Based Compensation   The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.   Basic and Diluted Earnings Per Share   Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 10,030,000 options/warrants outstanding as of February 28, 2018. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.   Foreign Currency Transactions and Comprehensive Income   U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains of $1,153,503 and $1,240,844 at February 28, 2018 and August 31, 2017, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.   Statement of Cash Flows   Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.   Recent Accounting Pronouncements   In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.   In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.   In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.   Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

Note 3 – Related Party Transactions   Due to related parties   Amounts loaned to the Company by stockholders and officers of the Company that are payable upon demand.   On January 31, 2018, a related party converted $813,125 of outstanding amounts loaned to the Company into 1,976,483 shares of the Company’s common stock. The per share price used for the conversion of this loan was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price. At February 28, 2018, the amount due to related parties was $880,915.

Note 4 – Other Receivables   Other receivables at February 28, 2018 and August 31, 2017 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%">Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 18%; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 18%; text-align: right; line-height: 107%">39,940</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 8% per annum; secured by certain assets; due May 23, 2018.</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">292,800</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">299,550</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Advance to corporation; non-interest bearing; unsecured; payable upon demand</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">31,232</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">32,534</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Advance to corporation; non-interest bearing; unsecured; payable upon demand</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">78,080</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total other receivables</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">402,112</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">372,024</td> <td style="line-height: 107%"> </td></tr> </table>

Note 5 – Property and Equipment   Property and equipment at February 28, 2018 and August 31, 2017 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 56%; line-height: 107%">Leasehold Improvements</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 20%; text-align: right; line-height: 107%">331,696</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 18%; text-align: right; line-height: 107%">329,985</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">204,013</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">177,514</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">23,113</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">21,020</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">23,771</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">24,319</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">26,010</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">18,218</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">608,603</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">571,056</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Accumulated depreciation</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(294,161</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(268,105</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">314,442</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">302,951</td> <td style="line-height: 107%"> </td></tr> </table>   Depreciation expense for the six months ended February 28, 2018 and 2016 was $32,719 and $30,540, respectively.

Note 6 – Notes Payable   Notes payable at February 28, 2018 and August 31, 2017 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%">Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 18%; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 18%; text-align: right; line-height: 107%">7,134</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%"> Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 27, 2019.</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">390,400</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">399,400</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%"> Notes payable to financial institution assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $623; unsecured; due April 8, 2019.</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">20,515</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">20,988</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">410,915</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">427,522</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Current portion</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(6,205</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(13,171</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Long-term portion</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">404,710</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">414,351</td> <td style="line-height: 107%"> </td></tr> </table>   Aggregate future maturities of notes payable as of February 28 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 107%">Twelve months ending February 28,</td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; line-height: 107%">2019</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 26%; text-align: right; line-height: 107%">6,205</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">2020</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">404,710</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">410,915</td> <td style="line-height: 107%"> </td></tr> </table>

Note 7 – Debentures, related parties   On September 30, 2013, the Company issued five debentures totaling CAD$6,402,512 ($4,968,900 at November 30, 2017) in connection with the acquisition of certain business assets. The holders of the debentures are current stockholders, officers and/or affiliates of the Company. The debentures are secured by all the assets of the Company, accrue interest at 8% per annum and were originally due on September 30, 2016. On December 2, 2017, the debenture holders agreed to extend the due date to September 30, 2019.   On January 31, 2018, the debenture holders converted seventy-five percent (75%) of the debenture value of $3,894,809 plus accrued interest of $414,965 into 10,475,872 shares of the Company’s common stock. The per share price used for the conversion of each debenture was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price. At February 28, 2018, the amount of debentures outstanding was $1,249,770.

Note 8 – Stockholders’ Deficit   Convertible preferred stock   The Company has authorized 1,000,000 shares of $0.001 par value convertible preferred stock. At February 28, 2018 and August 31, 2017 there were 0 and 0 convertible preferred shares issued and outstanding, respectively.   Common stock   The Company has authorized 499,000,000 shares of $0.001 par value common stock. At February 28, 2018 and August 31, 2017 there were 214,673,720 and 201,837,254 common shares issued and outstanding, respectively.   During the six months ended February 28, 2018, the Company issued 384,110 shares of common stock for the acquisition of Executive Fitness Leaders valued at $233,155. The value was based on the closing price of the Company’s common stock on the acquisition date. In addition, during the same period, the Company issued 12,452,356 shares of common stock for the conversion of debt totaling $5,122,899. The per share price used for the conversion was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.   Stock options/warrants   On September 8, 2015, the Company adopted the 2015 Incentive Compensation Plan (the “2015 Plan”), which authorizes the issuance of up to 5,000,000 shares of common stock to employees, officers, directors or independent consultants of the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. During 2017 and 2016, the Company did not grant any awards under the 2015 Plan. As of August 31, 2017, 4,987,500 shares were available under the 2015 Plan for future grants, awards, options or share issuances. However, because the shares issuable under the 2015 Plan or issuable upon conversion of awards granted under the Plan are no longer registered under the Securities Exchange Act of 1934, as amended, the Company does not intend to issue any additional grants under the 2015 Plan.   On January 16, 2018, the Company adopted the Novo Integrated Sciences, Inc. 2018 Incentive Plan (the “2018 Plan”). Under the 2018 Plan, 10,000,000 shares of common stock are authorized for issuance to employees, non-employees, directors and key consultants to the Company or its subsidiaries. The 2018 Plan authorizes equity-based and cash-based incentives for participants. There were 9,950,000 shares available for award at February 28, 2018 under the 2018 Plan.   The following is a summary of stock option/warrant activity:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Options/</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Remaining</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Aggregate</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Warrants</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Contractual</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Intrinsic</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Life</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Value</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Outstanding, August 31, 2017</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">7,860,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">0.27</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">3.53</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">660,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right">2,170,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Forfeited</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Exercised</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Outstanding, February 28, 2018</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">10,030,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right">0.30</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right">3.44</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right">781,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Exercisable, February 28, 2018</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">8,970,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt">$</td> <td style="padding-bottom: 2.5pt; text-align: right">0.30</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right">3.32</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt">$</td> <td style="padding-bottom: 2.5pt; text-align: right">781,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   The exercise price for options/warrants outstanding at February 28, 2018:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="5" style="border-bottom: black 1.5pt solid; text-align: center">Outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Exercisable</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Number of</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Number of</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Options/</td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Options/</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center">Warrants</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Warrants</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 25%; text-align: right">5,500,000</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">0.16</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">5,500,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">0.16</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">1,000,000</td> <td> </td> <td> </td> <td style="text-align: right">0.32</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.32</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right">50,000</td> <td> </td> <td> </td> <td style="text-align: right">0.33</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">50,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.33</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">120,000</td> <td> </td> <td> </td> <td style="text-align: right">0.40</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">60,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.40</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right">2,000,000</td> <td> </td> <td> </td> <td style="text-align: right">0.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,000,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.42</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">100,000</td> <td> </td> <td> </td> <td style="text-align: right">0.50</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">100,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.50</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right">1,000,000</td> <td> </td> <td> </td> <td style="text-align: right">0.62</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,000,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.62</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">250,000</td> <td> </td> <td> </td> <td style="text-align: right">0.80</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">250,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.80</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1.5pt solid; text-align: right">10,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">10,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 2.25pt double; text-align: right">10,030,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">8,970,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   For options granted during fiscal year 2017 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.58 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2017 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.   For options granted during fiscal year 2018 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $0.41 and the weighted-average exercise price of such options/warrants was $0.42. No options were granted during fiscal 2018 where the exercise price was less than the stock price at the date of grant or the exercise price was greater than the stock price at the date of grant.   The fair value of the stock options is being amortized to stock option expense over the vesting period. The Company recorded stock option expense of $1,109,416 during the six months ended February 28, 2018. At February 28, 2018, the unamortized stock option expense was $165,515.   The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 67%">Risk-free interest rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 30%; text-align: right">1.83</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected life of the options</td> <td> </td> <td> </td> <td style="text-align: right">2.5 to 3.5 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">314</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected dividend yield</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>

Note 9 – Commitments and Contingencies   Litigation   The Company is party to certain legal proceedings from time to time incidental to the conduct of its business. These proceedings could result in fines, penalties, compensatory or treble damages or non-monetary relief. The nature of legal proceedings is such that the Company cannot assure the outcome of any particular matter, and an unfavorable ruling or development could have a materially adverse effect on our consolidated financial position, results of operations and cash flows in the period in which a ruling or settlement occurs. However, based on information available to the Company’s management to date, the Company’s management does not expect that the outcome of any matter pending against the Company is likely to have a materially adverse effect on the Company’s consolidated financial position as of February 28, 2018, results of operations, cash flows or liquidity of the Company.   Leases   The Company leases its office space and certain facilities under long-term operating leases expiring through fiscal year 2023. Rent expense under these leases was $409,350 and $387,110 for the six months ended February 28, 2018 and 2017, respectively.

Note 11 – Subsequent Events   Michael Gaynor Resignation   On March 15, 2018, Michael Gaynor resigned his position as the Company’s Treasurer. Mr. Gaynor will continue to act as the Company’s Secretary and as a member of the Company’s board of directors.   Emily Mattacchione Appointment   Effective March 15, 2018, Emily Mattacchione was appointed as the Company’s Treasurer. ALMC-ASAP Holdings, Inc. (“ALMC-ASAP”) owns approximately 59.1% of the Company’s outstanding common stock. ALMC-ASAP’s shares are held by the Mattacchione Family Trust. Ms. Mattacchione and her spouse, Robert Mattacchione, are co-trustees of the Mattacchione Family Trust and share voting and depository power over the ALMC-ASAP shares.   At August 31, 2017 and February 28, 2018, the Company had a debenture totaling $2,396,400 and $585,600, respectively, due to ICC Healthnet Canada, Inc. Also, at August 31, 2017 and February 28, 2018, the Company had a debenture totaling $1,597,600 and $390,400 respectively, due to Healthnet Assessment Inc. Each of ICC Healthnet Canada, Inc. and Healthnet Assessment Inc. is owned by Mr. Mattacchione, Ms. Mattacchione’s spouse. The conversion rate used for the respective periods August 31, 2017 and February 28, 2018 is $0.7988 and $0.7808.   Amendment of Brands Letter of Intent   On December 26, 2017, the Company entered into a binding letter of intent (the “LOI”) with Brands International Corporation (“Brands”), pursuant to which the Company agreed to acquire 60% of the issued and outstanding shares of Brands in exchange for the arrangement of secured debt financing in the amount of CAD$2,350,000 (approximately $1,873,256 per the Bank of Canada posted exchange rate of 0.7977 on December 29, 2017) arranged or provided by the Company (the “Acquisition”). Upon completion of the Acquisition, the Company will own 60% of Brands’ issued and outstanding shares and Brands will be a majority-owned subsidiary of the Company. In connection with the Acquisition, the Company will enter into a shareholder agreement with Mark Rubinoff and a management agreement with Mark Rubinoff and DJ Rubinoff. In addition, pursuant to the terms of the LOI, the Company agreed to provide Mark Rubinoff with a buyout structure for the remaining 40% of Brands’ shares with a trigger date of 24 months from the closing of the Acquisition.   The parties to the LOI agreed to proceed reasonably and in good faith toward negotiation and execution of a definitive acquisition agreement, and to use their commercially reasonable best efforts to obtain necessary board, stockholder and regulatory approvals and third party consents.   The LOI provided for a termination date of January 30, 2018. On January 30, 2018, the Company and Brands executed a letter agreement (the “Letter Agreement”) that had the effect of amending the LOI to extend the termination date to March 20, 2018.   On March 16, 2018, the Company and Brands executed Amendment #2 to the LOI, as amended, that had the effect of amending the LOI to extend the termination date to April 20, 2018. The terms of the LOI, as amended, otherwise remain in full force and effect.

Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 8%; line-height: 107%"> </td> <td style="width: 57%; line-height: 107%">Leasehold improvements</td> <td style="width: 35%; line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%">3 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%">5 years</td></tr> </table> Other receivables at February 28, 2018 and August 31, 2017 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%">Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 18%; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 18%; text-align: right; line-height: 107%">39,940</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 8% per annum; secured by certain assets; due May 23, 2018.</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">292,800</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">299,550</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Advance to corporation; non-interest bearing; unsecured; payable upon demand</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">31,232</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">32,534</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Advance to corporation; non-interest bearing; unsecured; payable upon demand</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">78,080</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Total other receivables</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">402,112</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">372,024</td> <td style="line-height: 107%"> </td></tr> </table>

Property and equipment at February 28, 2018 and August 31, 2017 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 56%; line-height: 107%">Leasehold Improvements</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 20%; text-align: right; line-height: 107%">331,696</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 18%; text-align: right; line-height: 107%">329,985</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">204,013</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">177,514</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">23,113</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">21,020</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">23,771</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">24,319</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">26,010</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">18,218</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">608,603</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">571,056</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Accumulated depreciation</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(294,161</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(268,105</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">314,442</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">302,951</td> <td style="line-height: 107%"> </td></tr> </table>

Notes payable at February 28, 2018 and August 31, 2017 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">February 28, 2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">August 31, 2017</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; line-height: 107%">Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 18%; text-align: right; line-height: 107%">-</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 18%; text-align: right; line-height: 107%">7,134</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%"> Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 27, 2019.</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">390,400</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">399,400</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%"> Notes payable to financial institution assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $623; unsecured; due April 8, 2019.</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">20,515</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">20,988</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">410,915</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">427,522</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Current portion</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(6,205</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(13,171</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Long-term portion</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">404,710</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">414,351</td> <td style="line-height: 107%"> </td></tr> </table>

Aggregate future maturities of notes payable as of February 28 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; line-height: 107%">Twelve months ending February 28,</td> <td style="line-height: 107%"> </td> <td colspan="2" style="line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; line-height: 107%">2019</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 26%; text-align: right; line-height: 107%">6,205</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">2020</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">404,710</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">410,915</td> <td style="line-height: 107%"> </td></tr> </table>

The following is a summary of stock option/warrant activity:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Weighted</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Options/</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Average</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Remaining</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Aggregate</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Warrants</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Contractual</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Intrinsic</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Life</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Value</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Outstanding, August 31, 2017</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">7,860,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">0.27</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">3.53</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">660,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right">2,170,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Forfeited</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Exercised</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Outstanding, February 28, 2018</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">10,030,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right">0.30</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right">3.44</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right">781,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Exercisable, February 28, 2018</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">8,970,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt">$</td> <td style="padding-bottom: 2.5pt; text-align: right">0.30</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right">3.32</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt">$</td> <td style="padding-bottom: 2.5pt; text-align: right">781,000</td> <td style="padding-bottom: 2.5pt"></td></tr> </table>

The exercise price for options/warrants outstanding at February 28, 2018:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="5" style="border-bottom: black 1.5pt solid; text-align: center">Outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Exercisable</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Number of</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Number of</td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Options/</td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Options/</td> <td> </td> <td> </td> <td colspan="2" style="text-align: center">Exercise</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center">Warrants</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Warrants</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 25%; text-align: right">5,500,000</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">0.16</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">5,500,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">0.16</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">1,000,000</td> <td> </td> <td> </td> <td style="text-align: right">0.32</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.32</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right">50,000</td> <td> </td> <td> </td> <td style="text-align: right">0.33</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">50,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.33</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">120,000</td> <td> </td> <td> </td> <td style="text-align: right">0.40</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">60,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.40</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right">2,000,000</td> <td> </td> <td> </td> <td style="text-align: right">0.42</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,000,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.42</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">100,000</td> <td> </td> <td> </td> <td style="text-align: right">0.50</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">100,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.50</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: right">1,000,000</td> <td> </td> <td> </td> <td style="text-align: right">0.62</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,000,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.62</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: right">250,000</td> <td> </td> <td> </td> <td style="text-align: right">0.80</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">250,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.80</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="border-bottom: black 1.5pt solid; text-align: right">10,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">10,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right">2.00</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="border-bottom: black 2.25pt double; text-align: right">10,030,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">8,970,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt"></td></tr> </table>

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 67%">Risk-free interest rate</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 30%; text-align: right">1.83</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected life of the options</td> <td> </td> <td> </td> <td style="text-align: right">2.5 to 3.5 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">314</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected dividend yield</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>

263403

202314

3567

623

3567

623

165515

P3Y5M9D

233155

Bank of Canada posted exchange rate of 0.7977 on December 29, 2017 NVOS 0.60 0.40

3650030

3004847

4273902

3064163

-87341

66895

-211528

-94248

Note 10 – Acquisition of Assets   On December 1, 2017, the Company and Executive Fitness Leaders, located in Ottawa Ontario Canada, entered into an Asset Purchase Agreement, pursuant to which the Company acquired substantially all of the assets of Executive Fitness Leaders in exchange for the issuance, by the Company, of 384,110 restricted shares of its common stock valued at $233,155. The purchase price was allocated to furniture and equipment of $7,772 and goodwill of $225,383. The transaction closed on December 1, 2017. The purchase of these assets was not considered significant for accounting purposes; therefore, pro forma financial statements are not presented.

5122899

813125

12452356

1976483

10475872

0.4114

0.7988

0.7808

7772

384110

2018-04-20 2018-03-20

Use of Estimates   The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Principles of Consolidation   The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, NHL, Novo Peak Health Inc., Novo Healthnet Rehab Limited, Novo Assessments Inc., an 80% interest in Novo Healthnet Kemptville Centre, Inc., a Back on Track Physiotherapy and Health Centre clinic operated by NHL, and a fifty percent stake in a joint venture with the Sophie Freeman Dental Hygiene Professional Corporation operated as Novo Dental. All of the Company’s subsidiaries are incorporated under the laws of the Province of Ontario, Canada. All intercompany transactions have been eliminated.

Noncontrolling Interest   The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation, which governs the accounting for and reporting of non-controlling interests (“NCIs”) in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCIs be treated as a separate component of equity, not as a liability, that increases and decreases in the parent’s ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially owned consolidated subsidiary be allocated to the NCI even when such allocation might result in a deficit balance.   The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents   For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly liquid debt instruments with original maturities of three months or less.

Accounts Receivable   Accounts receivable are recorded, net of allowance for doubtful accounts and sales returns. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentration, customer credit worthiness, current economic trends and changes in customer payment patterns to determine if the allowance for doubtful accounts is adequate. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Delinquent account balances are written-off after management has determined that the likelihood of collection is not probable and known bad debts are written off against the allowance for doubtful accounts when identified. As of February 28, 2018 and August 31, 2017, the allowance for uncollectible accounts receivable was $484,145 and $507,636, respectively.

Property and Equipment   Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 8%; line-height: 107%"> </td> <td style="width: 57%; line-height: 107%">Leasehold improvements</td> <td style="width: 35%; line-height: 107%">5 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Clinical equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Computer equipment</td> <td style="line-height: 107%">3 years</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Office equipment</td> <td style="line-height: 107%">5 years</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">Furniture and fixtures</td> <td style="line-height: 107%">5 years</td></tr> </table>

Long-Lived Assets   The Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review at February 28, 2018 and August 31, 2017, the Company believes there was no impairment of its long-lived assets.

Goodwill   Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. Under accounting requirements, goodwill is not amortized but is subject to annual impairment tests. At February 28, 2018, the Company recorded goodwill of $390,400 and $226,432, respectively, related to its acquisition of Apka Health, Inc. during fiscal year ended August 31, 2017 and Executive Fitness Leaders during the fiscal year ended August 31, 2018.

Acquisition Deposits   The Company has signed letters of understanding with two potential acquisition candidates which includes refundable acquisition deposits totaling $1,135,824 and $1,162,009 at February 28, 2018 and August 31, 2017, respectfully.

Fair Value of Financial Instruments   For certain of the Company’s financial instruments, including cash and equivalents, restricted cash, accounts receivable, advances to suppliers, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their fair values due to their short maturities.   FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the fair value of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px; line-height: 107%"> </td> <td style="width: 24px; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="line-height: 107%"> </td> <td style="line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement. </td></tr> </table>   The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.   As of February 28, 2018 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition   Revenue related to healthcare services provided is recognized at the time services have been performed. Gross service revenue is recorded in the accounting records on an accrual basis at the provider’s established rates, regardless of whether the health care entity expects to collect that amount. The Company will reserve a provision for contractual adjustment and discounts and deduct from gross service revenue. The Company believes that recognizing revenue at the time the services have been performed is appropriate because the Company’s revenue policies meet the following four criteria in accordance with FASB ASC 605, Revenue Recognition: (i) persuasive evidence that arrangement exists, (ii) services has occurred, (iii) the price is fixed and determinable and (iv) collectability is reasonably assured. The Company reports revenues net of any sales, use and value added taxes.

Income Taxes   The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.   Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented.

Stock-Based Compensation   The Company records stock-based compensation in accordance with FASB ASC Topic 718, Compensation – Stock Compensation. FASB ASC Topic 718 requires companies to measure compensation cost for stock-based employee compensation at fair value at the grant date and recognize the expense over the requisite service period. The Company recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees and non-employees.

Basic and Diluted Earnings Per Share   Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS is based on the assumption that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. There were 10,030,000 options/warrants outstanding as of February 28, 2018. Due to the net loss incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented.

Foreign Currency Transactions and Comprehensive Income   U.S. GAAP generally requires recognized revenue, expenses, gains and losses be included in net income. Certain statements, however, require entities to report specific changes in assets and liabilities, such as gain or loss on foreign currency translation, as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income. The functional currency of the Company’s Canadian subsidiaries is the Canadian $. Translation gains of $1,153,503 and $1,240,844 at February 28, 2018 and August 31, 2017, respectively, are classified as an item of other comprehensive income in the stockholders’ equity section of the balance sheet.

Statement of Cash Flows   Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

Recent Accounting Pronouncements   In January 2017, the FASB issued an Accounting Standards Update (“ASU”) 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date. The Company is in the process of evaluating the impact of this accounting standard update.   In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, which requires restricted cash to be presented with cash and cash equivalents on the statement of cash flows and disclosure of how the statement of cash flows reconciles to the balance sheet if restricted cash is shown separately from cash and cash equivalents on the balance sheet. ASU 2016-18 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 is effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for targeted changes with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice. ASU 2016-15 is effective for interim and annual periods beginning after December 15, 2017, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its statements of cash flows.   In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018 and interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update on its financial statements.   In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle-based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted only in annual reporting periods beginning after December 15, 2016, including interim periods therein. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company’s financial statements and disclosures.   Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

0.75

EX-101.SCH 6 nvos-20180228.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Other Receivables link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Debentures, Related Parties link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Acquisition of Assets link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Organization and Basis of Presentation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Other Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Stockholders' Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Organization and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Notes Payable - Schedule of Future Maturities of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Debentures, Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Stockholders' Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Stockholders' Deficit - Schedule of Stock Option and Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Stockholders' Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Stockholders' Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Acquisition of Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 nvos-20180228_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 nvos-20180228_def.xml XBRL DEFINITION FILE EX-101.LAB 9 nvos-20180228_lab.xml XBRL LABEL FILE Legal Entity [Axis] Turbine Truck Engines, Inc [Member] Turbine Truck Engines, Inc One [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Share Exchange Agreement [Member] NHL [Member] Report Date [Axis] Period End [Member] Currency [Axis] CAD [Member] Novo Healthnet Kemptville Centre, Inc [Member] Property, Plant and Equipment, Type [Axis] Leasehold Improvements [Member] Clinical Equipment [Member] Computer Equipment [Member] Office Equipment [Member] Furniture and Fixtures [Member] Receivable Type [Axis] Notes Receivable Dated November 15, 2014 [Member] Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member] Advance to Corporation One [Member] Advance to Corporation Two [Member] Debt Instrument [Axis] Note Payable One [Member] Note Payable Two [Member] Note Payable Three [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member] Exercise Price Range Five [Member] Five Debentures [Member] Plan Name [Axis] 2015 Incentive Compensation Plan [Member] Range [Axis] Maximum [Member] Exercise Price Range Six [Member] Average Period [Member] Award Date [Axis] 2018 [Member] Exercise Price Range Seven [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Brands International Corporation [Member] Shareholder Agreement [Member] Title of Individual [Axis] Mark Rubinoff [Member] Apka Health, Inc. [Member] Executive Fitness Leaders [Member] Asset Purchase Agreement [Member] 2018 Incentiven Plan [Member] Exercise Price Range Eight [Member] Exercise Price Range Nine [Member] Minimum [Member] Related Party [Axis] ALMC-ASAP Holdings, Inc. [Member] ICC Healthnet Canada, Inc. [Member] Healthnet Assessment Inc. [Member] Letter Agreement [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets: Cash and cash equivalents Accounts receivable, net Other receivables Prepaid expenses and other current assets Total current assets Property and equipment, net Acquisition deposits Goodwill TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Current Liabilities: Accounts payable Accrued expenses Accrued interest (principally to related parties) Due to related parties Notes payable, current portion Total current liabilities Debentures, related parties Notes payable, net of current portion TOTAL LIABILITIES Commitments and contingencies STOCKHOLDERS’ EQUITY (DEFICIT) Novo Integrated Sciences, Inc. Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at February 28, 2018 and August 31, 2017 Common stock; $0.001par value; 499,000,000 shares authorized; 214,673,720 and 201,837,254 shares issued and outstanding at February 28, 2018 and August 31, 2017 Additional paid-in capital Other comprehensive income Accumulated deficit Total Novo Integrated Sciences, Inc. stockholders’ equity (deficit) Noncontrolling interest Total stockholders’ equity (deficit) TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Convertible preferred stock, par value Convertible preferred stock, shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Cost of revenues Gross profit Operating expenses: Selling expenses General and administrative expenses Total operating expenses Income (loss) from operations Non operating income (expense) Interest income Interest expense Total other income (expense) Loss before income taxes Income tax expense (benefit) Net loss Net loss attributed to noncontrolling interest Net loss attributed to Novo Integrated Sciences, Inc. Comprehensive loss: Net loss Foreign currency translation gain (loss) Comprehensive loss: Weighted average common shares outstanding - basic and diluted Net loss per common share - basic and diluted Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Fair value of vested stock options Changes in operating assets and liabilities: Accounts receivable Prepaid expenses and other current assets Accounts payable Accrued expenses Accrued interest Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of furniture and equipment Amounts loaned for other receivables Repayments of other receivables Net cash provided by (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Payments to related parties Payments on notes payable Net cash used in financing activities Effect of exchange rate changes on cash and equivalents NET DECREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF PERIOD CASH PAID FOR: Interest Income taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Related Party Transactions [Abstract] Related Party Transactions Receivables [Abstract] Other Receivables Property, Plant and Equipment [Abstract] Property and Equipment Debt Disclosure [Abstract] Notes Payable Debentures, Related Parties Equity [Abstract] Stockholders' Deficit Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Business Combinations [Abstract] Acquisition of Assets Subsequent Events [Abstract] Subsequent Events Use of Estimates Principles of Consolidation Noncontrolling Interest Cash Equivalents EX-101.PRE 10 nvos-20180228_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Feb. 28, 2018	Apr. 09, 2018
Document And Entity Information
Entity Registrant Name	Novo Integrated Sciences, Inc.
Entity Central Index Key	0001138978
Document Type	10-Q
Document Period End Date	Feb. 28, 2018
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		214,673,720
Trading Symbol	NVOS
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2018

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Feb. 28, 2018	Aug. 31, 2017
Current Assets:
Cash and cash equivalents	$ 1,036,602	$ 1,896,572
Accounts receivable, net	1,348,847	1,128,898
Other receivables	402,112	372,024
Prepaid expenses and other current assets	217,286	252,536
Total current assets	3,004,847	3,650,030
Property and equipment, net	314,442	302,951
Acquisition deposits	1,135,824	1,162,009
Goodwill	616,832	399,400
TOTAL ASSETS	5,071,945	5,514,390
Current Liabilities:
Accounts payable	1,743,738	1,703,342
Accrued expenses	291,098	341,657
Accrued interest (principally to related parties)	142,207	403,119
Due to related parties	880,915	1,812,613
Notes payable, current portion	6,205	13,171
Total current liabilities	3,064,163	4,273,902
Debentures, related parties	1,249,770	5,114,327
Notes payable, net of current portion	404,710	414,351
TOTAL LIABILITIES	4,718,643	9,802,580
Commitments and contingencies
Novo Integrated Sciences, Inc.
Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at February 28, 2018 and August 31, 2017
Common stock; $0.001par value; 499,000,000 shares authorized; 214,673,720 and 201,837,254 shares issued and outstanding at February 28, 2018 and August 31, 2017	214,674	201,837
Additional paid-in capital	9,834,276	3,381,643
Other comprehensive income	1,153,503	1,240,844
Accumulated deficit	(10,823,822)	(9,091,977)
Total Novo Integrated Sciences, Inc. stockholders’ equity (deficit)	378,631	(4,267,653)
Noncontrolling interest	(25,329)	(20,537)
Total stockholders’ equity (deficit)	353,302	(4,288,190)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 5,071,945	$ 5,514,390

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Feb. 28, 2018	Aug. 31, 2017
Statement of Financial Position [Abstract]
Convertible preferred stock, par value	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	1,000,000	1,000,000
Convertible preferred stock, shares issued	0	0
Convertible preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	499,000,000	499,000,000
Common stock, shares issued	214,673,720	201,837,254
Common stock, shares outstanding	214,673,720	201,837,254

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2018	Feb. 28, 2017	Feb. 28, 2018	Feb. 28, 2017
Income Statement [Abstract]
Revenues	$ 2,145,919	$ 1,834,620	$ 4,399,656	$ 3,652,759
Cost of revenues	1,307,596	1,189,908	2,715,289	2,354,021
Gross profit	838,323	644,712	1,684,367	1,298,738
Operating expenses:
Selling expenses	30,601	8,259	68,740	18,560
General and administrative expenses	1,934,479	589,378	2,914,754	1,170,242
Total operating expenses	1,965,080	597,637	2,983,494	1,188,802
Income (loss) from operations	(1,126,757)	47,075	(1,299,127)	109,936
Non operating income (expense)
Interest income	160	11,010	211	21,988
Interest expense	(304,132)	(114,617)	(438,285)	(231,705)
Total other income (expense)	(303,972)	(103,607)	(438,074)	(209,717)
Loss before income taxes	(1,430,729)	(56,532)	(1,737,201)	(99,781)
Income tax expense (benefit)	(54,216)
Net loss	(1,376,513)	(56,532)	(1,737,201)	(99,781)
Net loss attributed to noncontrolling interest	(1,956)	(2,764)	(5,356)	(4,491)
Net loss attributed to Novo Integrated Sciences, Inc.	(1,374,557)	(53,768)	(1,731,845)	(95,290)
Comprehensive loss:
Net loss	(1,376,513)	(56,532)	(1,737,201)	(99,781)
Foreign currency translation gain (loss)	(211,528)	(94,248)	(87,341)	66,895
Comprehensive loss:	$ (1,588,041)	$ (150,780)	$ (1,824,542)	$ (32,886)
Weighted average common shares outstanding - basic and diluted	206,091,162	167,797,406	203,953,457	167,797,406
Net loss per common share - basic and diluted	$ (0.01)	$ (0.00)	$ (0.01)	$ (0.00)

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Feb. 28, 2018	Feb. 28, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,737,201)	$ (99,781)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	32,719	30,540
Fair value of vested stock options	1,109,416
Changes in operating assets and liabilities:
Accounts receivable	(250,133)	(318,228)
Prepaid expenses and other current assets	30,326	31,770
Accounts payable	80,084	89,904
Accrued expenses	(43,843)	1,615
Accrued interest	303,699	158,039
Net cash used in operating activities	(474,933)	(106,141)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of furniture and equipment	(43,431)	(17,320)
Amounts loaned for other receivables	(39,215)
Repayments of other receivables		377,550
Net cash provided by (used in) investing activities	(82,646)	360,230
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments to related parties	(263,403)	(202,314)
Payments on notes payable	(7,108)	(57,986)
Net cash used in financing activities	(270,511)	(260,300)
Effect of exchange rate changes on cash and equivalents	(31,880)	(1,040)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(859,970)	(7,251)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	1,896,572	110,315
CASH AND CASH EQUIVALENTS, END OF PERIOD	1,036,602	103,064
CASH PAID FOR:
Interest	128,098	81,598
Income taxes

XML 16 R6.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation

6 Months Ended

Feb. 28, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Basis of Presentation

Note 1 - Organization and Basis of Presentation

Organization and Line of Business

On May 9, 2017, the Exchange closed and, as a result, NHL became a wholly owned subsidiary of Novo Integrated Sciences, Inc.

Basis of Presentation

Foreign Currency Translation

	February 28, 2018		February 28, 2017		August 31, 2017

Period end: CAD to USD exchange rate	$	0.7808	$	0.7548	$	0.7988
Average period: CAD to USD exchange rate	$	0.7959	$	0.7551

XML 17 R7.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Feb. 28, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

Use of Estimates

Principles of Consolidation

Noncontrolling Interest

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents

Accounts Receivable

Property and Equipment

	Leasehold improvements	5 years
	Clinical equipment	5 years
	Computer equipment	3 years
	Office equipment	5 years
	Furniture and fixtures	5 years

Long-Lived Assets

Goodwill

Acquisition Deposits

Fair Value of Financial Instruments

	●	Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

	●	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

	●	Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement.

As of February 28, 2018 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition

Income Taxes

Stock-Based Compensation

Basic and Diluted Earnings Per Share

Foreign Currency Transactions and Comprehensive Income

Statement of Cash Flows

Recent Accounting Pronouncements

XML 18 R8.htm IDEA: XBRL DOCUMENT

Related Party Transactions

6 Months Ended

Feb. 28, 2018

Related Party Transactions

Note 3 – Related Party Transactions

Due to related parties

Amounts loaned to the Company by stockholders and officers of the Company that are payable upon demand.

XML 19 R9.htm IDEA: XBRL DOCUMENT

Other Receivables

6 Months Ended

Feb. 28, 2018

Receivables [Abstract]

Other Receivables

Note 4 – Other Receivables

Other receivables at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018		August 31, 2017
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.	$	-	$	39,940
Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 8% per annum; secured by certain assets; due May 23, 2018.		292,800		299,550
Advance to corporation; non-interest bearing; unsecured; payable upon demand		31,232		32,534
Advance to corporation; non-interest bearing; unsecured; payable upon demand		78,080		-
Total other receivables	$	402,112	$	372,024

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

XML 20 R10.htm IDEA: XBRL DOCUMENT

Property and Equipment

6 Months Ended

Feb. 28, 2018

Property, Plant and Equipment [Abstract]

Property and Equipment

Note 5 – Property and Equipment

Property and equipment at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018			August 31, 2017
Leasehold Improvements	$	331,696		$	329,985
Clinical equipment		204,013			177,514
Computer equipment		23,113			21,020
Office equipment		23,771			24,319
Furniture and fixtures		26,010			18,218
		608,603			571,056
Accumulated depreciation		(294,161	)		(268,105	)
Total	$	314,442		$	302,951

Depreciation expense for the six months ended February 28, 2018 and 2016 was $32,719 and $30,540, respectively.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Notes Payable

6 Months Ended

Feb. 28, 2018

Debt Disclosure [Abstract]

Notes Payable

Note 6 – Notes Payable

Notes payable at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018			August 31, 2017
Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.		-			7,134
Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 27, 2019.		390,400			399,400
Notes payable to financial institution assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $623; unsecured; due April 8, 2019.		20,515			20,988
		410,915			427,522
Current portion		(6,205	)		(13,171	)
Long-term portion	$	404,710		$	414,351

Aggregate future maturities of notes payable as of February 28 are as follows:

Twelve months ending February 28,
2019	$	6,205
2020		404,710
	$	410,915

XML 22 R12.htm IDEA: XBRL DOCUMENT

Debentures, Related Parties

6 Months Ended

Feb. 28, 2018

Debt Disclosure [Abstract]

Debentures, Related Parties

Note 7 – Debentures, related parties

XML 23 R13.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit

6 Months Ended

Feb. 28, 2018

Equity [Abstract]

Stockholders' Deficit

Note 8 – Stockholders’ Deficit

Convertible preferred stock

Common stock

Stock options/warrants

The following is a summary of stock option/warrant activity:

					Weighted
			Weighted		Average
	Options/		Average		Remaining		Aggregate
	Warrants		Exercise		Contractual		Intrinsic
	Outstanding		Price		Life		Value
Outstanding, August 31, 2017		7,860,000	$	0.27		3.53	$	660,000
Granted		2,170,000		0.42
Forfeited		-
Exercised		-
Outstanding, February 28, 2018		10,030,000		0.30		3.44		781,000
Exercisable, February 28, 2018		8,970,000	$	0.30		3.32	$	781,000

The exercise price for options/warrants outstanding at February 28, 2018:

Outstanding			Exercisable
Number of			Number of
Options/	Exercise		Options/		Exercise
Warrants	Price		Warrants		Price
5,500,000	$	0.16		5,500,000	$	0.16
1,000,000		0.32		-		0.32
50,000		0.33		50,000		0.33
120,000		0.40		60,000		0.40
2,000,000		0.42		2,000,000		0.42
100,000		0.50		100,000		0.50
1,000,000		0.62		1,000,000		0.62
250,000		0.80		250,000		0.80
10,000		2.00		10,000		2.00
10,030,000				8,970,000

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

Risk-free interest rate	1.83	%
Expected life of the options	2.5 to 3.5 years
Expected volatility	314	%
Expected dividend yield	0	%

XML 24 R14.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

6 Months Ended

Feb. 28, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 9 – Commitments and Contingencies

Litigation

Leases

XML 25 R15.htm IDEA: XBRL DOCUMENT

Acquisition of Assets

6 Months Ended

Feb. 28, 2018

Business Combinations [Abstract]

Acquisition of Assets

Note 10 – Acquisition of Assets

XML 26 R16.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Feb. 28, 2018

Subsequent Events [Abstract]

Subsequent Events

Note 11 – Subsequent Events

Michael Gaynor Resignation

Emily Mattacchione Appointment

Amendment of Brands Letter of Intent

XML 27 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Feb. 28, 2018

Accounting Policies [Abstract]

Use of Estimates

Principles of Consolidation

Noncontrolling Interest

The net income (loss) attributed to the NCI is separately designated in the accompanying consolidated statements of operations and other comprehensive income (loss).

Cash Equivalents

Accounts Receivable

Property and Equipment

	Leasehold improvements	5 years
	Clinical equipment	5 years
	Computer equipment	3 years
	Office equipment	5 years
	Furniture and fixtures	5 years

Long-Lived Assets

Goodwill

Acquisition Deposits

Fair Value of Financial Instruments

	●	Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

	●	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

	●	Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the fair value measurement.

As of February 28, 2018 and August 31, 2017, respectively, the Company did not identify any assets and liabilities required to be presented on the balance sheet at fair value.

Revenue Recognition

Income Taxes

Stock-Based Compensation

Basic and Diluted Earnings Per Share

Foreign Currency Transactions and Comprehensive Income

Statement of Cash Flows

Recent Accounting Pronouncements

XML 28 R18.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation (Tables)

6 Months Ended

Feb. 28, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Foreign Currency Translation, Exchange Rate Used

The following table details the exchange rates used for the respective periods:

	February 28, 2018		February 28, 2017		August 31, 2017

Period end: CAD to USD exchange rate	$	0.7808	$	0.7548	$	0.7988
Average period: CAD to USD exchange rate	$	0.7959	$	0.7551

XML 29 R19.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Feb. 28, 2018

Accounting Policies [Abstract]

Schedule of Estimated Useful Lives of Assets

Depreciation of property and equipment is provided using the declining balance method for substantially all assets with estimated lives as follows:

	Leasehold improvements	5 years
	Clinical equipment	5 years
	Computer equipment	3 years
	Office equipment	5 years
	Furniture and fixtures	5 years

XML 30 R20.htm IDEA: XBRL DOCUMENT

Other Receivables (Tables)

6 Months Ended

Feb. 28, 2018

Receivables [Abstract]

Schedule of Other Receivables

Other receivables at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018		August 31, 2017
Notes receivable dated November 15, 2014; accrues interest at 8% per annum; secured by assets; due November 15, 2016.	$	-	$	39,940
Notes receivable dated April 1, 2015 and amended on May 23, 2017; accrues interest at 8% per annum; secured by certain assets; due May 23, 2018.		292,800		299,550
Advance to corporation; non-interest bearing; unsecured; payable upon demand		31,232		32,534
Advance to corporation; non-interest bearing; unsecured; payable upon demand		78,080		-
Total other receivables	$	402,112	$	372,024

XML 31 R21.htm IDEA: XBRL DOCUMENT

Property and Equipment (Tables)

6 Months Ended

Feb. 28, 2018

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property and equipment at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018			August 31, 2017
Leasehold Improvements	$	331,696		$	329,985
Clinical equipment		204,013			177,514
Computer equipment		23,113			21,020
Office equipment		23,771			24,319
Furniture and fixtures		26,010			18,218
		608,603			571,056
Accumulated depreciation		(294,161	)		(268,105	)
Total	$	314,442		$	302,951

XML 32 R22.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

6 Months Ended

Feb. 28, 2018

Debt Disclosure [Abstract]

Schedule of Notes Payable

Notes payable at February 28, 2018 and August 31, 2017 consisted of the following:

	February 28, 2018			August 31, 2017
Notes payable to financial institution; accrues interest at 7.2% per annum; monthly principal and interest payment of $3,567; unsecured; due October 2017. This note has been fully repaid.		-			7,134
Notes payable issued in connection with purchase of assets; accrues interest at 0% per annum; due on March 27, 2019.		390,400			399,400
Notes payable to financial institution assumed with acquisition; accrues interest at 6% per annum; monthly principal and interest payment of $623; unsecured; due April 8, 2019.		20,515			20,988
		410,915			427,522
Current portion		(6,205	)		(13,171	)
Long-term portion	$	404,710		$	414,351

Schedule of Future Maturities of Notes Payable

Aggregate future maturities of notes payable as of February 28 are as follows:

Twelve months ending February 28,
2019	$	6,205
2020		404,710
	$	410,915

XML 33 R23.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit (Tables)

6 Months Ended

Feb. 28, 2018

Equity [Abstract]

Schedule of Stock Option and Warrant Activity

The following is a summary of stock option/warrant activity:

					Weighted
			Weighted		Average
	Options/		Average		Remaining		Aggregate
	Warrants		Exercise		Contractual		Intrinsic
	Outstanding		Price		Life		Value
Outstanding, August 31, 2017		7,860,000	$	0.27		3.53	$	660,000
Granted		2,170,000		0.42
Forfeited		-
Exercised		-
Outstanding, February 28, 2018		10,030,000		0.30		3.44		781,000
Exercisable, February 28, 2018		8,970,000	$	0.30		3.32	$	781,000

Schedule of Options and Warrants Outstanding and Exercisable

The exercise price for options/warrants outstanding at February 28, 2018:

Outstanding			Exercisable
Number of			Number of
Options/	Exercise		Options/		Exercise
Warrants	Price		Warrants		Price
5,500,000	$	0.16		5,500,000	$	0.16
1,000,000		0.32		-		0.32
50,000		0.33		50,000		0.33
120,000		0.40		60,000		0.40
2,000,000		0.42		2,000,000		0.42
100,000		0.50		100,000		0.50
1,000,000		0.62		1,000,000		0.62
250,000		0.80		250,000		0.80
10,000		2.00		10,000		2.00
10,030,000				8,970,000

Schedule of Fair Value of Options Granted by Using Valuation Assumptions

The assumptions used in calculating the fair value of options granted using the Black-Scholes option- pricing model for options granted are as follows:

Risk-free interest rate	1.83	%
Expected life of the options	2.5 to 3.5 years
Expected volatility	314	%
Expected dividend yield	0	%

XML 34 R24.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation (Details Narrative) - USD ($)		6 Months Ended
	Apr. 25, 2017	Feb. 28, 2018
Common stock issued in connection with reverse merger transaction		$ 6,904
Turbine Truck Engines, Inc [Member]
State country name		Delaware
Date of incorporation		Nov. 27, 2000
Turbine Truck Engines, Inc One [Member]
State country name		State of Nevada
Date of incorporation		Feb. 20, 2008
NHL [Member] \| Share Exchange Agreement [Member]
Number of restricted shares of common stock	167,797,406
Percentage of common stock issued and outstanding	85.00%

XML 35 R25.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) - CAD [Member]	Feb. 28, 2018	Aug. 31, 2017	Feb. 28, 2017
Period End [Member]
Foreign currency exchange rate	0.7808	0.7988	0.7548
Average Period [Member]
Foreign currency exchange rate	0.7959		0.7551

XML 36 R26.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	6 Months Ended
	Feb. 28, 2018	Aug. 31, 2017
Allowance for uncollectible accounts receivable	$ 484,145	$ 507,636
Goodwill	616,832	399,400
Refundable acquisition deposits	$ 1,135,824	1,162,009
Potentially dilutive common stock options and warrants outstanding, shares	10,030,000
Gain on foreign currency transactions	$ 1,153,503	$ 1,240,844
Novo Healthnet Kemptville Centre, Inc [Member]
Equity method investment, ownership percentage	80.00%
Apka Health, Inc. [Member]
Goodwill	$ 390,400
Executive Fitness Leaders [Member]
Goodwill	$ 226,432

XML 37 R27.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)	6 Months Ended
	Feb. 28, 2018
Leasehold Improvements [Member]
Property and equipment, estimated lives	5 years
Clinical Equipment [Member]
Property and equipment, estimated lives	5 years
Computer Equipment [Member]
Property and equipment, estimated lives	3 years
Office Equipment [Member]
Property and equipment, estimated lives	5 years
Furniture and Fixtures [Member]
Property and equipment, estimated lives	5 years

XML 38 R28.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details Narrative) - USD ($)		6 Months Ended
	Jan. 31, 2018	Feb. 28, 2018	Aug. 31, 2017
Related Party Transactions [Abstract]
Related party debt, converted amount	$ 813,125	$ 5,122,899
Debt converted, shares issued	1,976,483	12,452,356
Debt conversion, description	The per share price used for the conversion of this loan was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.	The per share price used for the conversion was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.
Debt conversion price	$ 0.4114	$ 0.4114
Due to related parties		$ 880,915	$ 1,812,613

XML 39 R29.htm IDEA: XBRL DOCUMENT

Other Receivables - Schedule of Other Receivables (Details) - USD ($)	Feb. 28, 2018	Aug. 31, 2017
Total other receivables	$ 402,112	$ 372,024
Notes Receivable Dated November 15, 2014 [Member]
Total other receivables		39,940
Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member]
Total other receivables	292,800	299,550
Advance to Corporation One [Member]
Total other receivables	31,232	32,534
Advance to Corporation Two [Member]
Total other receivables	$ 78,080

XML 40 R30.htm IDEA: XBRL DOCUMENT

Other Receivables - Schedule of Other Receivables (Details) (Parenthetical)	6 Months Ended	12 Months Ended
	Feb. 28, 2018	Aug. 31, 2017
Notes Receivable Dated November 15, 2014 [Member]
Percentage of interest accrued per annum	8.00%	8.00%
Notes receivable due date	Nov. 15, 2016	Nov. 15, 2016
Notes Receivable Dated April 1, 2015 and May 23, 2017 [Member]
Percentage of interest accrued per annum	8.00%	8.00%
Notes receivable due date	May 23, 2018	May 23, 2018

XML 41 R31.htm IDEA: XBRL DOCUMENT

Property and Equipment (Details Narrative) - USD ($)	6 Months Ended
Property and Equipment (Details Narrative) - USD ($)	Feb. 28, 2018	Feb. 28, 2017
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 32,719	$ 30,540

XML 42 R32.htm IDEA: XBRL DOCUMENT

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)	Feb. 28, 2018	Aug. 31, 2017
Property and equipment, gross	$ 608,603	$ 571,056
Accumulated depreciation	(294,161)	(268,105)
Total	314,442	302,951
Leasehold Improvements [Member]
Property and equipment, gross	331,696	329,985
Clinical Equipment [Member]
Property and equipment, gross	204,013	177,514
Computer Equipment [Member]
Property and equipment, gross	23,113	21,020
Office Equipment [Member]
Property and equipment, gross	23,771	24,319
Furniture and Fixtures [Member]
Property and equipment, gross	$ 26,010	$ 18,218

XML 43 R33.htm IDEA: XBRL DOCUMENT

Notes Payable - Schedule of Notes Payable (Details) - USD ($)	Feb. 28, 2018	Aug. 31, 2017
Notes payable	$ 410,915	$ 427,522
Current portion	(6,205)	(13,171)
Long-term portion	404,710	414,351
Note Payable One [Member]
Notes payable		7,134
Note Payable Two [Member]
Notes payable	390,400	399,400
Note Payable Three [Member]
Notes payable	$ 20,515	$ 20,988

XML 44 R34.htm IDEA: XBRL DOCUMENT

Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) - USD ($)	6 Months Ended	12 Months Ended
	Feb. 28, 2018	Aug. 31, 2017
Note Payable One [Member]
Percentage of interest accrued per annum	7.20%	7.20%
Debt periodic payment	$ 3,567	$ 3,567
Notes payable, due date	Oct. 31, 2017	Oct. 31, 2017
Note Payable Two [Member]
Percentage of interest accrued per annum	0.00%	0.00%
Notes payable, due date	Mar. 27, 2019	Mar. 27, 2019
Note Payable Three [Member]
Percentage of interest accrued per annum	6.00%	6.00%
Debt periodic payment	$ 623	$ 623
Notes payable, due date	Apr. 08, 2019	Apr. 08, 2019

XML 45 R35.htm IDEA: XBRL DOCUMENT

Notes Payable - Schedule of Future Maturities of Notes Payable (Details)	Feb. 28, 2018 USD ($)
Debt Disclosure [Abstract]
2019	$ 6,205
2020	404,710
Total	$ 410,915

XML 46 R36.htm IDEA: XBRL DOCUMENT

Debentures, Related Parties (Details Narrative)				6 Months Ended
Debentures, Related Parties (Details Narrative)	Jan. 31, 2018 USD ($) $ / shares shares	Dec. 02, 2017	Sep. 30, 2013 CAD ($)	Feb. 28, 2018 USD ($) $ / shares shares	Nov. 30, 2017 USD ($)	Aug. 31, 2017 USD ($)
Accrued interest				$ 142,207		$ 403,119
Debt converted, shares issued \| shares	1,976,483			12,452,356
Debt conversion price \| $ / shares	$ 0.4114			$ 0.4114
Debt conversion, description	The per share price used for the conversion of this loan was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.			The per share price used for the conversion was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.
Debentures, outstanding				$ 1,249,770		$ 5,114,327
Five Debentures [Member]
Debentures, related parties	$ 3,894,809				$ 4,968,900
Debt interest rate			8.00%
Debt due date			Sep. 30, 2016
Debt extended due date		Sep. 30, 2019
Percentage of debt converted	75.00%
Accrued interest	$ 414,965
Debt converted, shares issued \| shares	10,475,872
Debt conversion price \| $ / shares	$ 0.4114
Debt conversion, description	The per share price used for the conversion of each debenture was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.
Five Debentures [Member] \| CAD [Member]
Debentures, related parties			$ 6,402,512

XML 47 R37.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit (Details Narrative) - USD ($)				3 Months Ended	6 Months Ended	12 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	Jan. 31, 2018	Jan. 16, 2018	Sep. 08, 2015	Feb. 28, 2018	Feb. 28, 2018	Aug. 31, 2017
Convertible preferred stock, shares authorized				1,000,000	1,000,000	1,000,000
Convertible preferred stock, par value				$ 0.001	$ 0.001	$ 0.001
Convertible preferred stock, shares issued				0	0	0
Convertible preferred stock, shares outstanding				0	0	0
Common stock, shares authorized				499,000,000	499,000,000	499,000,000
Common stock, par value				$ 0.001	$ 0.001	$ 0.001
Common stock, shares issued				214,673,720	214,673,720	201,837,254
Common stock, shares outstanding				214,673,720	214,673,720	201,837,254
Common stock issued for business acquisition					$ 6,904
Common stock issued for conversion of debt, shares	1,976,483				12,452,356
Common stock issued for conversion of debt	$ 813,125				$ 5,122,899
Debt conversion price	$ 0.4114			$ 0.4114	$ 0.4114
Debt conversion, description	The per share price used for the conversion of this loan was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.				The per share price used for the conversion was $0.4114 which was determined as the average price of the five (5) trading days immediately preceding the date of conversion with a ten (10) percent premium added to the calculated per share price.
Stock options granted weighted-average grant date fair value						$ 0.58
Stock options/warrants weighted-average exercise price						$ 0.42
Stock option expense					$ 1,109,416
Unamortized stock option expense				$ 165,515	$ 165,515
2018 [Member]
Stock options granted weighted-average grant date fair value					$ 0.41
Stock options/warrants weighted-average exercise price					$ 0.42
2015 Incentive Compensation Plan [Member]
Number of shares issued for granted						4,987,500
2015 Incentive Compensation Plan [Member] \| Maximum [Member]
Number of common stock shares issued			5,000,000
2018 Incentiven Plan [Member]
Number of common stock shares issued		10,000,000
Number of shares issued for granted				9,950,000
Executive Fitness Leaders [Member]
Common stock issued for business acquisition, shares					384,110
Common stock issued for business acquisition					$ 233,155

XML 48 R38.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit - Schedule of Stock Option and Warrant Activity (Details)	6 Months Ended
	Feb. 28, 2018 USD ($) $ / shares shares
Equity [Abstract]
Options/Warrants Outstanding, Beginning Balance	7,860,000
Options/Warrants Outstanding, Granted	2,170,000
Options/Warrants Outstanding, Forfeited
Options/Warrants Outstanding, Exercised
Options/Warrants Outstanding, Ending Balance	10,030,000
Options/Warrants Outstanding, Exercisable	8,970,000
Weighted Average Exercise Price, Outstanding, Beginning Balance \| $ / shares	$ 0.27
Weighted Average Exercise Price, Granted \| $ / shares	0.42
Weighted Average Exercise Price, Outstanding, Ending Balance \| $ / shares	0.30
Weighted Average Exercise Price, Exercisable \| $ / shares	$ 0.30
Weighted Average Remaining Contractual Life, Outstanding, Beginning Balance	3 years 6 months 10 days
Weighted Average Remaining Contractual Life, Outstanding, Ending Balance	3 years 5 months 9 days
Weighted Average Remaining Contractual Life, Exercisable	3 years 3 months 26 days
Aggregate Intrinsic Value, Outstanding, Beginning Balance \| $	$ 660,000
Aggregate Intrinsic Value, Outstanding, Ending Balance \| $	781,000
Aggregate Intrinsic Value, Exercisable \| $	$ 781,000

XML 49 R39.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details)	Feb. 28, 2018 $ / shares shares
Number of Options/Warrants, Outstanding	10,030,000
Number of Options/Warrants, Exercisable	8,970,000
Exercise Price Range One [Member]
Number of Options/Warrants, Outstanding	5,500,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.16
Number of Options/Warrants, Exercisable	5,500,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.16
Exercise Price Range Two [Member]
Number of Options/Warrants, Outstanding	1,000,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.32
Number of Options/Warrants, Exercisable
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.32
Exercise Price Range Three [Member]
Number of Options/Warrants, Outstanding	50,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.33
Number of Options/Warrants, Exercisable	50,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.33
Exercise Price Range Four [Member]
Number of Options/Warrants, Outstanding	120,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.40
Number of Options/Warrants, Exercisable	60,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.40
Exercise Price Range Five [Member]
Number of Options/Warrants, Outstanding	2,000,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.42
Number of Options/Warrants, Exercisable	2,000,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.42
Exercise Price Range Six [Member]
Number of Options/Warrants, Outstanding	100,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.50
Number of Options/Warrants, Exercisable	100,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.50
Exercise Price Range Seven [Member]
Number of Options/Warrants, Outstanding	1,000,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.62
Number of Options/Warrants, Exercisable	1,000,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.62
Exercise Price Range Eight [Member]
Number of Options/Warrants, Outstanding	250,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 0.80
Number of Options/Warrants, Exercisable	250,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 0.80
Exercise Price Range Nine [Member]
Number of Options/Warrants, Outstanding	10,000
Number of Options/Warrants, Outstanding, Exercise Price \| $ / shares	$ 2.00
Number of Options/Warrants, Exercisable	10,000
Number of Options/Warrants, Exercisable, Exercise Price \| $ / shares	$ 2.00

XML 50 R40.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details)	6 Months Ended
	Feb. 28, 2018
Risk-free interest rate	1.83%
Expected volatility	314.00%
Expected dividend yield	0.00%
Minimum [Member]
Expected life of the options	2 years 6 months
Maximum [Member]
Expected life of the options	3 years 6 months

XML 51 R41.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative) - USD ($)	6 Months Ended
	Feb. 28, 2018	Feb. 28, 2017
Commitments and Contingencies Disclosure [Abstract]
Operating leases expiration date	2023
Rent expense	$ 409,350	$ 387,110

XML 52 R42.htm IDEA: XBRL DOCUMENT

Acquisition of Assets (Details Narrative) - USD ($)	Nov. 30, 2017	Feb. 28, 2018	Aug. 31, 2017
Purchase price of goodwill		$ 616,832	$ 399,400
Executive Fitness Leaders [Member]
Purchase price of goodwill		$ 226,432
Asset Purchase Agreement [Member] \| Executive Fitness Leaders [Member]
Issuance of restricted shares, shares	384,110
Issuance of restricted shares	$ 233,155
Purchase price of furniture and equipment	7,772
Purchase price of goodwill	$ 225,383

XML 53 R43.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative)	Mar. 16, 2018	Jan. 30, 2018	Dec. 26, 2017 USD ($)	Mar. 15, 2018	Feb. 28, 2018 USD ($) $ / shares	Jan. 31, 2018 $ / shares	Dec. 26, 2017 CAD ($)	Aug. 31, 2017 USD ($) $ / shares
Debt conversion price \| $ / shares					$ 0.4114	$ 0.4114
Subsequent Event [Member]
Debt conversion price \| $ / shares					$ 0.7808			$ 0.7988
Subsequent Event [Member] \| Shareholder Agreement [Member] \| Mark Rubinoff [Member]
Percentage acquired for issued and outstanding shares			40.00%
Subsequent Event [Member] \| Letter Agreement [Member]
Letter of Intent, termination date		Mar. 20, 2018
Subsequent Event [Member] \| Brands International Corporation [Member]
Debentures, related parties			$ 1,873,256
Percentage acquired for issued and outstanding shares			60.00%
Bank exchange rate, description			Bank of Canada posted exchange rate of 0.7977 on December 29, 2017
Letter of Intent, termination date	Apr. 20, 2018
Subsequent Event [Member] \| Brands International Corporation [Member] \| CAD [Member]
Debentures, related parties							$ 2,350,000
Subsequent Event [Member] \| ALMC-ASAP Holdings, Inc. [Member]
Equity ownership percentage				59.10%
Subsequent Event [Member] \| ICC Healthnet Canada, Inc. [Member]
Debentures, related parties					$ 585,600			$ 2,396,400
Subsequent Event [Member] \| Healthnet Assessment Inc. [Member]
Debentures, related parties					$ 390,400			$ 1,597,600

EXCEL 54 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
U9< >L:28F M_4[#3B(6A.5 ''MT@SJ&5[\95]-? I5D"/C\'6Y)J-65O>BO1.=D/.E,^,-P MH#Y,)Y/@5$7KF'WM&F,ZG*HQAMU:4M/M=KU6FNLM;!SDY@QYPJEE1C> 6IZD MJ>\]35IB[>0Y[A'V= &1_-,&OC$_<]SG N3.FK 3SY^)U"B>NTF[C9BUUR5W MY!+"2D>#];3>J-=6&C"< R$>18FJR%U<>P)!9T_&J?BH%J.J!UP M?EK1V(=G@/'9W2JYGR;:;4G,UFZC&@EIJ>$!$IJB5%+ M E$CL%CMT%WO(YP)970S=-/$Y N *% ACLV JXV(YV7^CVB1V>;JY =-@>- MEL\G+L .6<6PU1Q]]_>XJP@=N9BV8XVJ69S-MFNTKTF-KF@3K,8@\M O]R1O M4#2MV?S\VW;^H-2[>_1HTHA@51-WII NF?XMR*!X>H:: V%#7E3.Q1C,["8$ M=HDZP683,8@HE8.VGX,./I.YYI/*54I["2S\6X"JE'"16*VN)#D* 4 M]_4K(YC#B\?+!(F:W(W5HL@+X0;(OD(Y8)>*-.+7(\],-(3] \<5_T",J$4V M,AEP-S+Z(GZD"("RV^AK_@:-P$_HR _>QVN4S>K74^/_SU4GD)J3SK.2'8FI.WZ6892W&)=CGJ/AQ*^?'Y 1!4 MEIRKP9F*4L0F)8EM=]HH=P0#VSHJ:V[VJG+@QA0=-K"*GLR9WF P 3D,4*YR M&H3EK,(T\:D7[6<$TX, MNK Y!JC(:6\9&(E&8N9.(U\#MMP],"T8Y2]A.L'SA7?B), MILXGDXHB/-D[A-;:14=I]*1_(#J1LHOB:IYN[XO%=F7Y%QEM$;+(3,)2T-[[ M8'4@T!!B^:0==VMM;3LNQ_(*$ 2PK>=_P'A66@?W$0,"P0=Z,)P;!?)F=(&* ML PA*2^\:[ M)6)&A%V 52.YH /<,YP!(F13LW-U] >&+]$17.U4KXS1KL VJZ4ZH5-DY2B MIKC6++U'V)U@5D.<_'U+"B"/"GH&)6$SQT*_%8C4XW0!P%\4)*;-02V!%UH' M'NL*Q,_B+S#L,DWG 6D59EVTB,),3[#\DF PQR6.ZN@63&1,"_V A_!(<;H M.'GB3H)3PO"];@>$GAG =E:+I]5ZD ^]NJ\&DT'8'0QIU%?#SC@<]4<87,%@ M,+H75L^H%CCWARYT_ICP7ROB$$7!\J8(4"\[$1>HD\TI"4VK@2@+DDCKHW3] M*6,( H9F*L5#1EE"44Y.:D&TGK\%-./+#Q1<3^13M,IU&!4/U'@-C8\:P4GI M()OF)7.8?BYTVMM3G)/G"GDA.GZUBLOV,6Z+J;=T:<+F*JHQU^FC9']NH#1D M!5=S(HH/@B2CK%-D8I@P&1M^ZB8*DGO)38E$%&G85)S;-#MTR#_0"N:25!*, M *D+"RHH@J>"0A\D8*$T6:1 5L")!VN"1EW\4=*9*.'[7? >3 2*[8EXC;,J MR30D-U0>G)$:A&:(69[Y";CD%HG3_M17/UTO0&Q(3Y_+4D;C(OZ)$4O]+-YC M?L7[&"'/%_Q*"@-8 *M8,HLF .7*1QR >%=BO3\"L:[Q&SX!I(JP@O[Z&IS] M8$*2N5+HT5]')Z0"4,$FPPU10D6Q5-;4BF2[#6%0L%A%4!#*',, ;>@S*5V. MTU,9XGD$N-XY3S M($Q,R\P'ZWW5GW;"08=O/[WJ]4;AH-\KLQ%SJPWG1XW?C=6A+W;S)5+*LXJM M*;NZ$D"0->ZGG/ERMB7"NHP+"CX!2E*DV3'/>:B@<:@)Z@YV5>=*52FA#PH. MU-*0#(C?T('12>I@<\ *^U,J-BG:=+$.1:EQ9]AL3H:;=O<3I2-W7L!(+%\\ M-S&!)2(_@]V\ZH;=_C"<] 8,.*H8JXDQY^QOL!FL(.CIS>"<'/-$Q)D5$ ME8NC(3L& -6J3H-\"33!J5H!#9.E/K+Q @SBC (MV2\SYEBC_ M0 ,*JY0"',&T$):33#!+TH'M!V"4V\SQ-9T[P1$#]<"!>O!OOY^.QM.W@-! M1Z(+L 2&F>N(%WN2$$N8D5,2'DF?OV]32G3.*%T*^3NK%TA-FM5D);\*.7N) MB-91]@4:G%0F[^TUN38$Z@O(P;9#=WV#7ZI-F%WID)G$95%T)QQ2-6#^CI8DJ9/M[ M07:+=AGF X,&A7=YMHFS$34 LQ32PASWM!K6(C*,:S"Q[*8T!@DJ +ZUY\S@ M%C)BN:NSFZK4INYDLK.@0A>#"=#%.8=&@<\MD?Z^DD6:2)0[,TA9.AT]7?:<42QK4IKB;9,3":7,Q9)=#]'YS>2N%$ MM+A-8J3UI8#Z@BY85![X!IYJHQW9>K1L7O8X&/T"?T+',G JXVQE7ZZ:6:TK M<_V:@(P<'4>O!O%VS Q8*5T([!RB*>S-.^7$3\YM(>_MC,E V2]$M 'SYC*B M*J6+,NU%9)4YHDLW[]5&V$TY=W.&]BS)?T&*6N+!S.\,7F[>4/AYTPO*@K,AB"_HMHON& MQE52PG"54,17$#F%(L9;X7<3W&M<8R[$! MB+(1DG.&Y?$]-9XYC7T861% 8S1L2A.82"NE6Y9^>F?N8I[S74QQH3T3-W!8 M*G%.?X67.?D6)T"NE&(:-)-)#TU.SZAM\75B8($OR.Z$:FT^C G:.O2EF$IH MPF8A^2&4Y$O)!+V7)5^$]6W;W!_KC0YMVH6:CUE[+-7U.SQ[OFL JDG@N"/] M(C?D5!O M))_A+E\XQ5>E8JJ?>OLBTU4B04RSDFU"/*2U[$LO@$7<6;@I6O4 M(M'_R(=F <"Y6&;PG".1=:\[DXTGGR5H,*/\Z1V*DY@?7YV4\D;XX- #0;7>2+#3.E3Z$FUS!2>DT@3QF @R]MZG-]J@E(KFBAV[ M3L MC>'<93XS@8C&$&O@QD3(&V@(D1G&=J.4-KQC8XX$X4SN,M:&5-Z(>SL\ MX[#MJ9OKK$U'J\8UQ:Y-7D&J0>/&<6R A;4;9.%NWA==0V L="B'HPT9'EG* M&5_:$1[X]-+\A"(CE:25+$U29. Z4BK^&"7JGI_V,!,+-0GV@3=P]GE#^18V M9/;9A,QPH.,.8)BYRWAF$X1S<:0LYL[PM3@#:0FJN#Z&ZHODY8 &+YZ!CY?1,ZJ:E[_<[K[P VQA=Q1KX(F.1Z5J3[S#&JJ#I'1@>" M@:]0(SU6A=J(<#%W 'U?C"K72C&.4 G#X&^:8:D^39N[YA[NM;\084MT/#,> M9,W%J0<%S38*<^D;XTC8 HQ-%%W=_8+V^(4 MK\T<;6@'"W@-*'%"4QQC342MXQ*?.%-6@7)IGZD(6.[&\.:I9-U)J?K*:Y \ M!QE1#>J@M!*^P8$MGT$B2'V[(W1MJ-RL<$9:)]D D569I+H1[@GW^M*3*"R4 MR*=R[FN)#JS IVU]S/P81 ":33CCM#FOHSPSZ4UL]#//3 M5Q4*&!CHO'!1YE3M]"H#AFV6'PG2=84,V]Y7*#3N"8$U",W.WR ME=K!6^5VSVUF%:QP\BT=#D:0\'+DU;L>X2G>$F(%VFO7#2Z<#_TW X[ 2G M')E@MY7)O'J+58^.S93W,L)0U%M@MVJRMS[V@I#O]7NBWPN'_<$O._1X$G8F M'7$V;GTD2-MQ]Y8:[ 6309#0=X:<>H.YDZ M]]SJ#L-/MB^YX' Z[ U\('#"M M"RUZ73B 3CT0#C^/QUW1&X3][K0I'-X;P2P= 7RO!WQAU)F$(S (AV,8+&>%*]^E>(SJFZ$G]V-3WHEAD?G0D)95% M47@_'([&)>:"+-$QBL:H@U+J/1?]* M1E\+WU&O7X,N"[>)WD /B &$'/R']UD&7=)0Q !V..SU@K-R\5]Q- I[2+>@ M10$G 5;Q.GAOJH[H1LCK!T!N'?P$=-T':CY]>,!X#:;M<>YX.>&22F(%!NFK M 3BV*YR\H+LGN7J4S@TWU/VJ'!HOV]!ZX8]>1R\JP$7Q+MMJ);M&0D.M9#$V M)-Q291F5^EN\+\B7;JFX$0"OK)(SLJ*B&\S-4#8MX^ST_!5HZ\ 9AR!!CUX- MPBEPT"DFQA16R5%CCU\W71NNI,9H=<3.QL-O7]>.Q-8J!(8Z 2D[Z4S%9K7-=;Z*A12V09*L0UK^3G])3-EOE,>S0>2?E"%3%7:Z&%BU%E&NQ.5OU MN%9;'=&G6H%=@=X[MA^&7M6ZH!M,1->Z:+MWX*"U-'HU"=DMOMRVT7JI]H:M MNF3R-7MK*_I>*@H;[+?!+DXD9J@C[G@1*-4< MHL;XK2V^IO+8-&4SZ$RM*\RYW>!>AM6'&48T_V\XI&6/K(G$%W^ZT M/^ T _8Y5DY !Y'HG@LGO2./XL.PKW,#U7'R7W'84JB*)9JG1 M1X"3$@'J^P9J3?QCB'KH#GHC$]#*XX4^(N7#=&@1/9C.GY8@Z6Z5?"Y18B4X M@J-62DJR/636ZK(.SC50B4*ZLHWZ,]9 X3PEL@;17*=JI'=6WD_#Z;#\ HRA M!,IO0E0+O&Z@;1V0*B'$Y.W%E*UB2SRX5* M:>LOP#Y>J^JKQK0/_JHY.LC^;(87GC-Q;]DV$?S7S^-OA!460O[(ZY'D,ZKQ^&+ ?6^8)Z/[4JIR\6/!="9K.HH*/6Q*H6(E-?[+':$ZH]HT]13Z:\I_!$#FW MV5=W)*I?!-8DZ."6C^F_8&B^Z@OG<]#MF7/JB)']'/2<808]4?XSZ)H_AAWA M_E&:?M03Y3^#GIE[TA'N'P%S(-$#A5XXGP,'">R97MJC,L+94U^$YF F_:1(\UBK>XO2WA]WDX@,]D *)7VGO@V3L.1ZG;E):R P*L;B@-VS-0*;FU M/E90&^OD@ .<_ 8.<-#]WSG R6_W $G.E0!G^^G-Q3DG-P?VSB+>\'+:F,"2 MN3NIGXKP%]I1=QK\0W""9&<:#H MSDMF=]!N=K=YDK:)7;UW7O8DC8;HQU>Y MXD[U'OV,A+;+S)U%S94KE6ZC=,9T,MEBG<[ER M!9>M<%OQV'^*\R_'"\PR-,Y(RJ#MGDSZXMO@@NYGT!W@A3E-/6;O9(@'![)> M7=0UK1]3W!)>JL((HCO./$:#"HCF.<;*QQWQ[:Z'"<]:'B9L;[Q7*)"=<5/C MC&L?\3TH\@_U!'6\?$U92QBU5^Y[JDF*-WEF4G+M;DY=I7LB*?^/D2)5(5_; MZ6E"]U-4B48= R $(MJTPW&&&:>DJA=)4*\&[(M6G$IM)=K5T,(OI*G).("=4 MV1:4'HG%G: !:]M8%0L#306:@'P='LAI$3VF&>G7V9;\,E@W 2_+I1P$]R;4 M88XL5U]R4NM4'7Q?N2);#]-?)*E*H[*5PEIC+HEBI)$R\%E(R M;[6_S*F5&5@[HFSC&)]9N<;:G&I'[VAGS$^^3V5/QL)?< TK!'JP49$YMV"% M@\KZLDBZ%[3];C]OW34-_: 62=2K,3\0'^J2$H UA5$9=!!4I7"3@HX8BD^8*_*L\#=&NX=4%C:OS^%.;5]<-A],Q+DBQ M9Y5-Y%V<79@M/1C0VBXPO Y'T[)\6T*P/ #_BD6;J4(BX!%2>!D)JJACL9!0 MA_VCCH.<]/I2-H!3GTA?S=QUR"Q\8K)9L=0N X@+\9Y@A>UDKM.EO(Z13P9(?GPG4(_OW,=,?2LS4LPCN1[M]]=7MHPW1L;4]%1% M,-&/9+EU$C6+X(8V$J7K?J,3G_6]DGRJO0PSZNQZC<2ZSM6B?.^ZD$/@P5SG M46DW <4J[6.#^MJ^R6/ '"0,@;(#[*C,V "1)^-^V!N.*.I'AF.4?.'K0HB& M*&.0TY:K(L//>+KC,=8"L&^5$E>M!&KV MYFU5EUJN5$!(K-^/RNUC.(Q!_- &C@12\8OXM 4DIQIR5"G44>U-ZZ"A]?D? MS=^52'KUM832.TA +V$#8NM7PDIS!2K0.N[YGYG^3&-P &V"M.K/#ZU.=A/>0MHK@:FEK%^-(WJ M6*&7!<\PQ2".2.0#R$3[D(%D[5-?/IRKRXB/Y PI$D!*^$^WZ'3"4P"7$=[O-RLN(XW"FEIB2&%9*=Y<^1]&$V) M@-J#: '9J2B&R0%I7DNE$*OV=.%.RHE]U8W@SRH!V-V&4C?]H52P,JJ;L,+K M]ST'JZI!WU]HQ8%ZH,ZL^,Y+H>[U=Q%X< MZ4^UMZ*K=>9W_?Y2A_ZE#OU+'?J7.O05%VNM#GW])EEC6?H#FKY4L'^I8/\_ M7<&^[BST%K3?L]E+W7OYL^O>U^*%E3+XNW[_URF3W_ ZD5LU?X\F+X7U_WD* MZQ/UO136_\T4UM_O7OU+G?WHI<[^;['.?A5]:V7W=S;8HRX_,HN#ZO)7)WTI MT_\O6*:_+:E!5^W?I\W_AC_*[J\O WP\C; R]L +V\#_/.\#1 T MU;IUQ>BO]C9 H-X&8(!["BW6"K/OT>3E-8&7UP1^6Z\)5)'6+8[;]MO+PP,O M#P_\SSX\X"WLXGF'8-]V_YOO%=32N?=XON!K^OPZ3Q[4K(]=+R (WPL(!X_R M\H["RSL*_ZKO*-29EK=._)[-7EY?^'FO+_BJ1K<]QG!H^Y?'&UX>;XA>'F]X M>;RA4KT^>XA 6;%YS>_(]@84NF$M6"5]W%$E\%JVY^T,K/#MBEW 7F5*JPRF M4M(G/-7/P.WWNB]X5[(]"Z[S+@&W5R900\,&) )V75SQ55.N?C.NU5>^X8N] M,IE_AQN0V!]5/P>@M_& [4!ZS+JZON\")VC3$=3M48PZ[GEN+^ M*;I['-F%B2K"@6" _#WYS!JO@.X7_0QJT4_Q?S3Z67NP8:]3V?6BA)]27IZ" M>'D*XK?\%,1>J+_7*Q)^_']Y_.&W\OA#ZVL,>Z%!V_L-S74%7AY>>'EXX5_K MX856=9NO3WPH)?4>3CC_%&\[> NJ[\5)V _.=1+IQ%5%1"S82G4SJYW+!L=+ M"<[?: G.5OUY8Z, !J0NS%32F9Y^;T/TI>3G/VO)SU9&6DIDT\BC*0'4_<]D MPO[%)-BSI6SYR.B-?IR7@.&HNODZ%6-\8.0!M', M)N+85P305/QOUG,P9H>ER]8RPPL0SG6NVEEOLWN\L7&7;6'$B^2!*^M=)3/Q M7Q_(7*W5A2)OKB!?#;"$)*I'),_E"HM&U[]75X#L?37/BL!,/D$M*_C=[WH> M'MFRX&OXNGW1R);D8S2/:C%4>4_Z$$\ZJ:WIQ_=F9/'?.D1LRJ:;2@!-LUNN MZ*1\^M]QJ-FA? ,1I6VE94,AD.H DR$PE*_%W&/Q"(/HN'#[M74PV"M*=4UZ.F,;;QPB"D- MZ"PN/T?B*!,^(1\J9*Q=,:" >E,@O>&!Y+WNZS8>B/&V8V#B =C?M-[B>V4.TNW_95W2I?45-S5O>WSZ(SO^( M[QWHNQM-DW#-&LZ\MZ^K<63?^ZRG:12*TD-2+8USXL!SF<^R>..5\\N#GDO[ ME=[-_N5?2MO[Z9^? Y!_51A4$(A;[0[_E/F8)SSD2/T&PFGPS/N=KLZ=['-_ M5*99\?(/4(^IN(&4QM&<*(5;PZ%-[VSH4-G;Y.0 _NJ':*TM)=T5J8._V MQ =V:EU@!*E=U[1N2/6&HW%$UJ2N3^C6PUGJD4JOP@\G2;IW=U3]69T,_UIC MLDUAFD.XN.^=YSWG*9_,CL6T+*%)1E.BO:=8@3?&X26R]CA&>?V5&,?N99=< MWC7Q7W8@>^_,NLYC;_UAO9@V&BLU;*.L-A(4M>S@O02)IJ:%\&K)'^(,FMW=Z?5GT=^Q1KZ3)JZM,%P MM^._6?]E8UVY(AMINO$A91]S:%7LU!2OQ!NEC_F-I7,)AD6GYW?QRDS6Z?3";:6K3JGB*_VZP#[T*!+2VJVX[EQ:GQ24J M3;9M(YF><[$8QQOH;=%$)_I4&D0/]>7:ALAJ]QJD1@5EH3HOP;G&&+R^F@-U M]P.?.OYG55Z;4 30K\W5U!"%.]CJT\4VO=C046^([N.^Q4.T[Y];=\^^?>OO MO39Y<_8?P0NTFG^^]A 4/[)$.&!O@+:.Y3P.U?ZJ5-LH33K;YQWO%E7;4\BN M"6]V/OJZV_=;YJD(>07)KYX+86_6$G6/KT.;/&J0%2C]O8 =JAPUD,RK< MK G,C-@%S@:7JACI/)9NAZ3W+[>$=K32\P_U_-.?/WT+,NKI^GJZWL@[GTT5 M,JDH'#??!UV_=K Z:ATP4@67OH9W'II,LJ?MM=,X,;*GRF-*\#FD6PL&E&E0 M?*+@8*O?8+_EA17J;B7H/==^T)C>C;7Y.?P=6OT=WBZ76"7AL!ZHKQS4XS;^ MZ< .>''JL"X7R&(.Z_(Q;DTFV$UR/RDTF_9D9Z,EYJ3+0[ M\!F@#1DQ-0\2L.TV5;0M0:>F@E:D5]U;U:[V5J6?3VMM?OOR('/PVOMNGGT! MH1X7M&_FU5V[OI?D#EI.R2-4LJ>K654&$HT[Z>XP(LZ_!H^56. MS[3PS+54F";KH+73[ATN2K%AV7 ?P_,TWAY^0G*:-KD"V(G8\?](WD+])E3# M4?+H0_\ [=["5H=FFWO.656#F]+G3FP>L0K6ED2*AH8ZX4J]$N/%Q/);02UI M1MH5IZM:5JH,,O-[SMM57WX1I7%_U_;"P]IJ*WVG?:8J.M:UJYZ-A M3:L<>0% CVV5\%'' MPU"RY9V^K]E<\[M^]='>Y'GQ_?\'4$L#!!0 ( $5 C$S#*H\?7P( L- M - >&PO\ M9M=,52 1-5<1G/'_R]D>G\N>N;[CPN;X$A\_D+QI[1'THM'I'L4(S: C=//7[KLI]<]EO]@ MY+UV^^(P$WS8Q1ET#ET?,0S6B$;P"E&RDL1D98@1NG'NJ7$D@@H)E#X^FB\P MGNK!A0,W,B>KU6&$"VEKNPKN=]5.'P6ZD0$DE/: 4^@<<5@BI;#DUWI@)UOG M;R'0VLM-J0ESB3;!= Z'!'O1159"IECV90+8N>*0XLS@2)(7YJI$Z9F@4H)I M(R4H%QQ9ABZC-;1L@BF]-8_=7;:CW63 S3%;XD-@*#I3K[HUAUWS+?*VFM/> MEIWMI0M*LA;J89PL&>Q:, M0]35 860Y$'KF:.2: >6$*RQ5"39]OR4J%SB1G7'J(?._OL\YYE@B MN@VMS_XAW^7_3#P[_WMD^U89 Q_677UM1/,_?P20\V. 7!P#Y!$\-J9+.GC( MV<4K,WIMB['5Q^QT,;T7K&I"%>$M;4'2%#L>TT9&\+OI8NE.+S$T,UI>H97^ M,MG1U[DISE!-U8U9H@U&<+"_&O!@T<]:]A(1'.QO."4UN[ %A\^?^!=02P,$ M% @ 14",3)! SW=Q P >AP \ !X;"]W;W)K8F]O:RYX;6S%F5M/ MVS 4@/^*E9/,VD?VHZZ,'R7+$%:G:>J+I:JE_V)7RL"3N76U#'#I M%JE?.25+OU0JU%7*!X-A6DMMDO.S;5L3EYZ?M2??M7KVK_?;2R:+H-?J0^8096:M1LBW" MI"G9M0DZO+ ;LVD*RB:L>_5-.4HR. \R0)VU]GI6J82Y4PT/W$V9M>#Q(*^L M*97QJF1PYFVE2^ HV:6LI"D40Y"<@.3[A!0(4A"08B^0TQ8'JB+(G(#,]PEY MB" /"\0I!# G(8%W+:U+5T+RW55"^, MAFH2YOI%4=@&YCJ"/"(@C^)"WK7#2^#8F0BG$=TSP'4<>Z;!4 MCMVK0NFUA#=CK!,"ZR0NUL1![;;'NLC]U.A56P$'[ $5L0=QZ6YM4!Z&]$5V M[WV%(C42V2-C-8,"#I"21Q;9'A<%S 6ON[@,<>_">UA"83A* M&EED:TR;F5=/3;O@NEZW_8C!*%%D^S1%=H0Q*55DD5U!6C<[QIB4,;+(RJ![ M\P1C4@;)(BOD+[.Q@X?N^!$OJ2F-\,@:Z9=<+R8E%AY9+#NVZZ4C$Y-].*67 MDI(+CRP7N&1]4)CXN2$4Z+AT45#1" ^Q)B4=O@^M<.Q=CBE';ZW M%(4=C!5>GW%*._R],Q7VF4VAW;*!J&3G&)/2#G]W[2!,,< [)91[Q)[< P,N M=857;H)RCXCLGG]@;KL48U(2$I$EM*O(G>^2P3.,2>Z/1;80B2FPA01E(1'9 M0A3FUV:G-RD+B<@6(A+N=AYA3,I"(K:%^A=(OR]GG: M5F4LMG4<' _[,LZS(J7ZV;FX+,(ACT]5'KU=AK=J^74(9;I2\;<@<]>#M#](Z4'6'V3T(-\?Y.E!H_Z@$3UHW!\T MI@=-^H,F]*!I?]"4'C3K#YK1@V0(9!SRDQ#6?*T%<"U\KP6 +7RQ!9 M?+,% MH"U\M06P+7RW!< M?+D%T"U\NP7@+7R]%>BM?+T5Z*T/>-9&#]M\O17HK7R] M%>BM?+T5Z*U\O17HK7R]%>BM?+T5Z*U\O17HK7R]#>AM?+T-Z&U\O0WH;0\X M*T&')7R]#>AM?+T-Z&U\O0WH;7R]#>AM?+T-Z&U\O0WH;7R]/=#;\_7V0&_/ MU]L#O3U?;P_T]@\XZ^[H'8N\":N/U&S+3;QWR<7PFS4=N&,Z[7!E&ULS9G?;L(@%(=?Q?1VL0AT[D_4FVVW MF\GV JP]M8UM(8!.WWZTZI*9+G%1D]]-*1PXYX.2[Z:3CZTA-]C45>.F4>&] M>63,I075RL7:4!,BN;:U\J%K%\RH=*D6Q,1H-&:I;CPU?NC;'-%L\DRY6E5^ M\+0;;U-/(V5,5:;*E[IAZR8[2CK<)XPM5=T<5Y3&W80)T>!E$[*X,#:-0M1% M[(0*QPO;?ECWMB9KRXS^A:;SO$PIT^FJ#DMB9RRIS!5$OJYB5RA+V;NW9;/8 M\\Z5]:^J#HG9IF*_)L37X_#;BOH!NL@E*_MP+:BO5!?8/?E9!0^W(=66AL:& MJ/5ES_8"TCQ$'6LG7G*+U%Z=C+*3BH?4U_NP7]HNN_>^ _\).M8UYYWZY3@$ M"(<$X4A .&Y!.,8@''<@'/<@' \@''R$ H)B5(ZB5([B5(XB58YB58ZB58[B M58XB5HYB5H%B5H%B5H%B5H%B5H%B5H%B5H%B5H%B5H%B5H%B5HEB5HEB5HEB M5HEB5HEB5HEB5HEB5HEB5HEB5HEBU@3%K F*61,4LR97-&O7QK4JF[](/K5> M'NJS[@_6[!M02P$"% ,4 " !%0(Q,'R// \ 3 @ "P M @ $ 7W)E;',O+G)E;'-02P$"% ,4 " !%0(Q,9O,+8(( "Q M $ @ 'I 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 M ( $5 C$PW8+\P[@ "L" 1 " 9D! !D;V-0&UL4$L! A0#% @ 14", M3)MB"ZAC @ %@@ !@ ( !]P@ 'AL+W=O&PO=V]R:W-H M965T&UL4$L! A0#% @ 14",3&^4U^;_! &Q< !@ M ( !B!( 'AL+W=O&PO=V]R:W-H965T&UL M4$L! A0#% @ 14",3,E!0/ZR 0 T@, !@ ( !WAT M 'AL+W=O?;0! #2 P & M@ &P(0 >&PO=V]R:W-H965T&UL4$L! A0#% @ 14", M3+#PN[:S 0 T@, !D ( !FB, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 14",3*S>%H2U 0 T@, M !D ( !62D 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 14",3%B)^D>T 0 T@, !D M ( !&2\ 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ 14",3+PFF\>W 0 T@, !D ( !LS4 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ 14",3+6Z M2^G& 0 -P0 !D ( !>SL 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 14",3)V8'3_D 0 ,@4 !D M ( !S$$ 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ 14",3/+N.L(M @ 9P8 !D ( ! MVT@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 14",3/B400_@ 0 9@0 !D ( !V$\ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 14",3.,->JQG M @ P @ !D ( !&%< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 14",3->NH.CZ P 4A, !D M ( !\UX 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ 14",3'OKFW'S 0 IP4 !D ( !QFD M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M14",3,N)J0,- P H P !D ( !<' 'AL+W=O&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E M;'-02P$"% ,4 " !%0(Q,S"W63[(! #)&@ $P @ &O LKP 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 - T !X. "2L0 ! end XML 55 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 56 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 58 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 101 186 1 false 46 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://novointegrated.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://novointegrated.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://novointegrated.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://novointegrated.com/role/StatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://novointegrated.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - Organization and Basis of Presentation Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation Notes 6 false false R7.htm 00000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Related Party Transactions Sheet http://novointegrated.com/role/RelatedPartyTransactions Related Party Transactions Notes 8 false false R9.htm 00000009 - Disclosure - Other Receivables Sheet http://novointegrated.com/role/OtherReceivables Other Receivables Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://novointegrated.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Notes Payable Notes http://novointegrated.com/role/NotesPayable Notes Payable Notes 11 false false R12.htm 00000012 - Disclosure - Debentures, Related Parties Sheet http://novointegrated.com/role/DebenturesRelatedParties Debentures, Related Parties Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders' Deficit Sheet http://novointegrated.com/role/StockholdersDeficit Stockholders' Deficit Notes 13 false false R14.htm 00000014 - Disclosure - Commitments and Contingencies Sheet http://novointegrated.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 00000015 - Disclosure - Acquisition of Assets Sheet http://novointegrated.com/role/AcquisitionOfAssets Acquisition of Assets Notes 15 false false R16.htm 00000016 - Disclosure - Subsequent Events Sheet http://novointegrated.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 00000017 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - Organization and Basis of Presentation (Tables) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentationTables Organization and Basis of Presentation (Tables) Tables http://novointegrated.com/role/OrganizationAndBasisOfPresentation 18 false false R19.htm 00000019 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Other Receivables (Tables) Sheet http://novointegrated.com/role/OtherReceivablesTables Other Receivables (Tables) Tables http://novointegrated.com/role/OtherReceivables 20 false false R21.htm 00000021 - Disclosure - Property and Equipment (Tables) Sheet http://novointegrated.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://novointegrated.com/role/PropertyAndEquipment 21 false false R22.htm 00000022 - Disclosure - Notes Payable (Tables) Notes http://novointegrated.com/role/NotesPayableTables Notes Payable (Tables) Tables http://novointegrated.com/role/NotesPayable 22 false false R23.htm 00000023 - Disclosure - Stockholders' Deficit (Tables) Sheet http://novointegrated.com/role/StockholdersDeficitTables Stockholders' Deficit (Tables) Tables http://novointegrated.com/role/StockholdersDeficit 23 false false R24.htm 00000024 - Disclosure - Organization and Basis of Presentation (Details Narrative) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentationDetailsNarrative Organization and Basis of Presentation (Details Narrative) Details http://novointegrated.com/role/OrganizationAndBasisOfPresentationTables 24 false false R25.htm 00000025 - Disclosure - Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) Sheet http://novointegrated.com/role/OrganizationAndBasisOfPresentation-ScheduleOfForeignCurrencyTranslationExchangeRateUsedDetails Organization and Basis of Presentation - Schedule of Foreign Currency Translation, Exchange Rate Used (Details) Details 25 false false R26.htm 00000026 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://novointegrated.com/role/SummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) Sheet http://novointegrated.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEstimatedUsefulLivesOfAssetsDetails Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) Details 27 false false R28.htm 00000028 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://novointegrated.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://novointegrated.com/role/RelatedPartyTransactions 28 false false R29.htm 00000029 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) Sheet http://novointegrated.com/role/OtherReceivables-ScheduleOfOtherReceivablesDetails Other Receivables - Schedule of Other Receivables (Details) Details 29 false false R30.htm 00000030 - Disclosure - Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) Sheet http://novointegrated.com/role/OtherReceivables-ScheduleOfOtherReceivablesDetailsParenthetical Other Receivables - Schedule of Other Receivables (Details) (Parenthetical) Details 30 false false R31.htm 00000031 - Disclosure - Property and Equipment (Details Narrative) Sheet http://novointegrated.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://novointegrated.com/role/PropertyAndEquipmentTables 31 false false R32.htm 00000032 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://novointegrated.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails Property and Equipment - Schedule of Property and Equipment (Details) Details 32 false false R33.htm 00000033 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfNotesPayableDetails Notes Payable - Schedule of Notes Payable (Details) Details 33 false false R34.htm 00000034 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfNotesPayableDetailsParenthetical Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) Details 34 false false R35.htm 00000035 - Disclosure - Notes Payable - Schedule of Future Maturities of Notes Payable (Details) Notes http://novointegrated.com/role/NotesPayable-ScheduleOfFutureMaturitiesOfNotesPayableDetails Notes Payable - Schedule of Future Maturities of Notes Payable (Details) Details 35 false false R36.htm 00000036 - Disclosure - Debentures, Related Parties (Details Narrative) Sheet http://novointegrated.com/role/DebenturesRelatedPartiesDetailsNarrative Debentures, Related Parties (Details Narrative) Details http://novointegrated.com/role/DebenturesRelatedParties 36 false false R37.htm 00000037 - Disclosure - Stockholders' Deficit (Details Narrative) Sheet http://novointegrated.com/role/StockholdersDeficitDetailsNarrative Stockholders' Deficit (Details Narrative) Details http://novointegrated.com/role/StockholdersDeficitTables 37 false false R38.htm 00000038 - Disclosure - Stockholders' Deficit - Schedule of Stock Option and Warrant Activity (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfStockOptionAndWarrantActivityDetails Stockholders' Deficit - Schedule of Stock Option and Warrant Activity (Details) Details 38 false false R39.htm 00000039 - Disclosure - Stockholders' Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfOptionsAndWarrantsOutstandingAndExercisableDetails Stockholders' Deficit - Schedule of Options and Warrants Outstanding and Exercisable (Details) Details 39 false false R40.htm 00000040 - Disclosure - Stockholders' Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) Sheet http://novointegrated.com/role/StockholdersDeficit-ScheduleOfFairValueOfOptionsGrantedByUsingValuationAssumptionsDetails Stockholders' Deficit - Schedule of Fair Value of Options Granted by Using Valuation Assumptions (Details) Details 40 false false R41.htm 00000041 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://novointegrated.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://novointegrated.com/role/CommitmentsAndContingencies 41 false false R42.htm 00000042 - Disclosure - Acquisition of Assets (Details Narrative) Sheet http://novointegrated.com/role/AcquisitionOfAssetsDetailsNarrative Acquisition of Assets (Details Narrative) Details http://novointegrated.com/role/AcquisitionOfAssets 42 false false R43.htm 00000043 - Disclosure - Subsequent Events (Details Narrative) Sheet http://novointegrated.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://novointegrated.com/role/SubsequentEvents 43 false false All Reports Book All Reports nvos-20180228.xml nvos-20180228.xsd nvos-20180228_cal.xml nvos-20180228_def.xml nvos-20180228_lab.xml nvos-20180228_pre.xml http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/currency/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 60 0001493152-18-005063-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-18-005063-xbrl.zip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
-O*7Z.]GRB(V0YF92#[$6Q;!@Q7%0E+;VV7=??WOV[@_??%9TG05!6+R9 M?N^%P3R^]+8AG7VJMHY5TE:WX_60.YOQ%7!D&AQ]PYH4Q#JX]$K-7?5I67^%5Z(>JV8V) MHMUWODP-Z;[O-:0%AH_&4"5'4BI!%!22,+@GSN.,)WRN9]!F,V=8J^A*?/(= M7OVDN8@SR]*JA1O,2T5?EBP#LG#S(8QIE,M6KXH5*47UB&*6'[R4@NR]>=F1 M >.:%,#$99CV F%]1 X&2XZSVCGI4JIKIW=(A1Q_O1RZ[:[[U'%H3GF@SXZMH])CR5MM'" ML5K9W7K\D$'J)7J5)I@X8Q1\Q :&!&AAB MFF/5;96#B_V$!X$& S^MAB/2F81\&G&()#,.]MKD AK="69I0SNEM%-RJ8,Z MA2A<4@V$Q[P#L>Y\BI6\[/=2I.D]25;*,VX=":O9;$5HG82VS<^P=A1%8$)N6R:!MEP$!@T66TP\=JNS M?(-@Z DWC;S5]T>&8'>>'U$)@W$C0PB%<[65?)VF#4C"R$?,3W249JA.B_2$ M[&8=D0'L)AQI2X"AB!26<)^T$ *6O.]''%.Z1K,XF 6;, X9M;-PA_4L&=2R M.B29F= 9IO0J8(AEAE,8R0HM?M7)Z^@!(Y_@6DU=L.,!S6@@@Q7_J.#)#_0E MPA@&C##-+9 ]N23D@C0I72IA$#2AP!H&)5YL=JH>)3$0/ASE\1) MUY[J>2]]9&V@9S\WB'4YZW MI[!LX'B^6MSN0K$>='>E6"X+AET# $6O5J9+AG0WL@*EC](%*1=)MC51>$_$ M#D.^+Q@2XS4[DZ$;^>3PE/PH_0P,@BA=Z%B7"V1@&S6@P0J@AF J(G!^.QOJ M&%9%@C>T]8IL=3FU;E%'>^_Q*B'E5?2E]X+3ZQL-Z3 MON6OL)R5@$N8R.(,L544&*U/T33N]8"KYGN48S7VW-?,3DPZMA P/FM?Y"KN M(J\L P?L$9@8.0F8.L@^7K9- ,*7,*N5$EJ;>JM%L#2\I&FI:/ M&YN:TCMU/*0&QL>98Y6<06ZE26-DU1[J@!#RO -3[1)0L",>75:]&SKA"]=Q M\1*1_[HD7IQ2WK T*G' _U?$)YRSX#_S8IEY(,OB5!^SNMDY:85U]DLG^1*8 MKC*I>?U.5Q98/E;COZ*L*02MO3 N]W)A=$J-\Q[O[L$,K2.'5*M$W6'RE*18 M%]X-0SUP)+7'K[_1OO!,X\P9-=M;X[M\\X3)8L5O*;4N*;WWTM"G'>XJC%B@ MJJB7?0NSR:DW!I6-_/6ZPN MO?3Y)DH^#5V!T*O835(Y#+Z;>E(M#X9Z!B"%8^_U)(16LKLX='[P2(5;7G4\8H7TEBN/4#*8 M3G%4?;X$[JY7?SM$=T\+#Z@Q?WUPVPYO_L1S2Z7\U]XEDL@ 70S[TS9 M._&,8F&$.PO R\2PI@;ZTS2?LOMTRG25U7UWY?C? =/S)C1.?/&E_A3;FR#5 MQ_B#OSRN8IM<]-\^&^)R^A44MD\C>_6'@/36*TRGX7[(G9"B>KLB-GN'#%R; MU>W?P;!1 DI\:KP1@4$#/H.@\3\.V,(,CM-B"9$0"IN';>]?&Y%[[Y5GU_CD MD6"QYJ '*RSUF-[2>NM,Z\8*)O03MM/;&= MPMHW%2ARZ[%YR8XK%RF&J-,&=&.)CF0$4Y.O63-4M8=7&Z*DJZD%SQB,P2][TXH(L1"XEH9+QGF#V>N-5F0.XNF08 M%Z_JS7C/,JX@L\+<$G:,P7H*FY0$G]0CK.C3O%2M[\<7C\\63RKR[?2L=,U0 MR5_U4QI*[>6&:ST8/KAGAID#+I6@;:J; E:ZWFTA!IAZ)*=]M8E7QE2$H.J< M@ IC!CG8TSL)&LHQ2YC(!(%E#Q$-JLZRE_WJ#IO/HF2J;IFH-D;/1%$/\)Q) M"59%07 W#0[8*YID ^J4=A6/OYL([K;$X;;(3GX,[DJ [AY%RHZ)-N%'%PZ@ MN^Q9(0;=9F3)8$:*HYHSM D_O_OE^A'F)GRY,IXNDYG_CSPDF-8(-3-[O:<6 M971JRQ[0W#(1146.*<#J5=_1AG7NQ1AK0UNU&(U<6*F@H)YI[,3V.58YB<,L M)Y@O5^!*$Q9U;Q)";?0Q#G@RA]O$BX?7BTV575#6S" 97?6:4*EJA%J(US?% MVD5$I6F8LDI(N9S6K",#"5+:MCW@;6GT8L47#:_PD]*S#NM9SIU@9D;O?J%> M"4Q 8(I4?!FBDF4.$R@%#XMV)@FA3BDN/GX\?!+3R'&V**>1V[)8]/2*OBSG ME+^G_RD+/Y5)Y4T8>[$_T:1R=.$ .L^>%6+0B4:6#&8,.:HY0Y/*F_G=[.X2 MY*2R/7X^X(C%@?<>G8)H@AV]BMUGJX;!=Y^R4LM#B[@-L K3P2JZX:>8N0I[ M9Q:.NV[;=)=D>&"'6BWNBF0RT"J"M64ADTN"4TFL)$8Q$X>U#7V8+Y]D@#BE M4?_XH_U)A,SC;!G<>5E5Q8$+DJ]7*^QGB]7UB\^/F3Y0[["(697,XH#]%UMF MW'D1Z^&**AQ7A-7+X'L8U[D9/D(?3/"Z!^@^?XLBV#H(+@M!+!4;\LN3R-33 MTN![0/U>@J,)Q15C-*+.'<9T4,R/T83GJ/9 +;OEZB:ZN M+Q^N9X_7:'Z'^$QL=G=5_./ZKS_/?YG=7M\M'QVE>).;.*,#%"&O=/#@%UO, M6[6G:#DQW):WS&-&IQCCFU4%73J7EK7@&7I__>/\[HY-JQCYK1XD3+?;B-^4UI/S$.R_[E8E4LC7E1G>!I\G_PX95M-;'O,ZNCD ML3U&P6 (?TQKA/?46V6?H4[I?.&A73Y;JJB_@)I/@,LV=E"%786I'R5I3O 2 MOV3O*UH;OD&:,8V"U61A@\ [*;^4TF#(.0A1<;65[9Q4&N!\^F.XCL-5Z+-C MV8)]0Y[:5-GJ_'^409WIOY$F&#J.@BLD.,TW&X^\,I?7*@=)& N#INUS(JTW M!(9\X;":W?,69D9TSUWH=<#0T1"H>'*Y.,W#]5!;$9RK5%EH'MF.*@$",PWC MT1'JX/EJ'D6JJ0N%K_4%@$$W*9&TRS\EU"[/!#% ?%)A$WE32X+S9=GDW4'FMIFY5T%@N'L(>F%NS2\?/4"[?*2\@#K@&@WT M+-]_,S.C=_]-KP2&B*9(Q<1FA=X9XII\3:?6!>=DE5::^]9Q18!@J*$G':,/ MG[?F?K,JHLM=&(1E-S,:2P8\IDK8;BIV'>!N4G:9)!AB:>&)B=J?,M1(@_-[ M76.&7)Q2VAV1M(Y+(0J42D/NB$>#Z/XXEV'B79(R4GSW]MV[[S@E[GY9/#)$ MU,51,&EK,AZ:3#'&J]L@S;Y&,1:-U75.JST!2WQ66<(9:B^H@%EY9D-Q]CHP MYO6%K-X3D0+LW 3I2#AGCA:6<)N#"X$;RA[9HPO/211@DA80F<,T']Q&Z-M] M_V^D6=W' V5P3!P+&+QF,<6 H[4 M6A<\KH33HO60,];R&@:#W^=I&.,TI5"?PM@H58]>Q28[3<"WN:B3!\,\ Y!] MGE4JJ*T#SEE*##-WDJ;*CNEGZ!3--"%3TMP)\G2K:5@=*Y\!>LWE,7]*\3]R MZI^O=P;W+M3B=F\3ZD%WKP_*9<$P:P"@>$:P$D>%/#@GUS=H<-:MEG=)*OVL M6B4,EE;#9T][O()!II]3O%A=IUFX\3+EXSY](9NTD0-L8>I4[,XGA\%W9X]J>3!D,@ I;JV'=!*X9>?M*,,Z M!4RTLW5'&X=./ZDQ5'9=W:ANPC@]D_8KPMH.UY[&U;M<(_6=,^\ T.*N:KL4 M!.NJO2))D9G3,],%D&W*P V:*#IGY3YHA24SE@>MI06#AYTSJ.(3OH5IBMHP MU+7)PU'FM'EHI B&AV/0*M\ ?0#V_++R7)^95S17!W%"T\ WFNI">Q9T).Y3 M.IPYWVR]D# \"T+CD6V2>M%B=9O$Z]MPAX-B"=",K_L5937+S@'&=O+P[%$. M&%=[ /@^L9G2.=<"M5;\8Y($G\(HHCV5QL@4<$B'A )@]9,V#!BA;Y.]H\UJ M4]98&9KO'0N\S]%*:**Y>FO+Y K3OA0.>4MC+6LS,[U M4$L1!NWJU).&TQ2EN).$GR;3#84L&$H- %2D %W"20'Z^.P1_-Y+<7"9;+8X M3HL\<=LR>1P%3+TLG>>P!0#]$+M725:/#^QO:N=@P?ABP-!U?^S2(_SGO"C4 M+@L&JZ\]$H?QFKT4P4TV\X^#6E:O)YF9T+FOI%!5& M.;OO5I6#:$&(EP2#?3<)P>$ZOLP)P;'?S>H5!_Q_1L7Q5S->'E">U0G-H69W M)CG[%@:&Y8=:($R&BO)056 WZ5MQT0?'99,%]9E886 M4?D*0U4\8N4C]H')>T)UFCF@7UOE$=MH31>K8N]K#/?'E.. [>/-E/#;O!!H MC!Z-7,?ANC!4E(9X<<>[S#7(V7[JQS$\'=)UP$TSJF@0'XSNZ 1AX,Y0Q MZLAVU!QWQ^;8!R_+2\2^Y8*L),<:(JN MV_!"4%$*CS?^YA%2O()4E BDUTAK8,:@KOF"WOO71H3V=YXN_9-'@K)^?L$I MG4VR@.QEBWWZSV7"_K3(LS2C5H?QFO^&B1^FO J->IQC4.[/6]AN@.&C&[80 MP?$2$*I!.Z?>-IN:I7-)4:OX8I;3? "(PY$XWW;MM9TO.]1:U'J:YIOB;WL/ MV8=\Q/7P?7@%#0WE^W\!3H>=PBQM9-PY>%UUQQ]91\0!>GI%/Z>L&];?0JV/ M >F,U98TMUU5KSTANRF#90"[>8';$G#(*(.E/A'P*Q>#DOBJ@G4;QGA._ZG* M5R03=,(. :B4(;44/);TH6F8PD01ESTJ75+L?[5.=F\"'#*F?,/^P0CR38L@ M]$^_7<<9G;RP8U-DFY!ROD3!7;+C .3USMOT_8BQE@WJC#2!\P*6O;;09VH84P+' M,>97.="G,'NFKG6'28K1!I,U=;99<]4#!H][AU';)U ?Z&S.8W<'V*3N0E&+ M(_0=7F$:-DMS94FM#(;+8Q&KKB3YU;EA7!T5IG$OD%7YXGVJ#SA[3H)YO*,A M"[_L\BFF_>LYW#;CB**.1NC;?[UNA%GBPW8&RF"8.A:QXCF\#2^ .MRJA#.4 M5&6@;5T(#.;.HBCYY%$FT&YVE>1/V2J/Q 211>=5O08QL@R;#-[+O#:+1Q4 MALG[H!9R-%5EH%5"4![[212QZ($J(J_*"4J,*UOE<> 5;=/DU@I Y=::QWXQU'M1.1_C$_I91B?X3WG&]P^3 M2R^*JL-#<5!MS"OJZ: 2+>>C.=3T7LJ:?8L#XZ,.MT&8KB<9RRQ"55Y1P-(W ML!OJG5E[TCKS\:DZ\]&:OY^5:TR.G!EUT?DFY^\L\QL?G;OVQ57[VR1-[W"V M6"V]%^EX-:X(>*YO7P.$Q)0>G?'2AE_UIP^M:2X0OZB\G%%=65NIY@U&FB N MTHBF&-VD:=3 ^"USK-I$U;A2.T.XOE48L>N$,$C)#KM?)C%;(:(]I?@7A=AD M19QM6 BH6GLQ5[=)S[%&=:-',UTP1!T)6 PIN1-&6X]1-J"%G;$5Q*(0Y''= M$Z%J$5D4ZZE[$[97""C:2@T<1=Y.":=#81EL8;><%M(PMPKQRG5QB R^PJE/ MPJWDJ(:!O#M>2F"K*=@2!LHV$:&&6"E/8A$T*G!XU726LO^P%9S&S'L2^ECG M% WU;?-NE%E]'AHI@^+E&,0#/$5;)NQHBMM/A4#G<9K55[4TO(FK =9^PRR3 MS(M0PI,[$&C)'1I3_A9FS_/--N)&,$U77==,!P;C6GL> M[6Y!_QWA,FO^;)/0F/^?Q.7"F*7;*#RK;3,[XO>D:, MUPRPX>;9,>R2/ 5;%<^.%M3E.QHEE?#IU&N4EZ/RED?1C,W\="UIA%4ZGX3A MTGA$528X4IC8%;&:R%H"KI.DNO4[F,%/ DH>QFZ'TTI9JEO-RHY$S%87-'>G M.I#"F?OB=[1E[M692ZQ2E0TQ7"8'S05J,4K?RJ5SO8U) [A:@&^OE+3O=1BM M^ZJ5W2V]#QFD7G=7:<*;RXY ?=K+7EU3"\-"OTP!8U0]@HX[9BK@JPG94P S M[)N@E&[X;$M1%@_ R=/;-:?,BOEZI=XXT"FXHY<,N)I;;6F@Q)) U$:79T9+ MI/9XU<[1VN1:?< E^=/%ZIZZ:S_![_!+MOR$HQW^D,39LVI-[\ R;;+S M*.;+ L2]"@3#\6-8T>\&E(#?GR#G_XX]LOR4'*.BZJ+ ,KQG[-[$+LLY33YW MP8LT?O<6'HT-['9'NR$ZP9P^MY !7B]\Q'Y.V*KU4_\\4,\LF:#5/!1*H)V, M$X(4M(FM$J%D,D%_I++I&2*M,^$AE(-*ZBDZ3\H6#-Z^'U, C+46E6%FZRU] M;3##VVC(THEOO^-2%-@ZP>"-$LT95D-=4#>#5.=3C12=$V\? MM/I%^*!S&*/" $[)01)2)"4KU!RU0QD##\WQ)&+P6D ' M4A?2GTKVPC([Q-[I"V7Z /(7JLTR3@U[2AD,E8A-4ABR/$1/>1K&.$W;:6X< M9^VPDID2GK\9B_R0%G8XB[-Z[QI<*^^)W[2M6Y<2R]C,<5^VDB#B]%JYCWS_ M]CV!&(-?Y-QG6"L5P405'4.,PPFN=1IQ1!NJ.H-\)P,8P.0/A[Z4QU_,2N>Q M]BSAL3]R2F\\RBOHF&\V=K\ I_-,89:ZHW7Z%O?_Z^(QMQ/O9T5>WV8T+/S. M\MF+I?7T-QRNG]G;E73H\]:8_\A62]E[=SP\/G9K'1_?2?3NJ9KE*([AV.!. MWZ=,5"/B0USM1)^E T*?RM+.O:*XX@>^+X%6[!W*'2OR1/Q4.N"VRT=KL:HN MJ]]YTIA]F_G(($!YG$DJ>)1;.2J"T_$=4YBM=1!OZBS @H? 95G#Z9)#4-: 8K-P6UYMME+QB_(C)CK):;M5=PI^NH+V*=;V4GQ)L_WZ9 MI-E=DOT=9P_83]9Q^$^LFG9.^#VK#Z%,76V=AU.F^AB8SC2UA?W^^'/L%5D/ MV"."8/OFH;/UUGMVQ9Q\HE4!R7?<#RE'J*9C+@@)'[':]XJK?X^91S+M%MY$ M1O:[7RG^IGJ^ 2W:+RZ\Q^LPCND_T7LO8N_-?!Z]L3N;U;YR.\673JE':JIJ MND5:6)FMIK-M7&?\\;-8L"UMO$G("H?\G-/$NR/2+YU2%]14U3&[H.0SGTT7 M5-LVK@N6Y8#IA+H-6/YC;VU&V.[)*)QI4P6R7VE^JVV/+M%)! MI4X=PR&N=?9Y+.@-;3YKSZ=8.5,Q!@$HGW#\JCWJ:0KSS\.9K%FW>;13,%A+ M_*]QZA!G_7E/"8U,/VRD^LPGC@Y"5N.O@QJ>CENE$TT]P0Q+MB>D4XQ-,&>J M3\/U]33:<3[@C1>RG5B M^Z"GJ M K1+0;;B:?)JKR&QEOZYZC>8,A;6\7.ZJN$[[91^"TX(NROYL*K&*=%MS=8Q<1BKCAG)7$-T/ M_FX;9SA<<(,/EO.!52E[>JBSWJXX((]U;.?>"L @N6 M]KLV$SU?45GS!S-=!P<&J[>R2KE^V6*?.KY)CJD8?-#]P'[,BCO*AL+@UV!U MSRE-[/?+2@9%X8H_69@]XRI=+:#.>2R/59G[2Q+18J(P>[4ULJJ^?+)CJ[XJ M)QM=Y9^%U8&MV*KLR;M:^C/NP%?A+@QP'-CNOMWOGGSGE57CY%VW_='/N^-* M+%5VVZ"41:\AC@Y.QZ:XWK'8TMEX%L;K6TSM8#A#P@U5/6$^H&#MTH01\/I^ M@U;:.>6,(8KY<$H=%'$EEE&ZU +TZ#DW:$9)3WN(%UT72:\5O4XA:].O:N&V M?:%4T#F93- )DW$J8Y*-?,K13)?^[P&G&0F95^1BW,VJ$_7N51*\9S$/M*/? MQJPDMFW+YG2DUBY?33-Y]]1YTD\^J Y2P:P6A\H"D/K3S%S3YYS5A('BL Y! M/XKL,$C^OGQHFD:73V',Q^SF)8DY#?RR+2^QLRP)2155;^K;-3F2U.MN=SLJ'P712F];V M._4]->39JY[$8EU[E9.8Y[Q&'ITGX4K?40CS8Y($G\(HDK&D^@U>F"$@&Z[V M=:GBJ)Z+IQP_X.PY">;\E1[6Z(M/,2;I<[BEPX;/8MZU-&@W5H;74N.A"VL+ MO 245"IH6^M,M+[0@*I]OC6<< BK)5-C$<786T-8D_CZE6)D?K. M!X$#0 M.I2X%>64Q_,GF\O5FYLZ3IJ@C!6X*CK[WXH_7+]3'Q6O,%N:N<.J3 MD"_P:@:YYI9&%P:AA@GS], ^%2A9\<.$-!HS414VYQEK$CD>Q\ M0YRQ;=0R!E*ME@XH6&.+$?":+UII&(PQ@=CG3*'# IA"ZPQEC=[@>NE43<.] M:!IR['B;T'^E]TD4^J]+_)*]I^S\*+3/L,IO0>);:R3Z+?ZDMJ?RF,9XA4N- MC2+MW84F^K7014P9<>W_<-)NP8ZM,"R3RX1LDV+1?1'C#[C_#L"P-+#6,H J M-%2A@[($M;0054._?J"=C&J"::3EIV1$(]72\!NI#]6PD:B:XT;:?O1^PEZ4 M/<]C7]4TH@RP!E$"%)J!2J)"](R.1/Y7K/;=53Y;IZFF^+,UP7QO6]4*&F%@ MS3&,5&@7IH+JU8Y:R6WS%*?EBZ5P5:N(,L :0PE0:(,R;U4AZK3FCS7! M42 MPT!'3K2^FFI.GK!<&*NKD&"?ZJ1=ZG=,4DC:FXEKH38X"0OO=@+/+5K[/YNS2'*8#6MV?H16(.*R(0VY2)N M^PG]0^A[4;U9JJIGN1RP*M>"%&J_E$:U^.0=+-ELDI@?.;GW7MFVMJ:S*67M M=;P!N TY%(+ V*%'*="#BR,NCTH%IUWU"C]1\W)^6B^B@7-P[Q%V_.$J3/TH M2>D/ZB7>$;JP&FT\\'X[-B6<(5*4@;9%(2BH2T&_.E[_I3"SZY<,QP$[KX:E M&RD2&7"MI0 H:15V1+@014&.^8;)5-._*[S"A.#@+HDOO?1YL:+_DZ?!3C/- M5-!$RYHS-C>A19 M/B)4HQ;B:M#:2'DH1R,+OGT&#N3(6Z;:O4LM9F MTD-P:ZJH!&'Q9 !EGR2U.) 3*6QRT2S1*5M"%(+6"DJ$8@O0Z50C.WGOI'7] M?_(8WX4QSC!FQ_J6STF>>G&P? X)_],S2?+U\\+/$I:B-\8M&3:Y8#*:+GW< M#]CS U-43$/98Y8.C.L3F"9T$OH-Q#Z"+KX_HZ3^&I5%HK),='&&Z-^_F;K[ MW"9>;#"N2<7LW<=0@VQN88@RL&BE!BC]*?/UJ9X*HDG1:ZW<_W2HJN_X%5AWW80F9J7^Z=5NA]'?VHFL21<4;?SR% M;K/).G2%:*0^L,;9"[S0A)U2FC3$[3WF<5>-#ABU[I(,EV<6Q*7RKNU206LC MEQ9HBUX2*6@D4D,4J9+A^DB)\]7[%G+ULKU,"&P##"W4=^K?]0)]"[=N95$N M!K8)AM<2.XW@?@VQC5VY>"@3@ML$ \N%W08P7":EA3?T=',S:?\&#PZ3&RIC%8I:KZ) M^$<1_VHY:?\#3\A!OX/>?3SZ(''$YN MH]O/1R9SJ].&).@:IG"'0[4TJDBGY-[#>"W)1Y0'G^SCC3$D?=]_N[OQ+S/[ M+MEQF\I>W>OJ^K7[ \N#SXGQQAARHBH87?RA69Z?V!GN$G;5/DU9+:3SV&=_ M*?(AQ#A[P,_>TVVX"0NKDWOL?50DA^A6VN&E6G2)QZJ"5@\XM$AHG>!(]HC] M8)>@5LD\!<<9XG^NBT>\?%1^H/R5?:.=M\/Q]*M5&W_!FVVV"Z,(7U*3"-;3 M9%@-'A6,,4N;NVG71AT5^N8M><@C&]0Z$B9:!R;*V'M*0P&O>3VC)P"+'PIT MPEL9A5B1<]YMLEL)K" .K8-TRT5\RF:B';F5U!M>)^X(^2X=5Q8R]6 MK3O',HLU#3VH"[6138%K&CA9(;^X?9WRV]?R-G;5N&$27,>JY%F]W\$UD@2< MI"%8LBPJ-G4@^^1 M)X]XCS[QUFOJ_F;1]MF[CM?LL0MMW#Y*W1I_]S"J9NT(75A<'0]<> >-EX#* M(E!1!J*%(%X*:HJ9FI6/WG.R\2Z+\TF?:&AT>WNI)J%.VAKGAB'7%%.+PF+4 M(,X^@0H%U-) 5,7I9//1?\9!'M$P[SK-P@U;]?TYQ:L\N@UW.%VLBH=ZEOP M@O*XX#Z% &O*_2T0&KDLBH6]N"H,Y;PT%+'BV"\>+Q#]NBR.:[A-5M-83\=8 M'*[CRYP0'/NO2^+%:<1KK9T7E%9-8$R)?8N$2I #[='19544C?RR;)0UA9]U MTZPR0@7@Z+/(GC%I=I',_89>$2H5C%#K&CQA!2#2E#"R10\)(B9W:ZJDBZ_H W7ACS_%TT>O7\+/H3!&O[N/_QY_ MB*^6\4_TOQY_QU1H:'O&5?&+M]E&^(Q*7?S]#Q\NOK[Z'?W:EM8OVT1'=)1C M_S,A#,V*?I>/?3%&K]@CM 1V@WI#(3VG9WQ5."NOG:+ >W6SZ,];Z#F) DR, MG)Q4%" O=3BE#JY0@.+=J'41,FGU/Q2VRAM8&VW!W2A.:LR^'X, MRZJX8L6XN=#VF#_5CT0T ;0F!-7*VXM##6 W?-,( Z/7,%*!32V5]KG!B1<^ METGF1>S4#E_\+YQ3>H57H1]J)C F6M8X9&Y"S:1A%5A\,L;;9Q57+,[3M551 MJ3LYN]AR"PU/J%EBQM".@7)!>QS2 6UH(Y,"QA0-1($NVU28/&5,ZV/"A6J% 2TY%T10W_N6"8&EP="][S8++BRR M0'*O6V%!1](%$W17T.5B8-DP? 6]S8>O;?*A?\%<94$CYX0+RGOP,B&X/!BX M!]]FP3NGRQ7+G#R%,5Z2W/\X>*Y&)PRL+8:1"FU2J""N4YV3<7]-1FZ)9O34 MRY]",PV.J>J6'O_/T?.UYV]^*6[C%S_18] M1=9JOH.[K'$]+B$XXU)GJ)1S6LGJV@57K0/UZ:@:;T/O*8S"+,0ZPHI2@*I7 M T[P%(VH:_ZVH S4.,RJ-JEC1U7;/I-]_8\\S%YE-2Q* :IH#3CQPDPC^CM4 M"*-9EI'P*<_X98>0ZJ+QM"0*V6L^HY[U\FRR1OU]B$=0!PPAJKQO/Q^:B'NJ)%^ M)$F:WI-D%4I[;NMG0%4O0]6O92Z#"B%'=5MGF[U^83L_\@A"$ )4SVILZL2Z ME:CK.J?>,MG@6TH";:TW8A#K78).7?.%,/J2B?_>4?570T[) EG5]T0 5;L* MF;"T7KW>60HZJFLZVB==HFAJ72D,J/Z',4J>54T$_I=*[KI U6?9,^4LN488 MYQ1?V5&3.'V/66JN0F[IO;#M6%50BOG#)A&+#/87^$5)@0'953+7LM@:3[5^VK[ ME02ZH4<98-CTU0,!96%\)8X7AYQN]*E97C[&/:XGETJ@6U>%=6P?+O4A-1S) M<3"P@VBB![WY5'#-6Y"5@-QO2=ZQTY7I\SU)=F& @_>O+/'V/*[7V&9^%NZ* M+6S)%%0QKSJ@1$ -?R1#9#,W5BZJ"F:!V)>L;,J,WZ-F=;,I_TP^#7=$F3)0 M3)=)^8 9-81BRE[9(;.,'5>C?]UN%"K:B6V4%>J(:Z'F"* )N)/SVNF2BI9H$TCA:AO M%J[B>#*D<"8W8>S%_C']K&&)@%KW2(:,]+-U\6#]+ -/0T?V7RSFVWD1(W2Q MR-J?=$HW34;H Z+#7K"%;176\"Q:YO]HE7-6KE(CRW*8NSL^PUQ"OOX;3[9+9->1!H MT7[1KOCNB1*P3*[$EHNF(Z#P$4B.9S+;IB1@ZZLG3D#U&Y6=5&$3^T7=IS]/ M;VEDL34?6C\P6L)!W:1O)\KM5B^US6W#3W^>CMC(8FON^?/D=JO[TADGG62F MH<\/0D_LJ;L?^SQ]L\)&:]ZX_K[3H^V'7A5H=<)NA4YR]T+]-6@^=EHCK;G5 M89*V_W1+_T7_7/V)_C_V*?J7_P]02P,$% @ 14",3-,'$#WF+@ N2,# M !4 !N=F]S+3(P,3@P,C(X7W!R92YX;6SM7>MSW#AR_YZJ_ ^,4ZELJD[6 MP]Y;VW>7U.CE4T76Z"39F\L7%T5B1H@YY"P?(\W]]0'XF.$#3PXY:&IY'_9D M"0"[^]?= !J-QI__ZV7A62L41CCP__+F^.W1&POY3N!B?_Z7-U_O#R;W9U=7 M;ZPHMGW7]@(?_>6-'[SYK__\YW^RR/_^_"\'!]8E1I[[R3H/G(,K?Q;\R;JQ M%^B3]1GY*+3C(/R3]W?K"RGX/P1_36"=2&NP^2T$&;L6Z^3>^M M?SLYMTZ.CC\;0C9!&(_.C3 M2X3_\J;$ZO.[MT$X/SPAW0[_Y\OUO?.$%O8!]BE4#GI3]**CL/H=?_SX\3#] M:]&TT?+E,?2*;[P[+,C9C$S^B@7M2Y1$^%.4DG<=.':<:IKT,Q:W!?W70='L M@/[JX/CDX-WQVY?(?5,(/Y5@&'CH#LTL^O]$839?)5H28#]&15*3Z(_7%QYD=/5UZP;,6R8U.75(W M#>>VC_^1BH1(Y-2.,/GD;8@B\G$E:U(?H5.I)HN%':ZGLWL\]_&,*"&Q9\<) M$F+0_OPV\+"#D5S,6J-T2?\=\N@OB!7%ZX?0]B/;2;521K&L7Z>Z0^2YINPX!8<+RFOONW!"^IC H\ERPMSQ&Q/BR%4M"E2\K(Q+# <>I_ MTVDB=0=DL:T@0(6N75(Z<8A&1YCZ@.EL$D4**PQ!EVX]]&.$?DN(("Y65!IR M7\QNO_]9H]O9H\]91#[W/JAY;LUQ]H^)&A]MQNISQE24OK!7W[.G&HWRGGW- MI&KT\7OT/&,I*J:LXWZ]PCF*;>Q%-W9(-T,KZ6JE_8C[Y>N AE;D2S M?&F%Z3H:ON]UAZXFZHS1-^TED0K(:L.1WLA]K;E*5)1_KMXU:"^ZU(?HF?*24J1_G2[S M!?&OE!"Z&"+$X'BMNI[J[ O[XSLC*-I2%$V3.#UV)TM ZJU?4.C@2,/J^OK> M_F1R:>,P/2+?D/N94HKHF1[R*W&(A2W4G& _DU'>DH M^]^Q=6 5OO%)'2L("1NC2!6C&F'3D4;FCDU M>8O#9;K,/'">L+=1I%D8+'1%F8LMD#!2EBXA8>\0G!%&0MN[(G;S\M]H+<*@ MT501A&-X*'"X-@%#P<<#&98M_6H+1:&?0!(ZBT>3LKY%(0X(!R[-9!0+O=94 M4?KO($J?R;4)&":$&I=2=.G9<[;X:TT4Q?X>DMB97)H0=W9:$E_BR+&]OR,[ M%"H^O[4B"#]# D'&N[F)-TT$/R.DS(-0..W6&BJB\$=(* @X-KCR(?O P$]W MP?=/A//R[E^X#!+V4X3G%WCPJ,C#!%H/H4U)N%\O'@./#4RMB2(&'R!AP.32 MY!HI#=08:?SYD M!HIZCB*QKY=4PD8GUH&UN7] ?CX+R%?\"+GTIRCPL$N'M/*1K'RH775L9D>/ M*5Y)=#"W[255M%\.D1='Q6^HQOU2TKC\U]\WM$YGE]@G-&%B$$$6=A0$F_+N M:KUW-J'V[&5Q4SDC]7:F(D]:3[AW:KFCDJW554!K-C06DQ!)FP0$E[AE ^64F=CX;46J&E( P9\BD"U@Z3[6%L;=R<1/J%]AL@? MW>N,:RZ%*7EQ$-M>VM*PU66YFK>>G6T=BX1-XB9$YB;J92Q"I[-(5&$![\B,C-_#6.!.!QH9PS!@^1P$[C/V6 '3O,FVA;% G8[8ZPS! M$'/UGB]O0C$9?-/?FKZ6R>,:VX_82_.JB0UM,[M# M7$A73C LKT2UO>UR%03. M#DBP.0>#3I@0-]_@30@0KXLJ1KWM:=M@).8?!DQ7?HR(+&-5(^*U5P6HMQVN M-D!BSF&@O>TMM:U5P#,,4$J77&1)C(V6JG#TMJ]L-;NRN(6!Q<1U MT^,IV[NUL7OEG]E+'-N"$VMN!^6T1##(2'@' I#C)(LD#>*E^5V5=QV(9P\6 MZ>L.-RB>SA[L%^$1@=Y JH#VMI_4![2=K& ?4PM'K"7+0!/0E!ML8T(^@X1J.M*;Z?SAK:+NZ Q=-\BB\8HQ98Y/57U M"6JH254VG>H @.O*[,*ZE;O+[]K<7;9^JHS\'^-=YOV$FHC4IV%*LYON^F]1 MF!;T4(T^\?L/]^ZSGH1@K".J-&D.X.1)Q*X M\%U%4:(+7='']'7ICF&KB@(N9.*J4 (&VY2%ZG%[W2EX/9>&ZB2^KS\-*G4V M?;EZ!R0UA ,.3?7I3]C)]"7K;M"#/?$U")7->MP.IN]?=XD6Q/E.LP0BCS48 M!1![P$QMFC.SA6_Q^GIE2_]>;4N__8P5S*SMA])J]Y5/6?1;UD]??3MQ,>EJ M&1I-G$7 MV$^??Z'O'4E!D78TO3_214E1$C!@:S"GX=7,;X-TH>%R^VHFJ6T2G@*0Y<:F MJU*UG)B:_ X=RIO #ZK<%04(I>L.A:[&2S3IX:PL#!C>],I?H2B]Z)41*T]S MXO=01:JW39>Z[.O%*\1"@ )51I5T?=)H:+P*5GM@F"SK.\R/F*=D-"J-]W [&ZXJUT0TN MXS!F_2PT*=X>E=L8+QVFAT&3O:&;TPV*MTYGMQL%+88R7I-,<[?45E@PC+-" MOB*. &J3[8#1:[%2QCW0X@ZH/&JAU-EX@2S=(TAE@<"P/;V)\?L)@&I8.C+F M39.4$4@PB&Y57Y*%-9[[6>T\9_T0VGY$>*3B]MWT7UXF?/?_DBS^(K^SWM?W MC)?E:J\<_4( 0\T$TFGEI]4![RUHTAYP!6&TGI]7*'P,(F1^AOZ5Z.U3C-P) MHHYMD\8C"Z2S- "PE )[:$7:(+I]C+XE%V:QMQU/5$R";VMW$!L/8B^H. M1?:[,L;2CL;+KNF!J2@(D,FO]$W&2R]XYN2Y_MPFSY6.::6# DEH+64U;_C5 MNKC*Z&5V/TL)(JO-%2;8GZZ_$D"N_,W9]82L'%99/61&)%7AN+>C\>%<>.6B MWMQ$=RA9&&ZZK]!D;Z=4W6*@$<@T6LVM6-A'M/2_$_@.3I]X1'@)%L2@\ M -W+UTQG%/>J.'T"!$,%SQ$!S,&I-/BJ4VUE^F)NKZ@T'BYLB <&<.F:\]$F M?-$=)UF=Y>(/;7^>SG^GZVV36WN=KFB?[="=+E/-_X:BF,J$+%]QX%[:.$PO MM1X+5D:]?=%T&OL>%:IOV(:??D-D'B+"_3G*_K\DY;SBI]+5-.4Q3*?M[U'Y M]$4+P]IN\%M,!&!BY?2*_12^3OJY_G[##?6==1$K7Q3-]9 MZ$%M= 3Y&A6I]N9D&\>B^\A/G]D$?7D5_I,_ SW48+):>]E24QD:O17UH;=R M^/WH T=(KU$E:F]IDF6:CDJP>D.X0].U3O"E!&-!N5O0J*\8.H1;.GU&T[J1 M^M"SVSA2R.XY]7>.HSV^\8M)W9WDM)0M#%^5!X&BAV#B_);@$!'N",GQ^M:S M_9@LRVFEY25M(CCIT1C#_(6E;D$,6DOBM6QQ"IXO@Y!PZR#DIA=NK@/;5PJ@ MJ/8W?OUH+YJC)L57H#4E)N_0,N=^.DNC .)'B16Z&K^.U*^NJ,H.QA2SFRSZ M6HH N"_5JY)T(_57NAS.ZU#VMAS6'M_XY:WNEL,M90O#5Y7=Z1U*7Q>[M]($EJ>'KPF[B MZVLN 7#ML%>]ZD;J0U_/7,QFR"%S],6+\T1S>NZ(24Q]*AA:9YK\'PTPK&R/ MVA]?T_1&,7YYLL7:I(V<8*Q V#1F"5GUHQ ^PGJC&+\!V0+A-G(:NO6S>9X0 MQQB&:^+O9 ^HJW4W?CVR,VW@2*:U&BQ3[2+DA?'O0QET[L[OXWV=3M6!>9^^ MC4)<^ !6I??)^V#N(D_#N>WC?]AY MK0MZ=3J:SFY+W]F07+F8_$?KP#K'D>,%41(B\H_R0.GS.NE0]#IR93"#)5A* M!&XO3V=LETDLO;RTO5:M\#9$-\.;K%&S"P=;77@@>GA*R/S1DZR87S)\U;E3 MW:K7K>D)%C NZ#Y9+.QP/9W=X[F/9]BAZ1]9:G/ZS+V'G7(J:\4-_5)W0_E@ MU.^4AK.VXUF; 0W>-FYPIW!G6-#'Y%):A)F"*U#M;]C Y8C5%]%:<@%CB^53 MJ5(5+([U?:A;7][=2OM;E0%,GD>Q>9+;G+RGT6,V-G%:,['6((9M4!7'QB&; MMIS F&.:I;1-:>.8XC)+-,?=W+PK MD:EE;2V',VYW7 1KIK:3N, 879&'S$Q!+AO>\5'=\(JNZ09XV]EHZB@[IUIN MBPI=S>;$LJG3,DB]40S;H3*6S118;5&!,49F6DS%"(_K1IAVL8H^)@OZ/)9$ M+#]0R*V\&P[8BQ:)0:$G(-QC8(G61 0F)46N/R0B7')W4[V7;_ M0V7C9C8V8M1J_%404<(^')V.YC M0M53X!%11N=HAAW,6>2]:X082SW_W2KZ&LQS(_,Y6:U*+:7>SF34L"3"C"PZ M:6O--!I#&+8G-C[U>*&N1, 8TEFP6."L:A9-(TD32N?(Y\;LC]_7#:HT0KIQ MJHYAM)H^CS.=&4IS&+//!\@I5;!-W7$,&V@KG)N/#;00'1@C3J]@1S@[1ZP5 MEJH8[\]UXRWUI(=N>5]S.GR:1-A'440 ><2^ZMTT<2^#)LD@3,L45?L;-D$5 MU&H6IR<9,)9VGSQ&Z+>$#'JQJF345\RLD5ZS[6;E_4RF3U994,F7Y/4PF@5: M)4IET(4O$^JGXR>0#&J\H8>1KA*:S MBRC&"X*SX-Y5O=W0$D#8?,)(RZVDD:7\K)56]:)>II^MT 9(10B[PL6))[(? M;=UZ*#DD=!CM44P_$*$.42OV0%D8^\:=LJFI=3?^_(.VS>F(!0:2E4R&9AWO MC'8^DHK=C;^[H(NDEEA@(,D]!U047AQ=+&87HU+B2S MRC*(;&\ZNP[\^35>(3<+9"FK1KO13#]UH*TFNP@-AA?X' 3N,_8\HN-D36'[ M93]<8PO2C!-H :XO'I"/@+*]+(>ES1%04J]@Q[:G2T?0[ GJ+ M:'51P+#.S3-*I=M,5S[A+UEL5XI\RU3L;KKVO[95:HD%!I)W:(7\!-%GE.8^ MU@HT*'0U7JI?&T)E><" ;W-U67T%Q.UAO):^_C)'PCT,C(K'KJLOV&7/TZ7S MMT-$0Y9E=$TO=9VM!C->F5[_7EY[F<$ O?[8N;)]2CL:+S>O#::B+& =QF$ M",_]LX2LD'VG>H/-=]-_>MG!MS*D.PQIO$*\_AIH5_GU%,QG5=C1#>5KCF&\ M9+O>)J25A& 8[0UZ+O$:!C[YT4&E1;>RK>J/9+SFNK:)MI46F&0#>369=!XC<)*F1%YDX+E&I6>+1TXJHR'36 M-&N=H0:3M=2>16#V6*\X(+"\D\;]_4;A# @&9JB"AM2DF))6-R-9=_A5+_3X M 68GK"H7(EMI7+-GU[J 8#"_OZ(7N^2NP#&YS@M.VE'ZQXR1,G[#)TH\>4+AHAY[J M2*83W%M"JB/-NAF_/X#47$WNEB[66)'/+C M0T!_-4WB*"8;"OI(&?T;"AT<;19)*OIDF"[3LX2:,H( #X@B,PRSS'+9,&D* M7B:J*$H6V>]V<72[?,?T9:[67F]WX8)9I,B/"\]1;&,ONK%#^KCBBEW"\*11 M$4?UX# ?WMJ,/YXA GY@8T/.@_@YW'H[F:DWK&(XAX($]_H')_7Y([^=7W:S2W MO0L_II/+"V8)G+1J-!J"I%ETEY:#>Y-P]OWS8&%CGRW>:@O#LF6)K2'8*L7; M#5^7)U\/2?A(C.,A3)P?%_Z<%A^Z\ITO:/&(0H8<:1]Q%V-[A8; FN=:*LSV ME%#)_O341RU$7>IE;,'<6MH-EOLJ1_'7:Z%H2W\W5G% 08@--F!L,!_(!Z:S MTN::,ZWE[3G-AS#!B3DHV9=!-$IDT;3QF\"WM[\IYY1S+:)(K=$=" :"0FVL M :G-8C_S;AHZ*+(")_,0I=\7>BQQ%^-E4]KI8"7M1$$F7;H_O;4EO3X7+H,P MCVP3GW%&T]#"]8V]8.U[-\Y=TM%TC3WN=K"Q$E62 !" S@EUTUGE5\H8,?N: MCH&WQ4D@"!A+B31<>A5%"7+/DY!F=:9OJJ?.(+I#41QB&HU/FZ7QU<]A$ EC M%NW&,QU[E@.\(X.]+K<)#?22J3TGRD;+1N>'?QF9M*32]AB%,[UIC6!ZMI.# MIC4=&XY'1>&0T'AG!.S+:H?QJB#8K M>G&XK=ER0 @TB>_R/&F7G/"9G7@QPZ@II;+(FEIO&##Q%*WQHJ *2_V$S[*E MUX7O"B-FC5:F-_$Z.E3;2+#8[6DO-UFAD.Q9LH\*!_'>9]-SH5>I?1W8PY;*):F[VBP!,-CU#;SY1W\';%'F^[- MJ5D>\]V)QA#@3S+T60(6R5&KRZ&6G\MXC4N]0@>H'%T0Q3K&T$B;PI5CO..U MQSO&%-DQ17;8*;(W9#+^*[*]^,E'\7^CQ3)>8<]#9X3V$,F2954[0TZ;U1- M7T&)Y0\[(T(FWI\\^H?<)+[<9!?P5B<800]FQ:4L% M!I@3SPN>;=]!9,=Y'B2/\2SQFL^*9?M0T5Y%;QC306YE5%N)!P:RQ;-!?-"V M+0:36%9G"H:HBR=^LD*-] %-F;WP>\!/&Y.RT(!FJ"_5^4X69;.]/#4NS5^< MQ'&('Y,XO2,?G-F>5]0/\=U?TXSR6+ 9WVE0T^=6RLK1@>A@F#9Q]LDB\6B, M,RTT20MWA.@)^1%9JV7/U5P'472#XNGLP7X11O/T!C+]E*7Z'-E.1!W[!\C1 M[@.U"K_";,5?=HB%5S,6-R18&0U62@3]2T8&B S%,6!N.K@U!LS'@'GG*'!+ MQIZNZ0U)<=J(4NQF>Y,PS<-/13N1ARBH\E*,]#4F 2<.\0VE [M8F=)=+FZ@E7C9>5,R'L]+QK/* P!(M>7RKO. D MZVGTA.DQ/@O\%0JC[$XG^8D0>^43VI*TG-""1FD$2=+J(QA_ $H-P<9QE)Z$ M8#A9*=79N4EVI7\7=&OCF-ZQ]04R4UP0H3Y'D1/B):?H#Y/=2A?3^[Y. &0( M 0Y66Z7*]0S33(\-[;!BJ]#CI M> H*Y'0-\"EHD4&:/BIY'=AI_E->#,"?;Y7L=+W]67X\NMNH T)V-T9A'*A6 M*9.=H+);PX"L"V6N .HYC?H?/VL7KSJ1'P]';*RJ)LL0^Q-?50C*Z.5_/3% M7C\\$P&M'\C0Y5;W:$5^W0;Y[CYI?MO?7BVZ%GQ?M_C<%;WP\1"<;B MMA+?+K-0<17EU.KE?*4 MWQW70PO%4.GS/9O!@.4H<_/)Y7$$A:YFZ^"$R,&\IPPW>6/E5H;=I3(6S>HW M#59?10B098RE,*# 5MDF>J)HHM40H,2.1^L=8X(=&?(8(30=1P(<(1S+5>CR M R.L-Y:K&,M5C.4JQG(58[F*L5P%/*#&J)XL@C/,GK+FL"9,P.OJ"Z<5BFS*\G0A5/YKY M,8L@^FA.B3!?OYO+X@UJ$Z1+>YE>P.[N#TK,MPY8QT%L>R#"U>D)]ZV]IG&+ M4IBZ_&MA>/I=/3R=]K3RKK6H=/5O$(+1] [^EGQY!)K7'D*DU*7709F-3?OR5B#L? ,46L#D.O#G M#RA'FL _14K_8,=''>'TNO,DNZF-ZMFJ)$8MQ,->9 M.9&7RX3F3N:48_KJMW*2RL\ZX9?L.];V0V/F2L_A4DK:5MQW:)EYCHC>EL6^ M@Y>V=^7?$%UZ>$;>"GT)_/A)L$W=<5C#DZQ6:*<3"<+PS%JL_!W9(5EQ=Z0# MF]%,S[C]85\3&#S(U: T/^&VAN@5'8T0=LB ]")#]?T;M9HC?ZQ/QMOA_E!Y M)Q$C:(\COH(Y=SSW&,\]QG./\=QC//?X?9U[7)*I_'K9Q-SL6%++9_-^9 A&)I.H\&2T \ M1HBR^ZC$_"1>H]$2ANJJ>8X&\:7#2*-+E9F=>'%>$-SV-LQ$E%)9:0.UWC!@ MXBE:8P&CPA*("DAWMC^7V$RI"0P4E(RE1'6I6HEI2@VQ Z2X*HX MA"*DOX" 5$LL<-#<4GB.(B?$2]GS(=PNBFA] (&6D&T8Z.2;5[4\)V9C140^ M&D=$P&K'$Z*9G*?[.'!^T,KA1.7.T0P[6/&)I5_JZ4[ED?[=RL<"ENA$BQW& M:WF"4[T=A+2:028VL04^)C0!"[CWGM!4'&^["%, WM,?J-S?E^1.?O7]&LUM M[\*/J=*P#S9(JT:C(4B:17>7V4JJ$LZ^STT5($VJ+0S+EB6VAF"K%/>3$7#Q M0E8"=/ZZQ+&/HN@:V72F$V8)2/H8B[0U1-:,KRFQ"V,U2BL9T[PIR:M+E59# M\!A,PKO,.=I=Y-(GDVKM8(B=I3 *C( P8<\;O*'7& M<(+9F#JS+TE_L5_P(EG(9%UK9GH*8.A'3=),OF"XD'KI,D?@I"_(]M?)_U1)&XWU"2(]7XAXC5K1U.PRR9[YOM)>@6 MA2GYJICQ^P\FR5%/(!!!+&'/MS/90J'>&G M.ZIR @FOLV"Q"'S-Z4O8:3"9C@JL@\-(?]I2ZFQZ;]D&LV%,6 TED\U6W Z# M24Z4L P4%Z5)2MS+=!"X/4)@IZ>4QDQ_RI5;G;-%7#Z#-I&$=7ONQ]D*Z_ MHZH1Y@-._4AXX-J371;93D29:3P\V3Z3ZU]1>H3K3H@CM.$&A@R/$$T#Q]W0)MH-.=TR'JN*:CTN: M00BR=NIJD3K: (*80HYAH'*Q6'K!&J%[%*Z(RK!)OJ%+_(AJ&57%Z(&^DU#^ M^UD0Q3=!_'<4WR$GF/OBP]4>/ZFJ&^:#HKW+'MXI,@7IX:XN7P';<1 MI0.ZFT2<-M[#IPRG(ZK=3>]+PJVCJUA>W;H2M$_56(/V%K*'Y%7'E2EGV61&BY4),)YXO>]E[!Z6!G!4 M^%$NLD=MN[]#M#0$^?U9X*>@);9'ZSJ?2-1YW\08SQU65VTS./54VVW_'#$4 MCU)B@A#C&=!BI3,E%G!+U!WXYT\F//X%=R&,$&,\ZWLOGG$'G I:C=+]RO" M)_8C[/25U"O_I/$DW7UOE]@R_YV$G0:DFAI;^?X2<FZ$K)5 M*$+?R\>&I =]\-_ELTM&]*C)F*P2=B\? Z)'_=EC=\K(%V)OKU75OC?U^:\P MY \^\7N83I+OT59JCU[)I-;3N4/SRP_/@29>I1ZFD]&-X=60VO[P(NUU+:S2 MQW3JN#G,FI+;&VJ701)J@E;N8CJ3VQAF3;GM#S*\TK6S,73<1*/8P7*#8%6$-J^\,+K23OP$CZF,[9-H=94W)[0RU]T483M4H?T]G) MQE!C2&YOJ-U@[8U9N8OI/%YCF#7E!CGQH:5 LGM+TUGI&",_YMA3J$=$P%!> MD]HS(H#4L'&BV9+I)K.B3.13-,<^S5 ZMNG0V(SW91%@/%QDU/WR(0&DAUU9:)-9D87NR]UJ4V4\6&;$O;8$;R"%Y#8U M63?)/^GE3^2>KK]&9):@?\L CJ)DD;40I?Z\/VJ3^D.IL%(RRHE .276X]I* M:;$VQ%@E:L8TH#$-:$P#@IK^ 3<-2"%Y9Y@I-^ 295*"N"&R,M6J0;']2%N6 M3E(A><)$L9+*N-3.=;,#0CYJDF7S!V"A\L5^41%YM9GKSIR!R M%E\P1-[Z)LIFL5M:/M[AZ,=EB&C:/R(@Q'?$P^I&!SK]]+"CLCV@ $CIVMPP M8;%[\;)$#MG:]'4_5^&; X^5=BEX0 K6E3T5?'X+/#*,1[9*>_1KO(^;7F>8 M<6UB*%ZQ[IWC%7:1[QK0O.JG32^VS.H="P8PP4GZXCB.TYIT$]^E%1$P8=5W M,"JBC#?T)F",5UO:*^'&XWJXL31B>F&P,N8F5FAMAC49-11QO^%)'E34'*;+ M=)CI$E$Q^O-K1'22ZAP.4_4X9QL][23I8WC]VPJ3YZ97D3HB)60/F+4O/OD]GQ-6C6-%+GM2]9&DD>N*2C07,.YXF M$9DOHXC@^XC]5(R1W!F*>T&(^@_RO$4%C/'T!=A) .#3EP?R >+#MDM;\4D, MI_F L.!P ..$IEP;FLR"-X%O;W_S0'Z*B)E3DY>%N;4'@H&@4!MK0&JSV,\% MX73*ODU"YXFN7.8A2K\O3$07=S&]C&NI@^6EMXI,NEQY1\AY.P]6AR["U-;> MTQ\H5.]+)D9^1=;9<[*H).O2>,UQWB2['E>(,YCMQ)7JVKNZU0^!A$"$#=03;_:52X M.W61#6=Z$;&KNJB)"X:'8&S)M^]97[E$"'B&Z:2=17?2D ]1:[*VNB:_IB=1 M&$7I@0%R;\-@B<)X37.@8UKHC[1=4CEJ!5KZ^/Q@#@WW"@<,#?P$$*4@PP5RT 8P\10=N_PP\0U7:)Q.DF]35Z'(>'!XP%&L)A!GK1Z);\+ M$%S$>B8'J*,P32\(R8+VG.;&]W(R/1.C C&HQ6]OVK?Q=:=RGB5CN*_-9&AF*(NHI9?(6=S%=J$%-X"ILCZ>U>SJM?3>>UL(_K3TE\[,; MI7?DL@"S[9T%X3+(\HN%#D.MJ[$"D@IGMSK,PUCMGR4AX=F1K.>KK8;@1IB$ ME^:4SOR(DW\A$WGQK[JXB]]_GWA>3A--_>9YEZ(YLS4,\;,4IQ"^D/Q^W,[9 MY%SH6TI_-U;-5"B6IC-IL 3#8XQ9L15G\O.8%3MFQ6JYJC3=)RLVII83*^J@ M&B2 G!(K%TA/F]IK%,>J('#:JLJ_M\!!!_(7B@'(I$//_*>S*]^E-X43VY-, M.NSF,%R6VJ3#YJ#T#@4D-'[%\5,:4*&*]H27#X%D^\SC4C80# 2%VB@#4L9B M/Y/.%SO\<9<\8C^8S81^CM70^"334N'*3HXO !@>+BL6^07%3X%[Y:]0E-X6 MGC[[**0,WJ+0H2*?"U)M-(882L:TME1>09(T(OM$Y)ZCQSC;)8HRPQAM31\; MJ:G">ZI:'E M@P*"8CF2/L8?0U02 MN1+C6E56\K_0_]"Z?^0W_P]02P$"% ,4 " !%0(Q,M.+;C92/ #LGP4 M$0 @ $ ;G9OH%0/ #O@ %0 M @ %ZG@ ;G9O&UL4$L! A0#% @ 14", M3+=$LGA.'0 :^H! !4 ( ! :X &YV;W,M,C Q.# R,CA? M9&5F+GAM;%!+ 0(4 Q0 ( $5 C$R3)S.RU40 "OC P 5 M " 8++ !N=F]S+3(P,3@P,C(X7VQA8BYX;6Q02P$"% ,4 " !%0(Q, MTP<0/>8N "Y(P, %0 @ &*$ $ ;G9O&UL4$L%!@ & 8 B@$ *,_ 0 $! end